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Various emerging nanotechnologies possess unprecedented advantages in 
biomedical applications. Among them, transition metal chalcogenide nanomaterials 
represent a novel type of material with versatile physicochemical properties that have 
enabled new horizons for applications in both cancer diagnosis and therapy. Studies 
have demonstrated that transition metal chalcogenide nanomaterials may be used in 
diverse aspects, including i) bioimaging for organ visualization or cancer detection 
due to their high propensity towards tumour markers; ii) molecular imaging for 
guided tumour therapies; and iii) drug and gene loading, for photothermal and 
photodynamic cancer therapies. In this doctoral thesis, the construction of three 
transition metal chalcogenide based molecular probes for biomedical applications are 
presented. 
Firstly, we synthesized a seeded watermelon-like mesoporous nanostructure 
(mSiO2@CdTe@SiO2, mSQS), composed of a novel dendritic mesoporous silica 
core, fluorescent CdTe quantum dots (QDs), and a protective solid silica shell, by 
loading the QDs into dendritic mesoporous silica nanoparticles through electrostatic 
interaction, and then coating them with a solid silica shell by the modified Stöber 
method. The shell thickness of mSQS can be tuned from 0 to 32 nm as desired by 
controlling the reaction parameters, including the amount of silica precursor, 
tetraethyl orthosilicate, that is introduced, the solvent ratio (H2O: ethanol), and the 
amount of catalyst (NH3⋅H2O). These fluorescent mSiO2@QDs@SiO2 nanoparticles 
possess excellent stability and thickness-dependent cytotoxicity, and have been 
successfully applied in bioimaging.  
Secondly, we report ultra-small polyethylene glycol treated (PEGylated) Cu2-
xSe nanoparticles with strong near-infrared absorption prepared by an ambient 
aqueous method. The resultant water-soluble and biocompatible nanoparticles are 
demonstrated to be a novel nanotheranostic agent for effective deep-tissue 
photoacoustic imaging, computed tomography imaging, single-photon emission 
computed tomography imaging, and photothermal therapy of cancer.  
Finally, on the basis of the Cu2-xSe probe, we developed a facile and chelator-
free doping method for constructing Fe-doped Cu2-xSe nanoparticles. The position 
and intensity of the near-infrared-localized surface plasmon resonance in the hybrid 
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nanostructure can be tuned by altering the feeding amount of Fe
3+
 ion precursors. 
Owing to their tunable near-infrared absorption and Fe doping, the hybrid 
nanostructures are demonstrated be a novel nanotheranostic agent for effective deep-
tissue photoacoustic imaging, magnetic resonance imaging, and photothermal 
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histogram of size distribution of Cu2-xSe-PEG-SH NPs, (c) EDS spectrum of Cu2-xSe-
PEG-SH NPs, with the inset showing the composition and atomic ratio of Cu, Se, 
and S, (d) XPS survey spectrum of Cu2-xSe-PEG-SH NPs, high resolution XPS 
spectra of (e) Se and (f) S, respectively. 
Figure 5.4 (a) Colloidal stability of Cu2-xSe-PEG-SH NPs and MSA-Cu2-xSe NPs 
dissolved in different media at 6 h after high speed centrifugation (10 krpm, 10 min), 
(b) zeta potentials of Cu2-xSe-PEG-SH NPs and MSA-Cu2-xSe NPs, (c) DLS 
measured sizes of MSA-Cu2-xSe and Cu2-xSe-PEG-SH in different solutions, 
including H2O, NaCl, PBS, DMEM, and FBS media. (d) linear fitting plots of 
ultraviolet-visible (UV-Vis)-NIR absorbance versus Cu concentration in aqueous 
                                                                                                                               List of Figures  
xv 
 
solutions at 808 nm. The inset shows a photograph of the Cu2-xSe-PEG-SH 
nanoparticle aqueous solutions with different Cu concentrations, labelled in units of 
µg/mL. (e) FTIR spectra of the MSA, HS-PEG-SH, and Cu2-xSe-PEG-SH NPs, and 
(f) TGA curves of MSA, MSA-Cu2-xSe NPs, HS-PEG-SH, and Cu2-xSe-PEG-SH NPs. 
Figure 5.5 Hydrodynamic size of PEGylated Cu2−xSe nanoparticles dispersed in 10% 
fetal bovine serum (FBS).  
Figure 5.6 (a) The stability of PEGylated Cu2−xSe nanoparticles after dialysis in FBS 
for different periods of time as indicated by the Cu contents measured with ICP-OES 
method The negligible change of Cu-percentage suggests their excellent stability. (b) 
UV-Vis-NIR absorbance spectra of PEGylated Cu2−xSe nanoparticles in FBS before 
and after dialysis. The well retention of strong NIR absorbance further confirmed the 
stability of PEGylated Cu2−xSe nanoparticles.  
Figure 5.7 (a, b) Photothermal heating curves and corresponding infrared thermal 
images of pure water and aqueous dispersions of Cu2-xSe-PEG-SH NPs at different 
Cu concentrations under continuous irradiation by a 808 nm laser with a power 
density of 0.75 W/cm
2
 for 10 min, (c) in vitro relative cell viabilities of 4T1 cells 
after being incubated with various concentrations of Cu2-xSe-PEG-SH NPs for 24 h, 
(d) fluorescence images of 4T1 cells stained with live/dead kit after in vitro 
photothermal ablation under NIR laser irradiation with and without the addition of 
Cu2-xSe-PEG-SH NPs solutions with different Cu concentrations. 
Figure 5.8 (a) The temperature profile of Cu2-xSe-PEG-SH NPs solution irradiated 
with a 808-nm laser, followed by natural cooling after the laser was turned off, (b) 
determination of the system time constant using linear regression of the cooling 
profile shown in (a). 
Figure 5.9 Temperature changes of MSA-Cu2-xSe (lower panel) and Cu2-xSe-PEG-SH 
NPs (upper panel) over five cycles of irradiation/cooling (0.75 W/cm
2
, 10 min). 
Insets: corresponding optical images of samples at 1 h after five cycles of 
photothermal stability testing. 
Figure 5.10 (a) In vitro PA images of Cu2-xSe NPs in different concentrations 
(concentration unit: µg/mL of Cu), (b) in vitro PA signals of Cu2-xSe-PEG-SH NPs 
as a function of Cu concentration, (c) in vitro CT images of Cu2-xSe-PEG-SH NPs in 
comparison with commercially used iopromide in different concentrations 
(concentration unit: mg/mL), (d) in vitro CT signals of Cu2-xSe-PEG-SH NPs and 
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iopromide as functions of their corresponding concentrations, (e) in vivo PA intensity 
of tumor determined at different time points after intravenous injection of Cu2-xSe-
PEG-SH NPs, (f) tumor uptake of nanoparticles at different time points after 
intravenous injection of Cu2-xSe-PEG-
99m
Tc NPs, (g) photograph of 4T1-tumor-
bearing mouse (tumor indicated by red circle) taken at 12 h post intravenous 
injection of Cu2-xSe-PEG-
99m
Tc, and (h) distribution of Cu2-xSe-PEG-
99m
Tc 
determined by counting gamma rays in the tissues and organs of a mouse sacrificed 
at 24 h post-injection.  
Figure 5.11 In vivo CT images of a mouse taken before injection (Pre), and 2 h, 4 h, 
6 h, 8 h, 10 h, 12 h, and 24 h post intravenous injection of Cu2-xSe-PEG-SH NPs (2.5 
mg/mL, 200 µL). The tumor is indicated by the circles. 
Figure 5.12 (a) In vivo PA images of tumor (highlighted by red circles) from a 4T1 
tumor-bearing mouse collected before and after tail vein injection of Cu2-xSe-PEG-
SH NPs solution (500 µg/mL, 200 µL) at different time points, (b) 3D in vivo CT 
images of a mouse bearing a tumor (indicated by the red circles) before (left) and 
after (right) intratumoral injection of Cu2-xSe-PEG-SH NPs (2.5 mg/mL, 200 μL), (c) 
in vivo SPECT images of a mouse bearing a tumor (indicated by the red circles) after 
intravenous injection of Cu2-xSe-PEG-
99m
Tc solution, (d) blood circulation and (e) 
biodistribution of Cu2-xSe-PEG-SH NPs after intravenous injection into 4T1 tumor-
bearing mice, as determined by measuring Cu concentrations in tissue lysates with 
ICP-OES.  
Figure 5.13 The Cu concentration in the excreted urine at different intervals of post-
injection of the Cu2-xSe-PEG-SH NPs solution and PBS solution (control group), 
respectively.  
Figure 5.14 In vivo photothermal therapy of tumors with Cu2-xSe-PEG-SH NPs: (a) 
infrared thermal images and (b) temperature curves of 4T1 tumor-bearing mice 
intravenously injected with Cu2-xSe-PEG-SH NPs solution (500 µg/mL, 200 μL) and 
then irradiated with an 808 nm NIR laser at a power density of 1.5 W/cm
2
 for 6 min, 
in comparison with injection of PBS solution followed by NIR irradiation, (c) H&E 
staining of tumor sections from different groups of mice sacrificed at day 3 of 
treatment, (d) relative tumor volumes normalized to their initial volumes (Analysis of 
Variance (ANOVA) was used to assess statistical significance. *p < 0.5, **p < 0.01, 
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Figure 5.16 Representative photographs of mice bearing 4T1 tumors taken at 
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injected with PBS and then irradiated with a NIR laser (top row), from healthy 
mouse (middle row), and from mice intravenously injected with Cu2-xSe-PEG-SH 
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Figure 6.1 Schematic illustration of the synthesis of Fe-doped Cu2-xSe nanoparticles. 
Figure 6.2 The characterization of Se nanoparticles. (a) TEM images at different 
magnifications, and (b) corresponding size distribution histogram. (c) XRD and (d) 
UV.  
Figure 6.3 (a) Ultraviolet-visible-near-infrared (UV-vis-NIR) absorption spectra of 
the formation and evolution of Cu2-xSe sample. (b) Corresponding photothermal 
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Figure 6.6 Evolution of (a) UV-vis-NIR absorbance spectra and (b) XRD patterns of 
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 molar ratios at room 
temperature (RT) without Vc and PVP. 
Figure 6.7 TEM images and corresponding size distributions of the nanostructures 
obtained with different Cu2-xSe:Fe
3+
 molar ratios: (a and a′) 1: 0.5, (b and b′) 1: 1, (c 
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Figure 6.8 TEM, HRTEM and corresponding FFT patterns (insets) of the 
nanostructures obtained with different Cu2-xSe:Fe
3+
 molar ratios: (a1 and a2) 1: 0.5; 
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Figure 6.10 EDS spectra for different Fe-doped NPs samples using carbon-coated 
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Figure 6.13 (a) The evolution of UV-vis-NIR absorbance spectra of samples reacting 
with Fe
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Figure 6.14 magnetization isotherms of NPs recorded at 5 and 300 K and 
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Figure 6.17 (a) Relative cell viabilities of 4T1 cells after being incubated with 
various concentrations of CuFeSe-PEG NPs for 24 h. (b) Photothermal heating 
curves of pure water and aqueous dispersions of CuFeSe-PEG NPs at different 
concentrations under irradiation by an 808 nm laser with a power density of 0.75 W 
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concentration of Cu for CuFeSe-PEG NPs aqueous solutions; inset: the 
corresponding PA images. (d) In vitro T2-weighted magnetic resonance (MR) 
imaging using different concentrations of CuFeSe-PEG NPs. The transverse (r2) 
relaxivities of CuFeSe2 NCs for per Fe ion and for per Cu0.91Fe0.031Se NPs were 









Figure 6.18 (a) In vivo tumor PA images from a 4T1 tumor-bearing mouse acquired 
before and after intravenous injection of CuFeSe-PEG NPs solution (dose = 7 mg/kg) 
at different time points, and (b) corresponding time-dependent PA signal intensity of 
the tumor. (c) In vivo MR images of a mouse bearing a tumor (highlighted by the red 
circles) before and after intratumoral injection of CuFeSe-PEG NPs. 
Figure 6.19 In vivo tumor photothermal therapy. (a) Infrared thermal images and (b) 
the tumor heating curves of mice bearing 4T1 tumors after intravenously injection of 
CuFeSe-PEG NPs (7 mg/kg). (c) H&E staining of tumor sections from different 
groups of mice sacrificed at day 3 of treatment. (d) The relative tumor volumes 
normalized to their initial volumes and (e) survival curves and (f) body weights of 
different groups of mice after various treatments. 
Figure 6.20 Representative images of mice taken at different times post-treatment.  
Figure 6.21 Representative H&E stained images of major organs from treated mice 
with CuFeSe-PEG NPs intravenously injection (top row) and control mice (bottom 
row), taken 30 days after photothermal therapy. Yellow circles represent tumor 
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Chapter 1 Introduction 
1.1 General background  
Nanotechnology (nanotech) involves manipulation of matter on an atomic, 
molecular, and supramolecular scale. A more generalized definition of 
nanotechnology is the manipulation of matter with at least one dimension from 1 to 
100 nanometers in size.
[1]
 One nanometer (nm) is one billionth, or 10
−9
, of a meter. 
By comparison, typical carbon-carbon bond lengths, or the spacing between these 
atoms in a molecule, are in the range of 0.12-0.15 nm, and a DNA double-helix has a 
diameter of around 2 nm (Figure 1.1). Several phenomena exist related to these very 
small dimensions, including statistical mechanical effects and quantum mechanical 
effects, for example, the ―quantum size effect‖, where the electronic properties of 
solids are altered with great reductions in particle size. The ―quantum size effect‖ 
does not come into play by going from macro- to microscale dimensions. Quantum 
effects can become significant, however, when the nanometer size range is reached, 
typically at lengths of 100 nanometers or less, the so-called quantum realm. 
Additionally, a number of physical (mechanical, electrical, optical, etc.) properties 
change when compared to macroscopic systems. One example is the increase in the 
surface area to volume ratio, altering the mechanical, thermal, and catalytic 
properties of materials. Materials reduced to the nanoscale can show different 
properties compared to what they exhibit on the macroscale, enabling unique 
applications. For instance, opaque substances can become transparent (copper); 
stable materials can turn combustible (aluminium); and insoluble materials may 
become soluble (gold).  
One of the most promising applications of nanotechnology is in the field of 
medicine. Indeed, a whole new field of ―nanomedicine‖ is emerging. Nanomedicine 
ranges from the medical applications of nanomaterials and biological devices, to 
nanoelectronic biosensors, and even possible future applications of molecular 
nanotechnology such as biological machines. With sizes comparable to biological 
molecules and structures, but orders of magnitude smaller than human cells, 
nanoparticles (NPs) can offer unprecedented interactions with biomolecules, both on 
the surface of and inside the cells, which may revolutionize disease diagnosis and 
treatment. Upon incorporation of certain targeting moieties, these NPs can be 
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employed to interrogate specific molecular and cellular events in living systems. 
Therefore, nanomaterials can be useful for both in vivo and in vitro biomedical 
research and applications. Thus far, the integration of nanomaterials with biology has 
led to the development of diagnostic devices, contrast agents, analytical tools, 
physical therapy applications, and drug delivery vehicles.
[2]
 There are three 
applications of nanomedicine: 1) nanomedicine for diagnostic purposes, including 
nanotechnology-based biosensors for in vitro and ex vivo diagnosis and nanoprobes 
for in vivo imaging; 2) nanomedicine as a potential platform for therapeutic 
applications; 3) nanotheranostics,
[3]
 which combines diagnostic and therapeutic 
capabilities into a single nanoagent (Figure 1.2). 
 
Figure 1.1 Comparison of sizes of nanomaterials.
[1]
 




Figure 1.2 The relationship between different technologies. 
 
Functional agents such as imaging agents and therapeutic agents serve as molecular 
probes, which are of significance for developing theranostic platforms. Advanced 
functional nanomaterials and relevant modification nanotechnologies contribute a 
great deal to the fabrication of various functional agents.
[4-17]
 In particular, much 
attention is being paid to nanostructured transition metal chalcogenide (TMC) 
materials ,including metal sulphides, selenides and tellurides, which include at least 
one metal cation and one chalcogen anion. TMC nanostructures have an incredible 
wealth of properties because chalcogenide elements are easy to form into compounds 
with different kinds of structures, and compositions. These have been widely 












 and water splitting;
[46-49]
 bioimaging, including 












 TMC quantum dots (QDs) represent one kind of 
promising probe for biomedical imaging of living tissue. For example, the 
development of near-infrared (NIR) quantum dots with maximum emission spectra 
ranging from 700 to 900 nm may overcome the limitations that endogenous 
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autofluorescence in the visible spectrum may interfere with signals from labelled 
probes and may even mask weak labelling signals.
[76]
 Polydentate phosphine-coated 
biocompatible NIR CdTe/CdSe QDs were developed to serve as imaging agents to 
direct lymph node surgery under the guidance of fluorescence imaging. A small dose 
of injected NIR QDs (400 pmol) enabled real-time imaging of a sentinel lymph node 
(approximately one centimetre depth under the skin) in both a mouse and a pig.
[77]
 As 
another type of TMCs, copper chalcogenide semiconductors are promising 
candidates as photothermal agents owing to their superior properties, such as low 
cost, high stability, environmental compatibility, and the intrinsic NIR region 
absorption derived from the d-d energy bandtransitions.  
In 2010, Li and co-workers
[78]
 first synthesized thioglycolic acid-stabilized CuS 
nanoparticles via a wet chemistry method and applied it as a new type of agent for 
photothermal ablation of cancer cells. These uniform CuS nanoparticles have a mean 
size of approximately 3 nm and show an increased absorption band in the NIR region, 
with maximum absorption at 900 nm. A further cell photothermal destruction assay 
of HeLa cells and toxicity assay indicated that the CuS nanoparticles displayed 
outstanding photothermal ablation efficiency and minimal cytotoxic effects. Layered 
transition metal dichalcogenides, such as MoS2, MoSe2, WS2, and WSe2, also 
showed great potential as photothermal agents. Chou et al. demonstrated for the first 
time that MoS2 nanosheets could serve as a new NIR photothermal agent, with 
approximately 7.8 times greater NIR absorbance relative to graphene oxide (GO) on 
a per mass basis.
[79]
 The extinction coefficient of MoS2 nanosheets at 800 nm was 
29.2 L/g·cm, which was higher than that of gold nanorods (AuNRs; 13.9 L/g·cm) 
and comparable to that of reduced GO (RGO; 24.6 L/g·cm). In another work, 
bismuth selenide (Bi2Se3) nanoplates were used as a theranostic platform for 




1.2 Challenges facing nanomedicine  
The advanced properties of nanomaterials (molecular platforms, surface to 
volume ratio, shape/size control, and inherent optical response) make the field of 
nanomedicine diverse and thus full of potential. Despite the remarkable progress 
over the last decades, there are several critical challenges facing nanomedical 
research for widespread use of TMC-based agents and potential clinical translation. 
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The first important problem is how to achieve appropriate nanostructured TMCs. The 
physicochemical characteristics of nanoparticles, such as size, shape, and surface 
chemistry, are critical for tumor-specific accumulation. Rigid nanoparticles with 
sizes in the range of 10-100 nm, according to our understanding of enhanced 
permeability and retention (EPR) effect,
[81, 82]
 have prolonged blood circulation times 
because they are large enough to avoid renal clearance but at the same time small 
enough to avoid capture by the reticuloendothelial system (RES).
[83]
 Surface 
chemistry influences both systemic-level processes (such as opsonization) and 
cellular-level processes (such as cell uptake). Cationic surface charges enhance 
cellular uptake of nanoparticles due to increased electrostatic interactions with cell 
membranes, while at the systemic level, positive charges can cause opsonization, i.e., 
adsorption of serum proteins and subsequent clearance in the RES.
[84]
 Therefore, 
hydrophilic, i.e. water-soluble, nanoparticles with a size of 10 nm to 100 nm and 
neutral or low negative charge on their surface are more appropriate and therefore 
preferred. In general, the synthesis of water-soluble TMCs is mainly achieved 
through two synthetic routes: 1) indirect organic-phase synthesis followed by a 
ligand-exchange process; 2) direct aqueous-phase synthesis. Although yielding good-
quality NPs with a narrow size distribution and high crystallinity, the organic-phase 
synthetic route is strongly limited by the high-cost, unfriendly experimental 
conditions and the laborious ligand-exchange process.
[62, 69, 70]
 Alternatively, the 
direct aqueous synthetic route provides a facile and greener approach to acquiring 
water-soluble TMCs.
[5, 85, 86]
 Nevertheless, due to the strong inherent dipole-dipole 
interaction or lack of suitable ligands, the NPs often tend to aggregate.
[87-89] 
Consequently, it is highly desirable to develop an efficient synthetic approach for 
achieving aqueous TMCs with excellent colloidal stability and size tunability. 
Aside from the fabrication of suitable TMCs, there are two important issues for 
further clinical applications of those TMCs in nanomedicine. One is the potential 
long-term safety concerns relating to the TMCs, especially those inorganic ones that 
are not biodegradable and would be retained inside the body for long periods of time 
after administration. For example, the potential toxicity of QDs is still a major 
concern, due to their chemical compositions, which include toxic elements such as 
Cd, Se, Hg, Pb, As, etc. Although a large number of reports have demonstrated that 
many inorganic nanomaterials, such as gold and carbon nanomaterials, if they have 
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appropriate surface coatings and sizes, are not noticeably toxic in vitro and in vivo in 
the tested dose ranges, it could still be extremely difficult for those nanoagents to 
finally achieve US Food and Drug Administration (FDA) approval for clinical use. 
The other issue is limited light penetration depth in phototherapy for cancer. For 
photothermal therapy, NIR absorbing photothermal agents are absolutely preferred 
over those with visible absorption, considering the reduced light absorbance and 
scattering in the NIR window. Even if NIR light is used to trigger phototherapy, the 
effective penetration depth of NIR light is still usually limited to no deeper than 1 cm. 
For some types of cancers, such as skin cancers, oral cancer, esophageal cancer, and 
even stomach cancers, light can be induced to locally irradiate the tumors with the 
help of certain facilities (e.g., gastroscopy, endoscopy). For other types of cancers 
with tumors located deep inside the body, effective phototherapy would require the 
appropriate design of medical devices (e.g., with optical fibers) that can deliver light 
into those deep lesions.  
 
1.3 Objectives of the research and thesis structure  
The main goal of this doctoral work is to construct robust transition metal 
chalcogenide based molecular probes for bioapplication, including bioimaging and 
therapy. For fluorescent imaging, the traditional CdTe QDs were selected as my first 
research subject, because their toxicity and stability can be significantly reduced and 
enhanced, respectively, by coating them with a silica layer. In contrast to the 
CdTe/SiO2 probe, multifunctional nanotherapeutic probes (Cu2-xSe nanoparticles) 
were fabricated, which demonstrated great feasibility for multimodal imaging-guided 
photothermal therapy of cancer. Based on the Cu2-xSe probes, the influences of Fe-
doping of the nanostructures on the properties and application were well studied. The 
scope of the research in this doctoral thesis is briefly outlined as follows: 
Chapter 1 introduces the general background, along with some challenges 
facing nanomedicine, the objectives of this doctoral research, and an outline of this 
thesis. 
Chapter 2 presents a comprehensive literature review on nanostructured 
transition metal chalcogenides, including their fabrication approaches, structural 
features, and related applications. 
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Chapter 3 introduces the chemicals and materials, and synthesis methods, as 
well as the generally used characterization techniques and and facilities, including 
some bioimaging techniques used in the thesis. 
Chapter 4 introduces a fluorescent seeded-watermelon-like mesoporous 
nanostructure (mSiO2@CdTe@SiO2) for bioimaging. 
Chapter 5 reports ultra-small PEGylated Cu2-xSe nanoparticles as a 
multifunctional nanotherapeutic probe for multimodal imaging-guided photothermal 
therapy of cancer. 
Chapter 6 develops a facile and chelator-free doping method for constructing 
Fe-doped Cu2-xSe nanoparticles, which were demonstrated be a novel 
nanotheranostic agent for effective deep-tissue photoacoustic imaging, magnetic 
resonance imaging, and photothermal therapy of cancer. 
Chapter 7 summarizes the work in this doctoral work and provides some 
prospects for further research work related to both the synthesis and applications of 
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Chapter 2 Literature Review 
2.1 Structures and properties of transition metal chalcogenides 
Chalcogens are the chemical elements of group 16 (i.e., group VIA) of the 
periodic table, including oxygen (O), sulfur (S), selenium (Se), tellurium (Te), and 
polonium (Po). A transition metal (Group 3 to Group 12) chalcogenide is a chemical 
compound consisting of at least one chalcogen anion and at least one more 
electropositive transition metal element. In general, the term chalcogenide is more 
commonly reserved for sulfides, selenides, and tellurides, rather than oxides and 
polonium compounds, due to the extremely strong non-metallic properties of oxygen 
and the strong metallic properties of polonium. There are various kinds of transition 
metal chalcogenides with different structures and compositions, such as ScS2, TiS2, 
TiSe2; CrS2, MnSe2, FeS2, Fe3S4, FeSe2; CoSe2, Cu1.97S, Cu2S; CuSe, Cu2-xSe; CdTe, 
HgS, etc., owing to the non-metallic properties of chalcogens and the unfilled d 
orbitals of transition metals. The family of transition metal chalcogenides is huge and 
diverse, and could be categorized in many different ways. For example, simply in 
terms of the chalcogen elements, they could be divided into sulfides, selenides, 
tellurides, and multi-chalcogen chalcogenides; while according to the number of 
elements, binary, ternary, quaternary, and multi-chalcogenides are defined. Most of 
the main group metal chalcogenides are stoichiometric compounds, but for transition 
metals, due to their unfilled d orbitals, it is easy to form off-stoichiometric transition 
metal chalcogenides (TMCs). Non-stoichiometric binary TMCs can be grouped into 
―chalcogen rich‖ phases, such as TaS2, TiS2, TiSe2, and Re2S7, and ―metal rich‖ 
phases, such as Ta6S,Ta2S, Ta6Te5, and Gd2Te. The complexity of metal-chalcogen 
bonding, as well as excess chalcogen-chalcogen or metal-metal bonding, further 
increases the diversity of structures for the binary transition chalcogenides. For 
example, based on the degree of sulphur-sulphur bonding, the transition metal 
sulfides could be classified as ―sulphur-rich‖ phases  featuring S-S bonding (such as 
FeS2), usually in the form of persulfide units such as S2
2-
, or compounds such as TaS3 
and TiS3 containing both per- and monosulfide units. In addition, there is also a wide 
class of transition metal sulphides, including members with isolated sulfide (S
2–
) 
centers, e.g., MoS2 and FeS. On the other hand, one would encounter metal-rich 
phases (such as Ta3S2) exhibiting metal-metal bonding, even to the point that they 
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should be considered as being metallic alloys. Consequently, atom sizes and 




Low-dimensional structures and metal clustering are frequently found among 
TMCs, because compared with the ionic three-dimensional (3D)-type oxides, these 
compounds tend to form covalent structures, so that the reduced relative charge on 
the metal favours metal-metal bonding. Thus preferred coordination polyhedra occur 
for the chalcogen atoms in the compounds containing M-M bonds. The linkage of 
these polyhedral often results in an arrangement of metal clusters, which are usually 
condensed by sharing common vertices, edges, or faces, because clusters are rarely 
isolated in the chalcogenide structures. They also form columns, in which the central 
metal atoms interact to give chains running in the same direction,
[2]
 while in layered 
chalcogenides, there are enough d-electrons in the transition metal for significant M-
M bonding, leading to the formation of a two-dimensional (2D) structure. Moreover, 
even 3D metal frameworks (i.e., as a metal packing arrangement, such as a cluster 
network) can be found in certain cases. It should be noted that the occurrence of M-
M bonds in TMCs has supported the use of classification schemes based on structural 
elements rather than oxidation numbers, thus rationalizing the coincidental integer 




Transition metal chalcogenides occur with various stoichiometries and kinds of  
structures, among which, however, the most common and most important structures 
are the chalcogenides with simple stoichiometries, such as 1:1 and 1:2 because most 
binary compounds belong or are related to the very basic structural types. ―Three-
dimensional‖ structures, commonly the cubic NaCl (rock salt; RS) and zinc blende 
(ZB), or the hexagonal NiAs and wurtzite (W) types, as well as ―2D‖ layered-lattice 
varieties related to the CdI2 type, are the major structure types observed, as shown in 
Figure 2.1. The simple compounds formed by selenium and tellurium are generally 
isomorphous with their sulfide analogues, although there are differences, especially 
for tellurides.  
The electronegativity (or electropositivity, the converse of electronegativity) of 
TMCs plays a key role in the determination of their structures. In particular, the 
alkali metal chalcogenides that are derived from the hydrides of the more 
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electropositive metals (such as Groups 1 and 2) show the antifluorite structure while 
many other monochalcogenides of rather less basic metals (e.g., the monosulfides of 
Pb, Mn, La, Ce, Pr, Nd, Sm, Eu, Tb, Ho, Th, U, and Pu) adopt the 6:6 NaCl-type 
structure. With cations of increasing polarizing power and increasingly readily 
polarized chalcogenide anions, the ionic RS structure gives way to the ZB and W 
types. Thus, the increasing covalency of many metals in the later transition-element 
groups affords chalcogenide structures with lower coordination numbers; for 
example, the monosulfides of Be, Zn, Cd, and Hg adopt the ZB structure,
[4-7]
 while 
those of Zn, Cd, and Mn adopt the W one.
[8-10]
 When the bonding becomes more 
metallic (i.e., decreasing electronegativity), the 6:6 NiAs structure is observed, where 
the metal is of octahedral coordination. This can be regarded as transitional between 
the RS structure and the more highly coordinated structures typical of pure metals. 
Most first row (3d) transition metal monochalcogenides MX (M = Ti, V, Cr, Fe, Co, 
Ni) come under this case. These compounds often contain vacancies at the metal site, 
so that the crystal becomes distorted owing to vacancy ordering, which varies with 
temperature as well as composition. Their magnetic and electrical properties are 
generally complex and depend on the type of vacancy order. 
 
Figure 2.1 Crystal structures for (a) NaCl (RS), (b) zinc blende (ZB), (c) wurtzite 
(W), and (d) nickel arsenide (NiAs) type.  
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Most transition metal elements react with chalcogen atoms to give 
dichalcogenides (MX2) with a precise 1:2 stoichiometry, crystallizing in either 2D or 
3D structures, which originate from the competition between cationic d levels and 
anionic sp levels. Two-thirds of the about 60 MX2 compounds assume layered 
structures, which found in particular for all the early transition metals of Groups 4-6. 
Although comprising a structurally and chemically well-defined family, the layered 
transition metal dichalcogenides demonstrate various remarkable characteristics, 
including a broad range of homogeneity, order-disorder transitions,
[11]
 strong d-p 
covalent mixing, and fast ionic diffusion.
[12, 13]
 They actually cover a wide spectrum 
of electrical properties, ranging from insulators such as HfS2, through 
semiconductors such as MoS2 and semi-metals such as WTe2 and TcS2, to true 
metals such as NbS2 and VSe2.
[14, 15]
 Moreover, this class of compounds has played a 
pivotal role in pioneering investigations on unusual electronic phenomena, such as 
superconductivity, quantum size effects, and charge density waves (i.e., coupled 
fluctuations of electronic density and atomic positions along a conducting chain or 
layer). Most of the non-layered MX2 compounds formed by the "late" transition 
metal elements in Group VIII (Mn, Fe, Co, Ni) are composed of infinite 3D networks 
of metal atoms and discrete X2 units. Two similar structures exist in this connection: 
pyrite (e.g., for the disulfides of Fe, Mn, Co, Ni, Cu, Ru, and Os) and marcasite 
(known only for FeS2 among the disulfides), as shown in Figure 2.2. 









. For example, FeS2, the most prevalent modification of the disulphide, is 
pyrite (band gap, Eg = 0.95 eV), which may be considered as a distorted NaCl 
structure, where Fe atoms occupy sodium positions and S2 groups are placed with 
their centres at the chloride positions. Another modification of FeS2 is the very 
similar to pyrite, but somewhat less regular marcasite structure (Figure 2.2b). 




Figure 2.2 (a) Pyrite-type crystal structure, shown as FeS2 for example, in which Fe 





Various stoichiometries and polymorphs are found in the binary copper 
chalcogenides, which are the well-known IB-VIA semiconductors and exhibit defect 
phases with large ranges of homogeneity.
[17, 18]
 In the Cu-S system, on the ―copper-
rich‖ side lies chalcocite, Cu2S, and at the ―copper-deficient‖ side the pyrite-type 
CuS2, with such intermediate phases as Cu2-xS (Cu1.96S, Cu1.94S, Cu1.8S), Cu7S4, 
Cu9S8, and CuS (covellite).
[17] 
Likewise, the Cu-Se system includes Cu2Se, Cu2-xSe, 
Cu7Se4, Cu3Se2, Cu5Se4, CuSe, and CuSe2 stoichiometries, some of which (in one 
polymorphic form or another) occur as minerals, e.g., berzelianite (Cu2-xSe), 
umangite (Cu3Se2), and klockmannite (α-CuSe).
[19]
 Non-stoichiometric phases of the 
Cu-Te system have also been found for different Cu/Te ratios, including Cu2Te, 
Cu7Te5 (rickardite), Cu3Te4, CuTe, and CuTe2.
[18] 
 
Cu2X (X = S, Se or Te) compounds are usually dimorphic. Although they have 
the simple chemical formula Cu2X, they also have quite complex atomic 
arrangements and show phase transitions.
[20-23]
 For example, low-chalcocite Cu2S 
(monoclinic phase at a temperature below 377 K) and Cu2Se undergo a α-β transition 
(at the transition temperature Ttr,α-β ~ 410 K) from the low-temperature monoclinic α-
phase to the high-temperature β-phase (face-centred cubic (fcc) structure, Figure 
2.3a-b), in which superionic Cu ions are kinetically disordered throughout the 
structure.
[24, 25] 
The high-temperature modifications of these compounds have defect 
structures, normally metal-deficient, such as in the (high-digenite) Cu2-xS (hexagonal 
phase at temperature between 377 K and 709 K), where the anions together with half 
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of the metal ions form a ZB structure, in the interstices of which copper ions are 
statistically distributed. CuS, as the mineral covellite (also known as covelline), 
exhibits a very unusual structure, in which the Cu is partly 3-coordinate  
 
Figure 2.3 (a) The β-Cu2Se crystal structure (blue and green are Cu and Se atoms). (b) 




 ions, with designations.
[23]
 (c) Covellite 




and partly 4-coordinate, with two-thirds of the sulfur atoms existing as S2 groups like 
those in pyrites (Figure 2.3c). The low-temperature form of CuSe also has a covellite 
structure, with the high-temperature modification (β-CuSe) being orthorhombic. All 
CuX2 compounds assume pyrite-type structures. 
     II-VI semiconductors are compounds consisting of elements from Groups IIB (Zn, 
Cd, Hg) and VIA (S, Se, Te) of the periodic table. Various semiconductors are 
composed of combinations of these elements and include binary, ternary, and 
quaternary compounds. All the monochalcogenides of the II-VI semiconductors 
crystallize in the tetrahedral zinc blende (ZB) or wurtzite (W) structures, with the 
exception of HgS, which also exists in a distorted rock salt (RS) form. Most II-VI 
semiconductors (except for HgTe and HgSe) have a direct band gap, which 
consequently endows the II-VI materials with great potential for optical and 
optoelectronic applications. In Table 2.1 we highlight some major structural and 
semiconductor properties of the main binary II-VI compounds. The applications of  
I-VI semiconductors have received in-depth investigation in various fields for 
various applications, including optical devices, luminescence, photovoltaics, sensors, 
lasers, biological labels, biological detection, and diagnostics.
[27-34]
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Table 2.1 Physical and chemical properties of II-VI semiconductors. 
Properties ZnS ZnSe ZnTe CdS CdSe CdTe 
Stable phase at 
300 K 







5.266 5.636 4.82/4.82 5.81/5.81 5.86 
Melting point (K) 1991 1799 1563 1750 1533 1370 
Thermal 
conductivity at 





0.27 (Z) 0.19 0.18 0.2 0.009 0.001 
















≤0.15 1-2 × 10
-3
 - ≤0.007 ≤0.0015 ≤0.003 
Exciton binding 
energy (meV) 
38 21 10 30.5 15 10.5 
Thermo-optical 
coefficient 
(dn/dT) (λ= 10.6 
µm) 
4.7 6.1 - - - 11 
For example, CdTe is the most attractive semiconductor for photovoltaic application 
among Si, and the III–V and II–VI compounds.
[35, 36]
 CdTe has a direct band-gap 
energy of about 1.47 eV, which is very close to the theoretically calculated optimum 




 at a 
wavelength of 700 nm), so that approximately 90% of the incident light is absorbed 
by a layer thickness of only 2 mm (compared with around 10 mm for Si). 
Furthermore, CdTe can be made from polycrystalline thin films on glass substrates, 
thus avoiding the need for expensive single-crystal substrates. CdTe is one of the 
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most promising photovoltaic materials available for use in low-cost, high-efficiency 
solar cells. The theoretical efficiency for the CdS/CdTe photovoltaic cell is about 30% 
at air mass 1.5. (The air mass number is 0 for no air mass (i.e. for a satellite solar 
array), 1 for the sun directly overhead, and 1.5 for the sun at 45º to the horizon.)[37] It 
is the first and only thin-film photovoltaic technology to surpass crystalline silicon 
photovoltaics in cheapness.
[38]
 The CdTe photovoltaic market is growing rapidly, and 
CdTe is the second most utilized solar cell material in the world.
[37, 39]
 
2.2 Synthesis approaches for transition metal chalcogenides 
     The microstructure (composition, size, shape, etc.) of nanomaterials determines 
the electronic density of states (DOS) of nanomaterials and ultimately determines 
their electronic, optical, magnetic, and mechanical properties, which are the 
fundamental to the current excitement and growing applications of nanomaterials. 
The wide application of TMCs, including in fuel cells, solar cells, sensors, Li/Na 
batteries, supercapacitors, biological labels, diagnostics, etc. is benefitting from the 
progress in the synthesis of novel nanostructured materials in different sizes and with 
new morphologies.
[28-30, 40, 41]
 New physical and chemical properties emerge when 
the size of TMCs is reduced to the nanometer scale, owing to the well-known 
quantum size effect.
[42]
 In addition, compared with their bulk counterparts, 
nanostructured TMCs possess a much higher specific area (i.e. more reaction sites). 
For example, well-studied semiconductor nanocrystals which usually are referred to 
as quantum dots (QDs) exhibit strong size-dependence of their optical properties 
when their size is smaller than the Bohr exciton radius.
[43]
 Their novel properties 
make these nanomaterials very attractive in diverse applications, ranging from 
energy conversion and storage to biomedical imaging and diagnostics. 
       Controllable morphology, size, composition, structure, and suitable surface 
modification of TMC materials play a key role in their practical application. A range 
of approaches have been utilized for the preparation of TMC nanostructures, and 
those synthetic routes can be classified as top-down (e.g., mechanical cleavage, 
chemical exfoliation, sonication-assisted exfoliation, and chemical reactions) and 
bottom-up approaches (e.g., chemical vapour deposition, direct wet chemical 
synthesis, and solvothermal reactions), as shown in Figure 2.4.
[44]
 In the top-down 
approach, the dimensions of bulk materials are progressively reduced to the 
nanodomain by using physical and chemical means. Examples involve ball milling 
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and acid-etching. Several top-down synthesis approaches are mostly based on 
exfoliating nanosheets from bulk crystals or larger morphologies, whereas bottom-up 
approaches are conducted through a range of synthesis routes with the addition of 
diverse kinds of metal and chalcogenide precursors. Conventional solid-state or 
gaseous-state strategies are  
 
Figure 2.4 Top-down and bottom-up approaches in nanotechnology. 
 
often unsatisfactory. For example, the drawbacks of the mechanical ball-milling 
approach are that it is easy to introduce impurities, the particle distribution is uneven, 
and the process is time consuming, while the equipment for gaseous-state strategies 
are often complicated, expensive, and high energy consuming. Comparatively, 
liquid-based wet chemical methods have been demonstrated to be powerful for 
obtaining desired nanostructured TMCs with controlled sizes, compositions, and 
shapes. In a liquid-based synthetic system, the target TMCs and/or 
surfactants/ligands can be selected based on rational criteria, and the nucleation and 
growth process of the products can be easily controlled by adjusting the 
thermodynamic and kinetic parameters of the reaction, such as the temperature, 
amount and type of ligands or surfactants, stirring speed, and even the feeding 
sequence of reactants, etc. Thus their composition, size, shape, and surface properties 
can be exquisitely tailored. Additionally, liquid-based synthetic routes avoid the use 
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of drastic conditions (such as high temperatures and high pressures), and the cost is 
relatively low because they do not need expensive facilities. Various liquid-based 
wet chemical methods have been established to synthesize high-quality TMCs. In 
this section, the main and general liquid-based wet chemical methods for controlled 
synthesis of TMCs are selectively reviewed and summarized.  
2.2.1 Hot colloidal chemistry 
     Various inorganic nanoparticles of varying types and compositions can be 
synthesized using general hot colloidal chemistry. They include semiconductor 
quantum dots, magnetic nanoparticles, plasmonic metal or alloyed metal 
nanoparticles, plasmonic transparent conductor nanoparticles, lanthanide-doped 
multicolour upconversion nanoparticles, etc. Hot colloidal chemistry allows 
manipulation of their optical or electronic properties in a rationally defined way. This 
approach typically utilizes mixing of relevant charged ions in a prefixed ratio at a 
defined crystallizing temperature in a ligand-regulated solution environment, 
followed by precipitation of the nanoproduct.
[45]
 This approach generally employs 
three components: (1) a high boiling point solvent, which is required to achieve a 
temperature high enough for complete solubilization and decomposition of reactants 
and crystallization of the inorganic nanoparticles; (2) selected ligands (also called 
surfactants or capping groups, such as trioctyl phosphine (TOP), trioctyl phosphine 
oxide (TOPO), oleic acid, and oleylamine), with the ligands or surfactants used for 
adsorption on the surfaces of the nanoparticles, limiting their growth; (3) metal salts 
or organometallic compounds as precursors. The precursors provide the inorganic 
elements (e.g., Cd and Se for CdSe QDs), from which the particles are formed.
[46] 
Typically, a solution containing surfactants/ligand is heated to 150 to 350 ℃ for 
synthesis of the desired nanoparticles,
[42, 47]
 employing a typical apparatus, as 
illustrated in Figure 2.5a. 
     The typical growth process for inorganic nanoparticles is illustrated in Figure 2.5b. 
The growth process encompasses four main stages: (1) monomer (precursor) 
accumulation in solution (phase I); (2) nucleation (phase II); (3) particle growth 
(phase III); and (4) recrystallization processes. An illustration of the corresponding 
phase I to phase III is depicted in Figure 2.5b. Phase I illustrates the first stage of 
accumulation of the monomer, which is produced from raw organometallic materials 
or by thermolysis of the corresponding precursors in solution. The nucleating process 
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of phase II does not take place until the accumulated monomer concentration in the 
solution reaches above the nucleation concentration. When the monomer 
concentration drops back below the nucleation concentration, the nucleation process 
will stop, and all the formed nuclei will gradually grow and crystallize into 
nanocrystals (phase III). When the concentration of the monomer drops to the 
saturation level, the growth phase is complete, and phase IV of the recrystallization 
process or Ostwald ripening process will occur. The Ostwald ripening process is 
unique, as it can cause the particle size to nonuniformity if the size is relatively 
uniform during the growth phase, while it also can lead the particle size to uniformity 
if the size deviation of different nanoparticles is large. Based on the preparation 
conditions, prevention of this process or intended utilization of this process can be 
selectively effected to produce uniform inorganic nanoparticles. 
 
Figure 2.5 (a) Typical laboratory-scale apparatus for preparing inorganic 
nanoparticles using hot colloidal synthesis. (b) Schematic illustration of the typical 
growth process for inorganic nanoparticles. 
 
     There are two ways of loading precursors into the-three neck round bottom flask 
shown in Fig. 2.5(a): (1) the ‗‗hot-injection method‘‘;
[48]
 (2) the ‗‗heating-up 
method‘‘.
[49]
 In the ‗‗heating-up‘‘ process, the temperature of the reaction solution 
containing pre-loaded precursors is elevated from room temperature to a specific 
high temperature to produce nanoparticles. The ‗‗hot-injection‘‘ process employs the 
injection of pertinent precursors into a hot solution containing a high-boiling-point 
solvent and the surfactants. The ‗‗hot-injection‘‘ process creates a burst of nucleation 
to sharply separate the nucleation process from the growth process, which is critical 
for producing uniform inorganic nanoparticles. The size of nanocrystals can be  




Figure 2.6 Transmission electron microscope (TEM) images of different 
morphologies of CdSe. The surfactant ratio was increased from (a) 8 to (b) 20 to (c) 
60% hexylphosphonic acid (HPA) in TOPO, with an injection volume of 2.0 mL of 
stock solution. The injection volumes used were (d) 1.0, (e) 1.5, and (f) 2.0 mL. 20% 
HPA in TOPO was used, as it was found to provide optimal rod growth conditions. A 




controlled by adjusting the temperature, the nature of the solvent, the surfactant(s), 
and the aging time. As the resulting nanoparticles at the end of the growth stage are 
generally uniform, prevention of the Ostwald-ripening process is necessary by 
terminating the reaction at a specific time point. Typically, semiconductor QDs are 
synthesized by the ―hot-colloidal injection‖ method.
[46, 48, 50]
 For example, arrow-, 
teardrop-, tetrapod-, and branched tetrapod-shaped nanocrystals of CdSe have been 
achieved by single-injection experiments, as shown in Figure 2.6. In this study,  




Figure 2.7 TEM images of different morphologies of Cu2S nanocrystals: (a) 
nanoparticles (insets: enlargement of nanoparticle and electron diffraction pattern);
[51]
 










three fundamental synthesis condition parameters including the ratio of the 
surfactants (HPA/TOPO); the volume of the initial injection; and the time 
dependence of the monomer concentration have strong relationships with the shape 
of the CdSe nanoparticles.
[50]
 Besides controlling the morphology of the nanocrystals 
in one reaction system, many other morphologies of high-quality semiconductor 
nanocrystals have also been synthesized by this method, such as Cu2S nanoparticles, 
nanoribbons assembled from β-Cu2S nanodisks, chain-like Cu2S nanocrystals, and 
Cu2S nanodisks, as shown in Figure 2.7.
[51-58]
  
     The second way of loading precursors into the three-neck round-bottom flask is 
the ―heating-up‖ approach, whereby the temperature of the reaction is elevated from 
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room temperature to a specific high temperature to produce nanoproducts. This 
approach generally explores two routes to produce uniform inorganic nanoparticles. 
One is to abruptly release metal ions from metal complexes at their thermal 
decomposition point, creating a burst nucleation process, followed by a size-focused 
growth stage,
[49]
 which are based on the same principles as described for the ―hot-
injection‖ method. The other route relies on the Ostwald-ripening process to lead 
nanoparticles of varying sizes produced by mixing related precursors at room 
temperature, to grow into a uniform critical size. This approach allows the synthesis 
of alloyed metal nanoparticles (Ag/Au). In contrast, when the hot injection method is 
used, Ag and Au prefer to nucleate by themselves (forming Ag and Au nanoparticles, 
rather than the Ag/Au alloyed nanoparticles).
[59]
 
     The hot colloidal approach can achieve high quality nanocrystals with good 
crystallinity and narrow size distributions. The drawbacks of this method lie in the 
following aspects, however: (i) toxic and expensive organics may be used, which can 
do harm to both humans/the environment and increase the cost; (ii) there are always 
capping ligands (such as oleic acid, oleylamine, TOPO, etc.) on the surface of the 
product, which are generally hydrophobic, so that further surface modification is 
required to make the nanocrystals dispersible in an aqueous solution or biological 
buffer, where surface hydrophilicity is a prerequisite; (iii) to prevent oxidation or 
absorption of water, purging of the protection gas or Schlenk line is needed, which 
leads to complexity in the operation; (iv) sometimes, in order to obtain 
monodispersed nanostructures, a low concentration of precursors is needed, meaning 
low yield. 
 
2.2.2 Solvothermal and hydrothermal method   
2.2.2.1 Solvothermal method 
     Along with the development of the hot colloidal chemistry technique, the 
solvothermal method was introduced to prepare semiconductors and nanocrystalline 
chalcogenides in 1996
[60]
 and developed rapidly. In contrast to the hot colloidal 
chemistry approach, the solvothermal process uses organic solvents as the reaction 
medium in a sealed steel pressure vessels with Teflon liners (Figure 2.8), which are 
then heated to the designated temperature (usually higher than the boiling point of 
the solvent) to promote the reaction. Because the reactants are placed in a closed 
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system, the solvent auto-generates pressure upon heating. The pressure in the 
solvothermal system is much larger than that under ambient conditions, which is 
helpful to further enhance the solubility, as well as the reactivity, of the reactants, 
and also improves the crystallinity of the as-prepared nanocrystals. By choosing an 
appropriate organic solvent, commonly used raw materials (e.g. elemental S, Se, Te, 
P, As, and Sb) can have enhanced solubility and will be more reactive than under 
conventional conditions. Under these extreme (high temperature, high pressure) 
conditions, even in pure solvent, some quite unexpected reactions will take place, 
accompanied by the formation of nanoscopic morphologies and new phases, which 
cannot be achieved by traditional reactions. The solvent properties, such as polarity, 
viscosity, and softness, have strong effects on the solubility and transport behaviour 
of the precursors in the liquid-based synthesis, which will control the reactivity, 
shapes, sizes, and phases of the final products. For example, various TMC 
nanocrystals have been synthesized with elegant control of their size and morphology, 





























 etc. (see Figure 2.9).  
 
Figure 2.8 Schematic diagram of solvothermal synthesis setup: (1) stainless steel 
autoclave, (2) precursor solution, (3, 4) Teflon liner, (5) stainless steel lid. 




Figure 2.9  TMC nanocrystals with various morphologies. Scanning electron 
microscope (SEM) images of (a) FeS2 with wire-like morphology,
[62]
 (b) Cu2Te 
nanowires/nanoribbons;
[66]
 (c) belt-like ZnSe;
 [65]
 TEM images of (d) CoTe 
nanotubes;
 [66]




 (f) and Cu2S
[69]





 (i) and CoS1.097
[72]
 (j); (k) α-MnSe 
nanospheres.
 [73]
 The insets of (a) and (b) are enlargements of single nanowires, and 
the inset of (e) is the corresponding electron diffraction pattern. 
 
During these solvothermal synthesis approaches, a reaction temperature was usually 
adopted in the range of 100-250 ℃ in order to reach the pressure of vapour saturation. 
Stabilizing/capping agents, appropriate solvents, and chalcogen sources have been 
extensively employed as ‗‗shape controllers‖ and are particularly significant for the 
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final TMC nanocrystals. For examples, single-crystalline, hexagonal covellite (CuS) 
nanoplatelets (diameter: 26 nm, thickness: 8 nm; Figure 2.9h) were successfully 
synthesized by the solvothermal method in toluene by using hexadecylamine as the 
capping ligand. Although the size of the nanoplatelets could be tuned by varying the 
reaction time and temperature, self-assembled stacking was mostly controlled by the 
capping agent and van de Waals attraction.
 [70]
 Zhang et al. reported the synthesis of 
CuS nanotubes (Figure 2.10a) by the solvothermal process in an oil/water (O/W) 
microemulsion system consisting of oleic acid, water, and polyvinylpyrrolidone 
(PVP).
[74]
 Another interesting case is the successful synthesis of concave-faceted 
cuboctahedral CuS crystals by a solvothermal reaction in ethylene glycol (EG) 
solution (Fig. 2.10b).
[75]
 Each concave-faceted cuboctahedron has four identical-
hexagonal flakes and contains 14 concave cavities. The usage of EG as a solvent is 
one of the key points for the formation of these geometric ‗‗stars‘‘. Wang et al. 
synthesized non-stoichiometric compositions of copper sulfide (CuS) via the 




 molar ratio in the precursor 
solutions.
[76]
 The assembly process through the route zero-dimensional (0D) → 2D 
→ 3D was attributed to the oriented-attachment mechanism of copper sulphides 
(Figure 2.10c). Besides changing the ratio of precursors, adopting different 
precursors can lead to the formation of different morphologies of TMC nanocrystals. 
CuS nanocrystals in the form of spherical nanoflowers, doughnut-shaped 
nanospheres, and dense nanospheres were obtain under the same reaction conditions, 
but changing the S precursor, Na2S, Na2S2O3, or CS(NH2)2, led to the formation of 
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Figure 2.10 SEM images of various morphologies of CuS nanocrystals synthesized 
by the solvothermal method. (a) CuS nanotubes prepared in water and PVP.
[74] 
(b) 
Concave-faceted cuboctahedral CuS crystals prepared in EG.
 [75]
 (c) Octahedral 
Cu9S5 nanocrystals.
 [76]
 (d) CuS nanoflowers prepared with Na2S2O3 + CuCl2 in 
ethanediol. (e) CuS doughnut-shaped nanospheres prepared with CS(NH2)2 + 




2.2.2.2 Hydrothermal method 
     Similar to the solvothermal method, the hydrothermal method uses water as the 
main medium, which is very low-cost and able to dissolve other water soluble 
coordinating molecules (such as ethylenediamine, hydrazine hydrate, 
mercaptoethanol, etc.). The temperature adopted is often higher than 100 ℃ for the 
hydrothermal process, so that autogenous pressure will be developed in the closed 
system. The pressure generated in situ within the reactor not only strongly depends 
on the reaction temperature, but also relies on other experimental factors, such as the 
amount of liquid added and any dissolved salts. The hydrothermal and solvothermal 
processes are relatively low temperature processes and have many advantages such 
as fast reaction kinetics, short processing times, phase purity, high crystallinity, high 
yield, homogeneous particle products, easy composite formation, and narrow 
particle-size distributions. They are also cost-effective, environmentally benign, and 
easily scalable. Moreover, the hydrothermal and solvothermal processes facilitate 
different reactions, such as mulitcomponent reactions, heat treatment reactions to 
modify or change the composition, phase transformation reactions, ion exchange, 
crystal growth, dehydration reactions, decomposition reactions, extraction, 
precipitation, disproportionation reactions, crystallization, and solidification. There 
are also a few disadvantages to hydrothermal and solvothermal processes, such as (i) 
the need for expensive stainless-steel autoclaves and Teflon liners, (ii) problems with 
reproducibility of the product, because many occasional factors such as residual 
solvent on the wall surface, situation of the vessel sealing, etc., could affect the 
properties of the final product; (iii) possible safety issues during reaction processes, 
and (iv) the impossibility of studying the mechanisms of the in-situ reactions due to 
the closed (or ‗black box‘) systems.
[78]
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     As discussed previously in the section on the solvothermal method, the 
stabilizing/capping agents, and appropriate solvent and chalcogen sources affect the 
morphologies of the final TMC nanocrystals. The application of ―mixed solvents‖ in 
the hydrothermal method can be rather effective in some cases in producing TMCs 
with unique morphologies or new nanoarchitectures.
[40, 79-82]
 The mixed solvents, 
with the assistance of small organic amine molecules, can play the role of effective 
structure-directing agents in assisting anisotropic crystal growth.
[83-86]
 Gao et al. 
reported Fe7Se8 polyhedra with high-index facets and Fe7Se8 nanorods can be 
selectively synthesized by a thermal treatment in a mixed solvent of 
diethylenetriamine (DETA) and deionized water (DIW). It was found that the 
morphologies of Fe7Se8 nanocrystals can be effectively controlled by adjusting the 
volume ratio of DETA to DIW, suggesting the ―magic power‖ of mixed solvents for 
shaping nanocrystals with new morphologies and structures.
[80]
 Zhao et al. fabricated 
CuS nanostructures with the assistance of different organic amines using CuCl and 
thiourea as the precursors.  




Figure 2.11 SEM images of solution-based synthesized CuS nanostructures obtained 
from precursors Cu(NO3)2: Na2S2O3 = 1: 1 at 70 °C in 4 h using the following 





Nanostructures, including nanowires, nanotubes, and nanovesicles, can be obtained 
in the presence of triethylenediamine (TEDA), trimethylethylenediamine (TEMA), 
and di-n-butylamine (DBA), respectively. Different interactions between CuCl and 
amines were the key factor in structural and morphological control.
[88]
 Without the 
assistance of organic amines, diverse CuS nanostructures can be achieved under 
hydrothermal treatment, as shown in Figure 2.11, simply by varying the ratios of 
water: ethylene glycol as solvent.
[87]
 CuS nanotubes consisting of nanoparticles were 
obtained with an optimum solvent ratio (1:3 of water: EG, Figure 2.11d-e). The 
authors proposed that the formation of different morphologies can be attributed to the 
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optimum ratio of water to EG, which affects the solubility, reactivity, and diffusion 
behaviour of the reagents and intermediates. The reaction medium plays an important 
role in controlling the shape of the basic CuS building blocks in their self-assembly 
process. In particular, the higher viscosity of EG increases the steric hindrance in the 




2.2.3 Ion exchange method 
     The chemical transformation of nanocrystalline solids for inorganic nanostructure 
synthesis has emerged as a very promising strategy. Among the various chemical 
transformations, the ion exchange reaction is especially interesting, as it can alter the 
composition of the existing ionic nanocrystal by replacing the ion within the crystal 
lattice with a different ion. Ion exchangers include cation exchangers that exchange 
positively charged ions (cations) and anion exchangers that exchange negatively 
charged ions (anions) (ie. cation exchange and anion exchange reaction). Typically, 
the ion exchange reaction is based on the big difference in the solubility product (Ksp) 
between the original nanocrystals and the final product. In thermodynamic terms, the 
solubility product (Ksp) of an ionic solid is referred to as the equilibrium constant 
between an ionic solid and its dissolved state. It is related to the free energy change 
of a solution. Because the free Gibbs energy for insoluble materials (ΔG) can be 
expressed by Equation (2.1), in which R is the gas constant, T is temperature of the 
reaction system, Ksp is the solubility product of the insoluble MCs (MaXb, M is metal 





) are the concentrations of cations and anions in the system, respectively. Thus, 
the transfer reaction from the higher Ksp material to a lower one may happen 
spontaneously. 
         
   
   
                 (2.1) 
     
 (   )              (2.2) 
Although the ion exchange reactions are heavily effected by various factors, such as 
the activation energy barriers to phase change and surface energy change, the real 
concentration of ions in the solution, the effect of solvents, etc., we can still roughly 
make a judgement as to whether the ion exchange reaction can happen or not by 
using the solubility product.
 [89]
 The cation exchange reaction is particularly effective 
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for the transformation of TMCs,
[90-93]
 the crystal structures of which are determined 
by the framework of the chalcogen anions, and the metal cations are relatively 
mobile in the structure, leading to an easier replacement of the cations. The exchange 
reaction was found to rely on the thermodynamic driving force and the kinetics of a 
transformation (activation barrier). It is also possible that the transformation reaction 
from lower Ksp reactants to a higher Ksp product can occur via control of the reaction 
conditions.
[90]
 The solubility product of the ionic solids in the reaction medium is 
supposed to determine the thermodynamic direction of the transformation. When the 
ionic solid product has a lower solubility than a reactant one in the reaction medium, 
a forward reaction will occur, and the kinetics of the transformation can be controlled 
by tuning the reaction temperature to overcome the activation barrier. Because a 
selective increase in the solubility of a product salt can proceed via the cation 
exchange reaction, selective ligand complexation to the product salt can be an 
effective approach to turn a thermodynamically unfavourable reaction into a 
favourable one (such as from lower Ksp reactants to a higher Ksp product). A 
milestone was achieved when Alivisatos and coworkers pioneered reversible cation 
exchange reactions between CdE and Ag2E (E = S, Se, Te) nanocrystals in the form 
of spheres and tetrapods (Fig. 2.8).
[90]
 The reverse exchange reaction (Ag2E→CdE) 
was realized in the presence of complexing molecules (tributyl phosphate 
(TBP)/TOP) under ambient conditions. In addition, they also investigated the 
structural changes in nanocrystals during the cation exchange reaction by comparing 
their equilibrium and non-equilibrium shapes. Owing to the small dimensions, 
comparable to the reaction zone (∼5 nm), the reaction was immediately completed in 
1 s. The morphological change occurs when the size of the nanocrystal is smaller 
than the width of the reaction zone. Since the structure of the anion sublattice must 
be changed during the cation exchange reactions, the structural difference between 
the reactant and the product can play a vital role in determining the activation barrier. 
Volume change during the transformation is another factor in the morphology. Son 
and co-workers have reported that the final morphologies of the product 
nanomaterials are affected mainly by the volume change during the cation exchanges 
from CdE to MxEy (E = S, Se, Te; M = Pd, Pt).
[94] 
The product nanocrystals with 
large volume reduction can release the lattice stress by generating voids. 
Transformations with large volume expansion lead to fragmentation of the products 
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into nanoparticles. The products experiencing small volume changes readily 
preserved their original morphology. 
 
Figure 2.12 (A) Schematic demonstration of the reverse cation exchange between 
CdSe and Ag2Se. TEM images of the initial CdSe nanocrystals (B), Ag2Se derived 
via a forward cation exchange reaction (C), and CdSe nanocrystals recovered using a 
reverse cation exchange reaction (D). TEM images of the initial CdTe tetrapods (E), 
Ag2Te tetrapods produced from cation exchange of CdTe (F), and CdTe recovered 
through a reverse cation exchange reaction (G).  
 
By taking advantage of the partial transformation of ionic nanocrystals via cation 
exchange, heterostructured nanocrystals can be achieved. Typical examples include 
the CdS-Cu2S binary nanorods reported by Alivisatos et al.;
[95]
 the CdS-PtS, CdSe-






Ion exchange reactions also can be employed to prepare hollow structures of 
various TMC nanomaterials through a Kirkendall effect,
[97-101]
 a classical 
phenomenon in metallurgy, which involves a non-equilibrium mutual diffusion 
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process at the interface of a diffusion couple, causing the net flow and coalescence of 
lattice vacancies, and the final formation of voids near the original interface and 
within the fast-diffusion side.
[102]
 A pioneering work was reported by Yin et al.,
[97]
 
where it was demonstrated that hollow Co3S4, Co9S8, or CoSe nanocrystals can be 
fabricated by reacting Co nanocrystals with either sulfur or selenium in solution 
through a Kirkendall-effect-induced method. Each resultant TMC nanocrystal has a 
single void. The diameter of the final voids is much smaller than that of the original 
Co nanocrystals, indicating that the void formation is controlled by both the inward 
transport of sulfur (or selenium) anions and the outward diffusion of Co cations. 
They also found that the reaction temperature has a pivotal effect on the voids in the 
nanocrystals.
[98]
 Performing the reaction at high temperature (> 120 ℃) can lead to 
the rapid formation of a single void inside each shell and a porosity/defect structure 
is observed in the shells, whereas at room temperature, multiple voids are generated 
due to the strongly temperature-dependent diffusivities for vacancies, which lead to 
obvious fracturing and open structures (Figure 2.13).
[98]
 Except for hollow 
nanoparticles, the Kirkendall-effect-induced method is also promising for preparing 
other hollow nanostructures of various metal chalcogenides (MC) nanomaterials, 









Figure 2.13 Schematic illustration of the temperature dependence of hollow particle 




2.2.4 Liquid exfoliation method 
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     The development of two-dimensional (2D) materials with designed physical and 
chemical properties has been experiencing a renaissance since the arrival of graphene 
(the well-known 2D nanocarbon).
[105-110]
 In the big family of 2D materials, layered 
transition metal dichalcogenides (TMDs) are playing increasingly important roles in 
both fundamental research and technological applications due to their unique crystal 
structures, wide range of chemical compositions, and various material properties.
[105, 
110-112]
 Originating from the competition between the cationic d levels and anionic sp 
levels, most transition metal atoms (M) will react with chalcogen atoms (X) to form a 
X-M-X configuration with stoichiometry MX2 (Figure 2.13).
[105]
 Transition metals, 
ranging from group 4 to group 10, have different numbers of d-electrons, which fill 
up the non-bonding d bands to different levels, resulting in varied electronic 
properties, including insulating (such as HfS2, TiSe2), semiconducting (such as MoS2 
and WS2), metallic (NbS2 and VSe2), and superconducting (such as PdTe2) 
properties.
[105]
 Although the bonding within the hexagonal M layer and the two X 
layers is covalent, adjacent sheets of the sandwich layers are coupled by weak van 
der Waals interactions to form a 3D crystal, allowing the crystal to be readily cleaved 
along the layer surfaces.
[113, 114]
 It is assumed that about 40 MX2 compounds are 
layered structures, and they particularly found in the early transition metals of 
Groups 4-7 (except for manganese), whereas some of the group 8-10 TMDs are 
commonly found in non-layered structures (Figure 2.13).[105, 115]  
     Before using the extraordinary capabilities of these layered materials, bulk TMD 
crystals must be exfoliated into mono- or few-layer nanosheets to meet their full 
potential. Some single-layer graphene and TMD nanosheets can be harvested by 
using adhesive tape for mechanical cleavage due to the weak van der Waals 
interaction forces between neighbouring layers.
[116]
 Thus, nanosheets can be 
harvested from bulk materials by peeling or exfoliation by insertion of other 
compounds. Although this solid mechanical exfoliation method can fabricate 
samples with high quality, it remains a challenge to scale up the process for their real 
utilization. Inspired by the milestone work on the synthesis of sheets from bulk clay 
materials in the 1960,
[117]
 intense studies have been focused on exfoliating sheets of 
TMCs in solution.
[118-122] 
Owing to their layered structures, TMD bulk materials can 
be intercalated by various kinds of intercalation materials, such as organic molecules, 
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transition metal halides, and lithium ions.
[120]
 The resulting intercalated compounds 
can be exfoliated to mono- and  
 
Figure 2.14 (a) About 40 different layered TMD compounds exist. The transition 
metals and the three chalcogen elements that predominantly crystallize in those 
layered structures are highlighted in the periodic table. Partial highlights for Co, Rh, 
Ir, and Ni indicate that only some of the dichalcogenides form layered structures. (b) 
Schematic illustrations of of 2D TMDs. M represents a transition metal, and X 
represents a chalcogen. 
 
few-layer 2D TMD nanosheets by simple ultrasonication.
[123-127]
 The ultrasonication 
method is time-consuming, however, and the degree of lithium insertion is 
uncontrollable. Therefore, a controllable electrochemical lithiation method to 
produce high-yield, single-layer TMD nanosheets was developed.
[3]
 The lithium 
intercalation in bulk materials can be monitored and finely controlled during the 
discharge process by incorporating the layered TMD bulk material as the cathode in 
an electrochemical cell. The obtained intercalated compounds were then 
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ultrasonicated and exfoliated in water or ethanol to achieve high quality TMD 
monolayers on a large scale.
[128]
 It should also be noted that lithium intercalation 
chemistry often results in structural deformation in TMDs to alter electronic 
properties and even leads to the decomposition of TMDs and the formation of metal 
nanoparticles and Li2S. 
     Besides those factors (such as the kind and amount of intercalation substance and 
the surface energy of the layered materials) that influence the exfoliation of 
nanosheets, the surface tensions of the solvents also pay a key role in the liquid 
exfoliation technique to produce nanosheets, including monolayers. After dispersion 
and ultrasonication of each inorganic starting material in about 30 common solvents 
with varying surface tensions, 
Coleman and co-workers
[129]
 found that the best solvents have a surface tension close 
to 40 mJ m
-2
 by using optical absorption spectroscopy to measure the quantity of the 
dispersed materials. They proposed that successful solvents are those that minimize 
the energy of exfoliation. For example, N-methylpyrrolidone (NMP) and isopropanol 
(IPA) are very effective solvents for exfoliating various layered compounds. 
 
2.2.5 Microwave method 
     Microwave chemistry has been widely applied to prepare various kinds of 
inorganic nanomaterials in liquid phase owing to its specific advantages, such as high 
reaction rate (can reduce reaction time often by orders of magnitude), low processing 
costs, high yields, and side reaction depression.
[130]
 In the microwave frequency 
range (usually 0.3 to 2.45 GHz), electromagnetic energy is converted into thermal 
energy, which induces a chemical reaction leading to the synthesis of nanostructured 
materials. The microwave dielectric heating mechanism consists of two main 
processes, namely dipolar polarization and ionic conduction,
[130]
 which is different 
from the direct absorption of high energy electromagnetic radiation needed to induce 
chemical reactions. The microwave stimulation method has been greatly expanded to 
the synthesis of various MC nanomaterials.
[131-134]
 Feng et al. reported that carbon-
supported Co3S4 and CoSe2 nanoparticles with small sizes and narrow distributions 
can be prepared in situ within a short time (3-5 min) by microwave stimulation, 
while at least several hours were needed for the conventional heating method at a 
refluxing temperature of about 142 ºC.
[131]
 In another report, non-stoichiometric 
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copper sulfide (Cu9S8) nanorods were prepared by the microwave-assisted 
decomposition method from a previously formed precursor, which was made from a 
composite of [Cu(NO3)2∙3H2O] - sodium dodecyl sulphate (SDS)-thioacetamide 
(TAA).
[135]
 Ramanath et al. reported the rapid and scalable microwave-stimulated 
solvothermal synthesis of sulfurized Sb2Se3 nanowires and nanotubes.
[134]
 The 
diameter and length of these one-dimensional (1D) nanostructures can be controlled 
by adjusting the microwave dose (i.e. the microwave power × time). A similar 
morphology control process was reported by El-Shall and co-workers in the 
microwave synthesis of semiconductor nanorods and nanowires (Figure 2.15).
[136] 
By 
simply varying the microwave radiation times from 30-60 s to 1-2 min to > 3 min, 
the growth of ZnS and ZnSe nanowires from small spherical nuclei to short aligned 
rods to long assemblies of nanowires was accomplished in a stepwise manner (Figure 
2.15 ). 
 
Figure 2.15 TEM of ZnS (a) rods, (b) wires, (c) ZnSe wires, and (d) CdSe rods. 
Higher resolution images are shown in the insets.
[136]
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2.2.6 Electrodeposition method 
     Besides the microwave method, electrochemical deposition or anodization is 
another simple, low-cost, and high-throughput technique to directly fabricate 
nanostructures on the substrate. The electrodeposition method is based on the 
cathodic reduction reaction under stable voltage and current in aqueous or organic 
solvents. The substrate material, such as indium-tin oxide (ITO), anodized 
aluminium oxide (AAO), or other materials, can be used as a cathode and is 
immersed in a solution containing the metal salt to be deposited. The dissolved 
metallic ions are attracted to the cathode and then reduced to the metallic form.
[137]
 
The distinctive advantages of the electrodeposition method lie in the capacity to 
enable the conformal deposition of structures, and it can accurate control the quality 
of products, such as the thickness, morphology, and compositions of the deposited 
products via adjusting the current density, voltage, temperature, surfactants, 
concentration, selection of electrolyte and deposition substrate, etc. For example, 
copper sulfide nanostructures were deposited onto Cu substrates or Cu foil acting as 
anode and Ti metal as cathode in the voltage range of 1.5-8 V in Na2S aqueous 
solution.
[138]
 Cu2S and CuS nanorod and nanowall arrays were achieved by 
manipulating the voltage as well as the reaction temperature (Figure 2.16). 
 
Figure 2.16 Field emission SEM (FESEM) images of the morphology of copper 
sulfide nanowalls oriented vertically to the substrate formed by anodization of copper 
                                                                                                     Chapter 2 Iiterature Review 
42 
 
foil in aqueous Na2S electrolyte at low voltage and/or low temperature: (a) 1.5 V at 
room temperature (profile view), (b) 3 V at 5 °C (top-view), (c) 1.5 V at room 




Single-crystal CuTe nanoribbons with thickness of about 50 nm, width of 300-600 
nm, and lengths of several micrometers could be uniformly deposited on ITO-coated 
glass substrate in an aqueous solution of 20 mM TeO2, 0.2 mM CuSO4 and 0.536 M 
NH3·H2O at pH 13.
[139]
 Polycrystalline BiTe arrays of nanowires and nanotubes were 




2.2.7 Photochemical method 
     Photochemical synthesis is based on the use of powerful lasers to induce the 
decomposition of a certain precursor and then promote the initiation of the nucleation 
and growth of the nanocrystals. Various high energy light sources including light 
emitting diodes (LEDs, and ultraviolet (UV) and γ-ray sources are often selected for 
synthesis. The photochemical method has been commonly adopted to fabricate 
different TMC nanomaterials, such as ZnS nanowires,
[141] 





 Bi2Se3 nanospheres and nanorods,
[144]





 etc. Mathew et al. reported that copper 
sulfide (CuxS) particles had been synthesized via the photochemical method from an 
aqueous solution containing copper sulfate (CuSO4) and sodium thiosulfate (Na2S2O3) 
in different compositions.
[147]
 The particles of various compositions were deposited 
in an acidic medium (pH ∼ 3) for 1-2 hours of photoirradiation. The amount of 
particles formed depended on the irradiation time, and about 75% of the reagents 
were converted into fine CuxS particles. The photochemical strategy is 
environmentally-friendly, low-cost, safe, and can be conducted at low temperature 
compared with other synthetic methods. It should be noted, however, that this 




2.3 Biomedical application of transition metal chalcogenide based nanomaterials 
     As briefly discussed in the introduction section, TMC nanostructures have been 
widely investigated for diverse applications due to their wealth of properties. Here, 
we will review recent progress on transition metal chalcogenide based nanomaterials 
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in biomedical applications, which include 1) bioimaging, such as fluorescence 
imaging, photoacoustic imaging, and multimodal imaging; 2) photothermal therapy; 
and 3) drug and gene delivery.  
2.3.1 Fluorescence imaging 
     Similar to the rationale of nanotechnology, when the size of materials is reduced 
to the nanoscale range, the resultant nanomaterials possess unusual optical, electrical, 
magnetic, mechanical, and chemical properties, which are distinctly different from 
those of their bulk analogues. The semiconductor nanocrystals (also referred to as 
quantum dots (QDs)) exhibit strong size-dependence of their optical and electrical 
properties when their size is small enough (e.g. smaller than the Bohr radius). 
Fluorescent QDs include semiconducting nanoparticles from Groups IV (C, Si, and 
Ge dots),
[149-151]
 II-VI (CdE and ZnE, E = S, Se, and Te), III-V (InP), and I-III-VI 
(CuInS2, CuInSe2),
[152-154]
 among which, the TMC II-VI QDs (especially CdSe and 
CdTe based QDs) have been extensively investigated as prototypes of semiconductor 
QDs due to their strong quantum confinement effects and high fluorescence quantum 
yields (QYs).
[155-158]
 The earliest reported bioapplications of fluorescent QDs can be 
dated back to as early as 1998 when Bruchez et al. coated core-shell CdSe@CdS 
QDs with a thin layer of silica and then conjugated them with biotin.
[28]
 The 
biotinylated QDs were successfully applied to label 3T3 mouse fibroblast cells. Chan 
et al. used small-molecule mercaptoacetic acid (TGA) for solubilization and covalent 
protein attachment to make hydrophobic CdSe@ZnS QDs water-soluble, and then 
conjugated them with transferrin proteins.
[27]
  The TGA-modified QDs and 
transferrin-QD conjugates were incubated with HeLa cells, respectively, and it was 
found that no QDs could be observed inside the cell in the absence of transferrin, 
while QDs were internalized into the cells in the presence of transferrin due to the 
occurrence of receptor-mediated endocytosis. 
    Inspired by the above pioneering research, intense nonspecific or targeted bio-
labelling and imaging have been carried out at different levels, ranging from in vitro 
to in vivo models.[29, 30, 159]  In vitro nonspecific cellular labelling is often 
achieved by using the hydrophobic and electrostatic interactions between the surface 
capping molecules of QDs and biomolecules in the cell membrane. Therefore, their 
surface ligand properties and the cell type largely determine the nonspecific 
adsorption and uptake of QDs. In order to overcome nonspecific adsorption, 
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polyethylene glycol (PEG) and its derivatives have been used to modify the QD 
surface, as they can effectively minimize and prevent the nonspecific interactions of 
QDs with biomolecules, cells, and tissues. Similar to the in vitro nonspecific 
adsorption of cells, non-targeted QDs can accumulate within tumours through the 
enhanced permeability and retention (EPR) effect. Such passive targeting is 
attributed to the leakiness of the tumour vasculature and its poor lymphatic drainage, 
which enables QDs or other nanoparticles to accumulate in tumours.
[160]
 The EPR 
effect could lead to more than a 50-fold increase in nanoparticle accumulation within 
tumours, compared with healthy tissues.
[161]
 Generally, the longer the nanoparticle 
circulation time, the greater the EPR-induced accumulation.
[162]
 It is still a challenge, 
however, to maximize nanoparticle accumulation through the EPR effect, as this 
effect varies from tumour to tumour, and strongly depends on the particle size and 
the surface charge.
[160]
 In addition, the EPR effect is not commonly observed in some 
types of cancers, including gastric and pancreatic cancer.
[163]
 In other cases, the 
tumour core may not be well-perfused.
[164] 
 
     In contrast to passive targeting, active targeting can be achieved by attaching 
various targeting ligands to QDs to enable recognition of specific cell surface 
molecules or proteins. A wide variety of targeting moieties, such as small molecules 
(e.g. folic acid and hyaluronic acid), peptides (e.g. arginine-glycine-aspartic acid 
(RGD)), and proteins (e.g. antibodies, antibody fragments, transferrin, etc.), have 
been investigated for in vivo targeted imaging with QDs. For example, In 2004, Gao 
et al. reported a landmark work on in vivo cancer targeting with QDs.
[165]
 They first 
encapsulated hydrophobic luminescent CdSe@ZnS core-shell QDs with an ABC 
triblock copolymer (i.e. polybutylacrylate-polyethylacrylate-polymethacrylic acid) 
by using strong hydrophobic interactions between the capping ligands of the QDs 
(tri-n-octylphosphine oxide (TOPO)) and the hydrophobic segments of the block 
copolymer (polymer hydrocarbon). Then, they conjugated tumour-targeting ligands 
and drug-delivery functionalities (such as peptides, antibodies, or small-molecule 
inhibitors) with the polymethacrylic acid segment. The in vivo imaging results 
indicated that these QD probes accumulated at tumour sites through passive and 
active mechanisms, but passive targeting is much slower and less efficient than 
active targeting. 
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      Fluorescent imaging in the second near-infrared window (NIR-II, 1000 to 1400 
mm) has attracted intense attention due to the minimal body autofluorescence and 
negligible tissue scattering in this region, affording maximal penetration depth (> 5 
mm) for deep tissue imaging with high feature fidelity
[166-170]
 and a signal-to-noise 
ratio of > 100 compared to emission in the visible region (400-700 nm) and the 
traditional near-infrared window (NIR-I, 700-950 nm). When combined with 
wavelength-resolved imaging, the QD probes allow sensitive and multicolour 
imaging of cancer cells in living animals. The use of near-infrared-emitting QDs 
should improve both the tissue penetration depth and the imaging sensitivity owing 
to the reduced photon absorption and scattering by tissues. In the past decade, great 
efforts have been devoted to identifying NIR-II emitting agents for in vivo imaging 







have been successfully developed, the intrinsic toxicity of the heavy metal elements 
(Pb, Cd, and Hg) prevents their potential use in in vivo imaging in practice. Therefore, 
NIR-II fluorescent nanoprobes without these aforementioned toxic elements are 
highly desirable for biological imaging in this beneficial spectral region. Qiangbin 
Wang et al. reported a new type of NIR-II QDs, Ag2S QDs, by using thermal 
decomposition of a single-source precursor.
[168, 174]
 The PEGylated-Ag2S QDs mainly 
accumulate in the reticuloendothelial system (RES) after intravenous administration 
and can be gradually cleared out, mainly by faecal excretion, demonstrating low 
toxicity.
[175]
 They also synthesized Ag2Se QDs with their emission spectra centred at 
1300 nm (the optimal wavelength for in vivo imaging with the deepest tissue 
penetration due to the lowest photon absorption and tissue scattering).
[176]
 After 
functionalizing the surface of Ag2Se QDs with an amphiphilic anhydride-alt-1-
octadecene)-polyethylene glycol (C18-PMH-PEG) polymer, the obtained C18-PMH-
PEG-Ag2Se QDs exhibited bright NIR-II fluorescence, good water solubility, and 
high colloidal stability and photostability, as well as decent biocompatibility.  




Figure 2.17 (A) PEGylated-Ag2S QDs photoluminescence (PL) emission spectrum, 
with the inset showing an NIR-II PL image of the PEGylated-Ag2S QD suspension 
under an 808 nm excitation (left),  and an NIR-II PL image (right) collected in the 
1100-1700 nm region of a tumor-bearing BALB/c mouse treated with a 15 mg/kg 
dose of PEGylated-Ag2S QDs at 24 h post injection.
[175]
 (B) Optical properties of 
C18-PMH-PEG-Ag2Se QDs, with the inset showing a PL image of the C18-PMH-
PEG-Ag2Se QDs suspended in water at a concentration of 0.6 mg/mL (left), and in 





2.3.2 Photoacoustic imaging 
     Photoacoustic imaging (PAI) is a newly emerging biomedical modality that 
provides both high spatial resolution and strong biochemical contrast, benefiting 
from the combined merits of ultrasound imaging and optical imaging.
[177-180] 
Based 
on the ultrasonic signal generated from the photoacoustic effect, it is possible to 
obtain images with high spatial resolution and optical contrast in a region up to 5-6 
cm deep in biological tissues, which breaks through the optical diffusion limit.
[181, 182] 
PAI is based on the detection of thermoelastic expansion and ultrasonic signals 
induced by photothermal expansion of light-absorbing tissues or contrast agents 
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under irradiation by short laser pulses. Although PAI facilitates imaging of biological 
tissue based on endogenous chromophores (oxyhemoglobin and deoxyhemoglobin), 
its potential applications can be significantly expanded by exogenous contrast agents. 
One of the most important factors necessary for the fabrication of photoacoustic 
contrast agents is the ability to convert absorbed light into heat to produce ultrasound 
waves. Exogenous contrast agents with NIR (> 700 nm) absorption can be utilized to 
enhance the photoacoustic signal, due to their relatively low absorption coefficient 
and low scattering coefficient within this wavelength region, thus providing a 
relatively clear window for imaging with optical techniques. A great many 
metal/semiconductor materials possess this function, such as silver, gold, carbon, 
quantum dots, etc. By reconstructing the composition, size, shape, and optical 
properties of the imaged tissues, these structures have great potential in the detection 
and imaging of cancerous tissue as distinguished from healthy tissue. Owing to their 
intrinsic absorptive properties, plasmonic nanomaterials, such as gold nanostructures, 
are widely applied as potential PAI contrast agents.
[181, 183-185]
 Those nanostructures 
also have several limitations as contrast agents for PAI, however, including 
dependence of the optical properties on shape, size, and geometry of the 
nanoparticles (NPs) and on environmental factors. In addition, these NIR-absorbing 
nanostructures usually have relatively large sizes (usually > 35 nm TEM size) which 
can result in rapid capture by organs of the mononuclear phagocyte system (MPS) 
and slow clearance from the body.
[186-188]
 
     Benefiting from the strong localized surface plasmon resonance (LSPR) effect 
originating from free holes, copper chalcogenide based nanomaterials such as CuS 
and Cu2-Se nanoparticles provide an alternative to Au particle-based photoacoustic 
contrast agent due to their inherent low hole density and high hole effective mass.
[58, 
189-192]
 Chun Li et al. initially reported the use of CuS NPs as a novel class of contrast 
agent for in vitro and in vivo PAI.
[193]
 The absorption of CuS NPs could be tuned to 
peak at wavelengths greater than 900 nm. This makes it possible to use a Q-switched 
neodymium-doped yttrium aluminium garnet (Nd:YAG) laser, which emits laser 
light at 1064 nm, as the light source for PAI. The Nd:YAG laser at a setting of 1064 
nm can provide high pulsed energy with a nanosecond pulse width, which should 
translate to a stronger PAI signal, a higher signal-to-noise ratio, and a greater field-
of-view. Because of the low absorption and scattering coefficient in normal tissue at 
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1064 nm (the second optical window), the strong light absorbed at this wavelength 
by CuS NPs allows deep tissue PAI. Successful CuS NP mediated PAI of the lymph 
nodes and brain has been achieved in mouse models. Figure 2.18 presents PAI 
imaging of a mouse brain with CuS NPs. A nodule on the left cortex was clearly 
imaged (Figure 2.18b) 24 h after intracranial injection of 15 mL CuS NPs compared 
to the photoacoustic tomography (PAT) image acquired before injection (Figure 
2.18a). Nevertheless, the brain nodule in Figure 2.18c disappeared 7 days after 
injection in the photograph of the mouse head shown in Figure 2.18d, probably 
because the CuS NPs had been cleared from the injection site. These promising 
findings suggest that CuS NPs may be used for molecular PAI in clinical applications, 
especially for superficial tumors or lesions, such as for imaging breast lesions up to 5 
cm in depth, or possibly other superficial lesions in the skin, lymph nodes, limbs, and 
head and neck. Swihart et al. synthesized Cu2-xSe nanocrystals (NCs) via a hot 
injection method.
[192]
 The particle size could be tunable by adjusting the ratio of 
oleylamine to oleic acid and the reaction time. They found that the PAI detection 
limit of Cu2-xSe NCs was 400 times higher than that of Au nanocages. Later on, the 
same group synthesized Au-Cu2-xSe nanodimers using the seeded-growth method 
and demonstrated their utility for high contrast multimodal imaging in vitro and in 
vivo. The high photoacoustic imaging depth achieved, up to 17 mm, showed that 
these novel contrast agents could be clinically relevant.
[194]
 




Figure 2.18 In vivo PAT images of a mouse brain. Images were acquired using laser 
light (A) at a wavelength of 532 nm without CuS injection, (B) at 1064 nm after 24 h 
and (C) at 1064 nm 7 days after intracranial injection of CuS NP solution. (D) 
Photograph of the head of the mouse. Laser light was irradiated from the top The 




2.3.3 Multimodal Imaging 
     Multimodality and multifunctional imaging has evolved into a fast-growing 
research field with the goals of detecting and measuring biological processes in vivo 
non-invasively.[195, 196] Many traditional medical imaging techniques, such as 
computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound, 
have been routinely used to monitor the therapeutic effects of cancer intervention.
[195, 
197]
 The field of molecular imaging, recently defined by the Society of Nuclear 
Medicine as ‗‗the visualization, characterization, and measurement of biological 
processes at the molecular and cellular levels in humans and other living 





has flourished over the last decade. In general, molecular imaging 
modalities include molecular MRI (mMRI), magnetic resonance spectroscopy, 
optical bioluminescence imaging, optical fluorescence imaging, targeted ultrasound, 
single-photon emission CT (SPECT), and positron emission tomography (PET).
[199]
 
However, monomodal imaging of nanoparticles makes it difficult to satisfy ideal 
imaging demands such as integrity of spatial resolution and ultrasensitivity, owing to 
the respective drawbacks of the various methods.
[200, 201]
 For instance, MRI has 
superb soft tissue contrast and good spatial resolution, but it suffers from poor 
sensitivity; fluorescent imaging has excellent sensitivity, but it faces the challenge of 
quantification and deep tissue penetration. Although PET is superior in sensitivity, 
quantification, and tissue penetration, its resolution is relatively low. The 
combination of multiple imaging techniques using a single probe can potentially 
overcome these disadvantages and provide synergistic information. 
Many hybrid systems that combine two or more of these imaging modalities 
are also commercially available, and certain others are under active development.
[202-
204]
 In the clinic, integrated examination using PET/CT has gained widespread 
acceptance as a tool for tumor diagnosis, staging, prognosis, treatment planning, and 
assessment of treatment response. Similarly, PET/MRI has begun to be used as an 
alternative hybrid modality for clinical applications. The combination of 
PET(PAI)/CT or PET(PAI)/MRI may offer new opportunities by providing 
potentially more comprehensive and accurate information as a result of the 
complementary features of these technologies. Therefore, attempts have been made 
to develop plasmonic CuS-based NPs as contrast agents for CT or MRI. The copper 
ion (II) is regarded as a candidate MRI contrast agent because it possesses unpaired 





 at 3 T, which was substantially lower than that of gadolinium-
diethylenetriamine penta-acetic acid (Gd-DTPA) (∼4.5 mM−1 s−1). Nevertheless, 
contrast enhancement with Cu2-xS NPs was visualized in vivo either after intravenous 
(IV) injection or intratumoral injection. In addition, due to their NIR optical 
absorption, these NPs also served as an efficient contrast agent for enhancing PAI.
[205]
 
Recently, Ni-doped CuS NPs were proposed for PAI/MRI dual imaging.
[206]
 The 
hybrid nanostructures demonstrated NIR absorption and enhanced T1 relaxivity, 
which is suitable for PAI and MRI, respectively. The relaxivity of the hybrid 
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, which was nearly 8 times higher than that of 
pegylated multidentate polymer with imidazole pendant groups (PMAH-PEG)-Ni
2+
. 
These dual modality Ni-CuS hybrid NPs were successfully used for in vivo lymph 
node PAI and MRI (Figure 2.19).  
 
Figure 2.19 In vivo PAI imaging of a mouse before (a) and after (b) injection with 
PMAH-PEG-capped Ni-doped CuS NPs; T1 weighted MRI of the mouse before (c) 





For a fluorescence/MRI dual-modality imaging nanoprobe, a core/shell nanoprobe 
was constructed for dual-modality imaging of breast cancer, which was composed of 
an Fe3O4 NP core and two outside layers of silica shell.
[207]
 CdSe/ZnS QDs (with 
emission peak at 600 nm) and NIR fluorescent CdSeTe/CdS QDs (with emission 
peak at 780 nm) were embedded inside each silica layer to form the dual modality 
agent, which was denoted as the MQQ-probe. After conjugation with an antibody 
against human epidermal growth receptor 2 (anti-HER2 antibody), the HER2-MQQ-
probe was injected into tumor-bearing mice. NIR fluorescence imaging demonstrated 
enhanced tumor specific accumulation of the HER2-MQQ-probe as compared to the 
non-targeted MQQ-probe. Meanwhile, MRI provided the detailed anatomical 
structure of the tumor. 
2.3.4 Photothermal therapy 
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     Recently, near-infrared (NIR) (700-3000 nm) laser-induced photothermal therapy 
(PTT), which can localize elimination of tumour cells without affecting healthy 
tissue, has emerged as a new effective cancer treatment.
[208, 209]
 As blood cells and 
water barely absorb NIR, NIR can penetrate tissues to reach deeply-placed, optically 
sensitive nanoparticles. As a result, near-infrared light-responsive nanomaterials 
which have strong absorption in the NIR region can absorb penetrating NIR to 
generate local heat for PAI imaging and produce hyperthermia (> 45 °C) to kill 
tumor cells directly.
[210]
 Thus, PTT as a highly promising non-invasive bioimaging 
technique that has attracted tremendous attention in the past few years owing to its 
highly specific selectivity towards the targeted sites. The key to PTT is the use of 
NIR-responsive nanomaterials, owing to their unique physical and chemical 
properties. It is well known that intravenously administered nanoparticles 
preferentially accumulate in tumours in a passive process through the enhanced 
permeability and retention (EPR) effect,
[211]
 and also have longer retention times in 
tumour sites than small molecules, so that they provide a much longer time window 
for tumour diagnosis and therapy. Various near-infrared light-responsive 







 and other related materials,
[220-222]
 are 
designed to achieve PTT. Herein, we would like to review the progress on copper 
chalcogenide nanocrystals, one kind of transition metal chalcogenide used for PTT. 
     Copper-based nanocrystals (NCs), such as copper sulfide (CuS) and copper 
selenide (Cu2Se), have emerged as excellent new photothermal agents due to their 
strong absorbance in the NIR region. In 2010, Li and co-workers first synthesized 
thioglycolic acid-stabilized CuS nanoparticles via a wet chemistry method and 
applied it as a new type of agent for photothermal ablation of cancer cells.
[218]
 These 
uniform CuS nanoparticles have a mean size of approximately 3 nm and show an 
increased absorption band in the NIR region, with maximum absorption at 900 nm. A 
further cell photothermal destruction assay and toxicity assay indicated that the CuS 
nanoparticles displayed outstanding photothermal ablation efficiency and minimal 
cytotoxic effects. The only challenging issue is that for in vivo applications, a high 
powered laser is required, as high as 16 and 24 W/cm
2
, which is ~48 and 72 times 
higher, respectively, than the conservative limit (~0.33 W/cm
2
) for activation due to 
their relatively weak absorbance and poor photothermal conversion efficiency. In 
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order to improve the photothermal conversion efficiency, Tian et al. reported 
hydrophilic flower-like CuS superstructures with a mean size of ~1 µm as an 
efficient 980 nm laser-driven photothermal agent for ablation of cancer cells, which 
were synthesized by using a controllable hydrothermal route assisted by poly(vinyl 
pyrrolidione) (PVP) and were assembled from hexagonal plate-like building blocks 
(Figure 2.20a).
[219]
 The uniform and monodispersed three-dimensional (3D) CuS 
hierarchical structures exhibited enhanced absorption and ~50% increased 
photothermal conversion efficiency upon irradiation with a 980 nm laser when 
compared to the nanoplates (Figure 2.20b). It was supposed that the faceted end 
planes of these crystalline hierarchical structures can serve as excellent laser-cavity 
mirrors for a 980 nm laser, which led to a great improvement in the reflection and 
absorption capability of the laser. The efficacy of these agents for photothermal 
ablation was evaluated both in vitro and in vivo, and the results showed that even at a 
low laser power density of < 1 W/cm
2
, the CuS nanostructures were capable of 
inducing cell death in vitro (Figure 2.20c). Furthermore, histological examination of 
the tumours treated with CuS hierarchical structures showed degenerative necrotic 
and karyolytic regions. Nevertheless, although the CuS hierarchical structures 
showed enhanced photothermal conversion efficiency, the large mean size (~1 µm) is 
a huge obstacle that prevents this material from being a suitable photothermal agent 
in biological applications. Unfortunately, the absorption intensity of CuS 
nanomaterials is greatly affected by the particle size and is reduced dramatically with 
decreasing size. For instance, the photothermal conversion efficiency of small CuS 
NCs (~ 3 nm) was too low for them to serve as in vivo PTT agents. Therefore, there 
is an urgent need to develop novel copper chalcogenide semiconductors with small 
size (< 100 nm) but high photothermal conversion efficiency to meet the demands of 
biological application. As a result, Tian and colleagues developed hydrophilic Cu9S5 
plate-like nanocrystals with a mean size of ~70 nm × 13 nm by a simple thermal 
decomposition route followed by a ligand exchange process.
[56]
 This Cu9S5 exhibited 
superior photothermal conversion efficiency, up to 25.7%, which is higher than that 
of as-synthesized Au nanorods (23.7%). More importantly, cancer cells can be 
efficiently killed in vivo by the photothermal effect, which can be realized by a very 
low concentration (40 ppm) aqueous dispersion of the Cu9S5 NCs under irradiation 
by a 980 nm laser with a low and safe power density of 0.51 W/cm
2
. Therefore, these 
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Cu9S5 NCs have great superiority as a new photothermal agent for the NIR-induced 
photothermal ablation (PTA) of cancer, due to their small size (< 100 nm) and high 
photothermal conversion efficiency, as well as their low cost and low cytotoxicity. 
 
Figure 2.20 Photothermal ablation with CuS hierarchical structures. (a) Schematic 
representation of a CuS hierarchical structure with nanosheets serving as laser-cavity 
mirrors for a 980 nm laser and its photothermal conversion. (b) The CuS hierarchical 
structures exhibited superior photothermal properties when compared with the 
building blocks. (c) CuS hierarchical structures can cause efficient photothermal 
ablation when excited with a 980 nm laser with power density of < 1 W/cm
2
. In vitro, 
only dead HeLa cells can be labeled with trypan blue. In PC-3 tumour-bearing mice, 





     Similar to CuS nanomaterials, amphiphilic polymer-coated Cu2-xSe nanocrystals 
approximately 16 nm in diameter were demonstrated to be an effective photothermal 
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transduction agent, as shown in Figure 2.21a.
[223]
 The nanocrystals readily disperse in 
water and possess strong NIR optical absorption with a high molar extinction 
coefficient at 980 nm. The photothermal conversion efficiency of Cu2-xSe 
nanocrystals was comparable to those of the Au nanorods (NRs) and Au nanoshells 
when exposed to an 808 nm laser with a 2 W cm
-2
 power density (Figure 2.21b). In 
vitro PTT of Cu2-xSe NCs in the presence of human colorectal-cancer cells (HCT-116) 
caused cell destruction after 5 min of laser irradiation at 30 W cm
−2
, whereas 
photothermal cell destruction was not observed in either the cells treated with Cu2-
xSe alone (without laser) or the cells treated with laser irradiation alone (without Cu2-
xSe), as shown in Figure 2.21c. The example discussed above demonstrates the 
promising application of copper based NCs as an ideal photothermal agent for in vivo 
PTT of tumor tissues, and surface-modification strategies are currently urgently 
needed to endow copper based NCs with drug-delivery capabilities for applications 
in thermo-chemotherapy. 
 
Figure 2.21 Copper selenide nanocrystals, to be used as a photothermal therapy agent. 
(a) TEM image of copper selenide nanocrystals. The inset shows a photograph of 
oleylamine-capped Cu2-xSe nanocrystals dispersed in chloroform. (b) Plot of the 
photothermal transduction efficiencies for the Cu2-xSe nanocrystals, Au nanorods, 
and Au nanoshells. (c) Comparison of photothermal destruction of cancer cells 
without (top row, left and right) and with (bottom row, left and right) the addition of 
Cu2-xSe nanocrystals. Cells irradiated at 30 W cm
−2
 with an 800-nm laser for 5 min 




2.3.5  Drug and gene delivery 
     During the past several decades, smart and multifunctional drug delivery systems 
have achieved great developments in terms of targeting, low toxicity, excellent 
intracellular biostability and biocompatibility, multidrug delivery, and 
theranostics.
[224-226]
 Diverse drug delivery systems, such as hydrogels,
[227]
 







 and inorganic nanoparticles,
[230-232]
 have been widely 
used as carriers for drug delivery. Among these carriers, CuS NPs have demonstrated 
promising potential as drug carriers. Some reports have shown that CuS 
nanomaterials, including hollow nanostructures[233] and mesoporous silica 
nanocomplexes,
[234]
 can be used to control drug delivery. Owing to the mesoporous 
and hollow structure of CuS NPs, they possess drug delivery capability and sustained 
drug-release properties. Hollow CuS NPs were used as a vehicle for enhanced 
transdermal drug delivery through a localized thermal effect on the skin from a 
nanosecond-pulse laser. Hollow CuS NPs were also coated with chitosan for the 
delivery of an immunostimulatory agent that enhances immunotherapy (Figure 
2.22a).
[235]
 In this study, it was shown that there was PTT-induced release of tumor 
antigens into the surrounding milieu, while CpG (cytosine triphosphate 
deoxynucleotide ("C") followed by a guanine triphosphate deoxynucleotide ("G"), 
with the "p" referring to the phosphodiester link between consecutive nucleotides), 
potentiated host antitumor immunity. The results demonstrated that combined 
photothermal immunotherapy is more effective than either immunotherapy or PTT 
alone against primary (treated) and distant (untreated) tumors. Moreover, these 
hollow CuS nanoparticles are biodegradable and can be eliminated from the body 
after laser excitation. Because hollow CuS NPs possess large specific surface areas 
and numerous mesoporous pores, one could efficiently load them with hydrophobic 
drug molecules. For example, camptothecin was loaded onto hollow CuS NPs, and 
its release from the NPs could be remotely controlled using a 980 nm NIR laser.
[236]
 
Synergistic antitumor activity was achieved by integrating PTT and chemotherapy, 
enabled by a single NP system. In another study, CuS nanocages were synthesized 
using a solid-liquid reaction between Cu2O nanocubes and thiourea.
[237]
 The CuS 
nanocages displayed exceptionally high drug loading capacity for doxorubicin (DOX) 
and released the anticancer drug in a pH-dependent fashion. Such strategies to 
develop multifunctional NPs represent a promising avenue for enhancing antitumor 
efficacy. 




Figure 2.22 (a) Schematic illustration of assembly of HCuSNPs-CpG conjugates, 
near-infrared light-triggered disintegration of HCuSNPs, and system reassembly. 
HCuSNPs-Chi: chitosan-coated HCuSNPs. Chi-CpG-NPs: chitosan-CpG 
nanocomplexes. SCuSNPs: small CuS NPs.
[235]
 (b) Schematic illustration of the 
synthetic protocol for Cu9S5 @mSiO2-PEG core-shell nanocomposites. Schematic 
illustration of the nanocomposites as a multifunctional nanoplatform for combining 





     Mesoporous silica is a form of silica that contains pores that are 2-50 nm in 
diameter. The large surface area of the pores of mesoporous silica NPs allows the 
particles to be filled with drugs or imaging agents. Song et al. coated CuS 
nanocrystals with a mesoporous silica (mSiO2) shell to form Cu9S5@mSiO2-PEG 
core-shell nanostructures for cancer drug delivery (Figure 2.22b).
[234]
 The 
mesoporous silica shell is provided as the carrier for loading DOX, and the release of 
DOX from the nanostructures could be triggered by pH and NIR light. The same 
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group also conjugated folic acid to CuS@mSiO2-PEG core-shell nanostructures for 
targeted delivery.
[238]
 In another study, DOX-loaded core-shell Cu9S5@mSiO2 NPs 
were incorporated into poly(ε-caprolactone) and gelatin to form nanofibrous fabrics 
using an electrospinning process. The resultant composite fibers could be implanted 
directly in the tumor to achieve combined chemotherapy via the controlled release of 
DOX from the mesoporous silica and PTT with the imbedded Cu9S5 NPs.
[239]
 Several 
other CuS NP-mesoporous silica systems based on similar concepts have been 
developed and tested.
[240, 241]
 In one system, mesoporous silica was conjugated to 
CuS NPs with two complementary DNA sequences.
[240]
 In this study, CuS NPs acted 
as both a gatekeeper, preventing premature release of drugs, and as a photothermal 
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Chapter 3 Experimental Methods 
3.1 Chemicals and Materials 
The chemicals and materials used in this thesis are listed in Table 3.1. 
Table 3.1 Chemicals and materials used in this work. 
Chemicals/Materials Formula Purity (%) Supplier 
Acetone (CH3)2CO > 99.9 Sigma-Aldrich 
Ammonium nitrate NH4NO3 98 Sigma-Aldrich 
Ammonium hydroxide solution NH3·H2O 28.0-30.0 Sigma-Aldrich 
Anhydrous ethanol C2H6O > 99.5 Sigma-Aldrich 
Ascorbic Acid C6H8O6 98+ Alfa Aesar 
Cadmium chloride 
hemi(pentahydrate) 
CdCl2·2.5H2O 98 Sigma-Aldrich 
Copper (II) Chloride Dihydrate CuCl2·2H2O >99 Sinopharm 
Copper(II) sulfate pentahydrate CuSO4·5H2O 99 Sinopharm 
Cyclohexane C6H12 99.5 Sigma-Aldrich 




25  Sigma-Aldrich 
Hydrochloric acid HCl 37 Sigma-Aldrich 
Iron (III) chloride hexahydrate FeCl3·6H2O 97 Sigma-Aldrich 
Iron (II) sulfate heptahydrate FeSO4·7H2O ≥99 Sigma-Aldrich 
Mercaptosuccinic acid C4H6O4S 99 Sigma-Aldrich 
Milli-Q water H2O  18.2 
MΩ∙cm 
NA 
Nitric acid HNO3 65 Sigma-Aldrich 
Rhodamine 6G C28H31N2O3Cl 99 Aldrich 
Selenium dioxide SeO₂ 99.9 Aladdin 
Selenium powder (-100 mesh) Se ≥99.5 Sigma-Aldrich 






Sodium borohydride NaBH4 99 Sigma-Aldrich 
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Sodium tellurite Na2TeO3 99 Sigma-Aldrich 
Tetraethyl orthosilicate C8H20O4Si 99 Sigma-Aldrich 
Toluene C6H5CH3 99.8 Sigma-Aldrich 
Triethylamine C6H15N 99 Sigma-Aldrich 


















3.2 Materials preparation 
     As discussed in the section of literature review, liquid-phase-based wet chemical 
methods have been witnessed to be powerful for obtaining desired nanostructured 
TMCs with controlled size, compositions and shapes. For the preparation of 
nanomaterials with different morphologies, liquid phase syntheses are always 
preferred. These synthetic reactions proceed at relatively lower temperatures and 
therefore require lower energies. The main preparation methods used in this thesis 
are also liquid-phase-based wet chemical methods including the aqueous refluxing or 
hydrothermal method, biphase stratification approach, aqueous reduction-precipitate 
reaction and high-temperature coprecipitation approach.  
3.2.1 Aqueous refluxing or hydrothermal method 
     The MSA-capped CdTe QDs in this thesis can be synthesized via refluxing or 
hydrothermal treatment method. Over the past decades, a variety of synthetic 
methods have been developed for the fabrication of QDs. Based on the different 
media used, these methods can be broadly classified into two types: the 
organometallic route and aqueous synthesis. QDs synthesized in these organic 
solvents possess nearly perfect crystal structures, and thus high fluorescence QY. 
Narrow size distribution is another advantage for QDs prepared via this route. On the 
other hand, the hydrophobic surface of QDs synthesized using this method is a major 
obstacle for biological applications. In contrast, aqueous synthesis, with the 
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advantages of improved simplicity/reproducibility and less toxicity, has gradually 
become a preferred option, despite the lower QY and broader size distribution. For 
example, hydrophilic thiol-capped QDs are more suitable for biomedical applications 
because of their higher stability and better compatibility in biological environment 
compared to those prepared in organic solvent. In this thesis, MSA-capped CdTe 
QDs were synthesized via refluxing method. Specifically, the cadmium chloride 
(CdCl2, 0.04 M, 4 mL) and sodium citrate tribasic dehydrate (400 mg) were diluted 
to 50 mL in a three-necked flask, and stirred at room temperature for 1 h. Na2TeO3 
(0.01 M, 4 mL), MSA (100 mg), and sodium borohydride (NaBH4, 50 mg) were then 
added under vigorous stirring. When the color of the mixture turned green, the flask 
was attached to a condenser and refluxed at 100 °C under N2 flow for 3 h. 
3.2.2 Biphase stratification approach 
     It is well known that soft-templating approach is one of the current most useful 
synthetic methods for the ordered mesoporous silica via surfactant molecular self-
assembly. It has indicated that the soft-templating approach usually needs a 
homogeneous reaction system, whether the soft templates are micelles assembled 
with surfactants or nanoemulsions constituted of surfactants and oil drops. In this 
doctoral work, we prepared uniform monodispersed mesoporous silica nanospheres 
with large center-radial pore channels in oil-water biphase stratification reaction 
system, which is a heterogeneous reaction occurred in the macroscopic interface. 
Typically, a mixed solution (the lower aqueous phase) containing 18 mL H2O, 12 mL 
CTAC (25 wt% in H2O), and 45 µL of TEA was added into a 100 mL round bottom 
flask and stirred for 1 h at 60 °C. Then, 1 mL TEOS (20% v/v in cyclohexane) as 
upper oil phase was gently dropped in, and the solution flask was attached to a 
condenser. The reaction was maintained at 60 °C for 8 h in an oil bath with reflux 
under magnetic stirring (100 rpm). The products were collected after removal of the 
upper oil layer, and then centrifuged and washed several times with ethanol to 
remove the residual reactants. 
3.2.3 Aqueous reduction-precipitate reaction 
     In this doctoral work, in order to develop a large scale, low cost and generic route 
to fabricate nanostructured TMCs with good properties control, MSA was used as a 
stabilizer and selenium powder, which are cheaper and more stable and easily can be 
reduced to Se
2-
 by using the common reduce agent of NaBH4, are selected to be 
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starting precursors due to that the Se
2-
 ions are not stable in water and air. After 
further optimizing of this route, ultra-small metal chalcogenide nanostructures can be 
fabricated by co-precipitation of cationic and anionic precursors in aqueous solution 
after a reduction procedure under room temperature. The typical procedure is that 
39.48 mg (0.5 mmol) Se powder was reduced by 56.75 mg (1.5 mmol) NaBH4 in 50 
mL H2O under magnetic stirring at room temperature with the protection of inert gas. 
0.17 g (1 mmol) CuCl2·2H2O and 1 g (6.66 mmol) MSA were completely dissolved 
in 5 mL distilled water and then added into the selenium precursor solution to 
immediately generate a black solution, which indicated the formation of copper 
selenide nanoparticles. The black solution was subsequently purified by 
ultrafiltration at 5000 rpm, using a membrane with a molecular weight cutoff of 30 
kDa. 
 
3.3 Physical and chemical characterization 
3.3.1  X-ray powder diffraction (XRD) 
     XRD is a basic and rapid analytical technique primarily used for phase 
identification and can determine the atomic and molecular structure of a crystal, in 
which the crystalline atoms cause a beam of incident X-rays to diffract into many 
specific directions. Prior to the determination of the average bulk composition, the 
analysed material could be finely ground and, homogenized. A crystallographer can 
produce a three-dimensional picture of the density of electrons within the crystal by 
measuring the angles and intensities of diffracted beams. From this electron density, 
the mean positions of the atoms in the crystal can be determined, as well as their 
chemical bonds, their disorder and various other information. X-ray diffraction is 
based on constructive interference of monochromatic X-rays and a crystalline sample. 
These X-rays are generated by a cathode ray tube, filtered to produce monochromatic 
radiation, collimated to concentrate, and directed toward the sample. The interaction 
of the incident rays with the sample produces constructive interference (and a 
diffracted ray) when conditions satisfy Bragg's Law (nλ=2d sin θ). This law relates 
the wavelength of electromagnetic radiation to the diffraction angle and the lattice 
spacing in a crystalline sample. These diffracted X-rays are then detected, processed 
and counted. By scanning the sample through a range of 2θ angles, all possible 
diffraction directions of the lattice should be attained due to the random orientation 
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of the powdered material. Conversion of the diffraction peaks to d-spacings allows 
identification of the mineral because each mineral has a set of unique d-spacings. 
Typically, this is achieved by comparison of d-spacings with standard reference 
patterns. X-ray powder diffraction is most widely used for the identification of 
unknown crystalline materials (e.g. minerals, inorganic compounds). Determination 
of unknown solids is critical to studies in geology, environmental science, material 
science, engineering and biology. 
 
3.3.2  Raman spectroscopy 
     Raman spectroscopy is a widely used spectroscopic technique to investigate 
vibrational, rotational, and other low-frequency modes in a chemical system in both 
qualitative and quantitative applications. Laser light from the monochromatic light 
source, which usually is in the visible, near infrared, or near ultraviolet range, is 
applied to illuminated the material, leading to both elastic scattering (Rayleigh 
scattering) and inelastic scattering (Stokes and anti-Stokes Raman scattering). The 
laser light interacts with molecular vibrations, phonons or other excitations in the 
system, resulting in the energy of the laser photons being shifted up or down. The 
shift in energy gives information about bands between molecular of samples and 
vibrational modes in the system. The unique position and intensity of peaks in 
spectrum make Raman spectroscopy able to identify the chemical elements in the 
qualitative analysis. Besides, compared to infrared bands, Raman bands are 
inherently sharper, which present for more straightforward quantitative analysis. In 
this doctoral work, Raman spectra of sampleswere collected using a Raman 
spectrometer (Lab RAM HR, Horiba Jobin Yvon SAS) with a laser at 632.8 nm 
excitation on a 300 lines/mm grating and a chargecoupled detector CCD. A neutral 
density filter is applied to adjust the laser intensity in the measurement. 
 
3.3.3  Fourier transform Infrared spectrometer (FTIR) 
     Fourier transform infrared spectroscopy (FTIR) is a kind of molecule vibration 
spectroscopy which is used to obtain an infrared spectrum of absorption or emission 
of a solid, liquid or gas. Infrared spectroscopy probes the molecular vibrations. 
Functional groups can be associated with characteristic infrared absorption bands, 
which correspond to the fundamental vibrations of the functional groups. Thereby, it 
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is most commonly used for the identification of unknown pure organic compounds. 
In FTIR, infrared radiation of a broad range of wavelengths is passed through an 
interferometer and a pathlength difference is introduced into one part of the light 
beam. This IR beam is then passed through the sample, which absorbs light energies 
corresponding to various bond-vibration and rotation frequencies. The beam is then 
focused on a detector, and a computer calculates the absorption of the IR frequencies 
by the sample, identifying compounds present and their concentration in the sample. 
In this study, FTIR spectra were collected on a Shimadzu IRPresting-21 model 
Fourier transform infrared spectrometer. 
 
3.3.4  X-ray Photoelectron Spectroscopy (XPS) 
     XPS is a surface-sensitive quantitative spectroscopic technique that measures the 
elemental composition, empirical formula, chemical state, binding energies and 
densities and electronic state of the elements that exist within a material in its as-
received state, or after some treatment, for example: fracturing, cutting or scraping in 
air or ultra-high vacuum to expose the bulk chemistry, ion beam etching to clean off 
some or all of the surface contamination and so on. XPS spectra are obtained by 
irradiating a sample with a beam of X-rays while simultaneously measuring the 
kinetic energy and number of electrons that escape from the top 0 to 10 nm of the 
material being analyzed. XPS detects only those electrons that have actually escaped 
from the sample into the vacuum of the instrument, and reach the detector. In order 
to escape from the sample into vacuum, a photoelectron must travel through the 
sample. Photo-emitted electrons can undergo inelastic collisions, recombination, 
excitation of the sample, recapture or trapping in various excited states within the 
material, all of which can reduce the number of escaping photoelectrons. These 
effects appear as an exponential attenuation function as the depth increases, making 
the signals detected from analytes at the surface much stronger than the signals 
detected from analytes deeper below the sample surface. Thus, the signal measured 
by XPS is an exponentially surface-weighted signal, and this fact can be used to 
estimate analyte depths in layered materials. A typical XPS spectrum is a plot of the 
number of electrons detected (sometimes per unit time) (Y-axis, ordinate) versus the 
binding energy of the electrons detected (X-axis, abscissa). Each element produces a 
characteristic set of XPS peaks at characteristic binding energy values that directly 
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identify each element that exists in or on the surface of the material being analyzed. 
These characteristic spectral peaks correspond to the electron configuration of the 
electrons within the atoms, e.g., 1s, 2s, 2p, 3s, etc. The number of detected electrons 
in each of the characteristic peaks is directly related to the amount of element within 
the XPS sampling volume. XPS experiments in this thesis were carried out on a VG 
Scientific ESCALAB 2201 XL instrument using aluminum Kα X-ray radiation. All 
the XPS data was analyzed using the commercial CasaXPS 2.3.15 software package. 
Before analysis, the spectra were calibrated by C 1s = 284.6 eV. 
 
3.3.5  Transmission Electron Microscopy (TEM)  
     TEM is a microscopy technique which can display morphology images of 
samples by using electrons beam transmitted through an ultra-thin specimen. The 
image is formed from the interaction of the electrons transmitted through the 
specimen and is magnified and focused onto an imaging device, such as a fluorescent 
screen, on a layer of photographic film, or to be detected by a sensor such as a 
charge-coupled device. TEM is specially used to reveal morphology, crystal structure, 
an internal structure in nanoscale specimen and are capable of imaging at a 
significantly higher resolution than light microscopes, owing to the small de Broglie 
wavelength of electrons. This enables the instrument's user to examine fine detail, 
even as small as a single column of atoms, which is thousands of times smaller than 
the smallest resolvable object in a light microscope. Selected area electron diffraction 
(SAED) is an effective technique for observing crystal orientation, which can be 
performed inside the TEM. As a diffraction technique, SAED can be used to identify 
crystal structures and examine crystal defects. For example, for thin crystalline 
samples, this produces an image that consists of a pattern of dots in the case of a 
single crystal, or a series of rings in the case of a polycrystalline material. Scanning 
transmission electron microscope (STEM) is the associated technique of TEM which 
can be modified into by the addition of a system that rasters the beam across the 
sample to form the image, combined with suitable detectors and enables various 
analysis techniques such as mapping by energy dispersive X-ray spectroscopy (EDS), 
electron energy loss spectroscopy (EELS), and annular darkfield imaging (ADF). 
Moreover, these signals can be obtained simultaneously, allowing direct correlation 
of image and quantitative data. The TEM images in this doctorial work were 
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collected on a JEOL-2010 and a JEOL ARM-200F microscope operated at 200 kV. 
Elemental mapping was performed on the X-ray spectrometer attached to the JEOL 
ARM-200F instrument by using Al grids. 
 
3.3.6  Thermogravimetric analysis (TGA) 
     TGA is a method of thermal analysis in which changes in physical and chemical 
properties of materials are measured as a function of increasing temperature (with 
constant heating rate), or as a function of time (with constant temperature and/or 
constant mass loss). Such analysis relies on a high degree of precision in three 
measurements: weight, temperature, and temperature change. As many weight loss 
curves look similar, the weight loss curve may require transformation before results 
may be interpreted. A derivative weight loss curve can be used to tell the point at 
which weight loss is most apparent. Again, interpretation is limited without further 
modifications and deconvolution of the overlapping peaks may be required. This 
technique is capable to determine selected characteristics of materials that exhibit 
either mass loss or gain due to decomposition, oxidation, or loss of volatiles (such as 
moisture). For instance, TGA is commonly employed in research and testing to 
determine characteristics of materials such as polymers, to determine degradation 
temperatures, absorbed moisture content of materials, the level of inorganic and 
organic components in materials, decomposition points of explosives, and solvent 
residues. It is also often used to estimate the corrosion kinetics in high temperature 
oxidation. 
     Simultaneous TGA-DTA/DSC measures both heat flow and weight changes 
(TGA) in a material as a function of temperature or time in a controlled atmosphere. 
Simultaneous measurement of these two material properties not only improves 
productivity but also simplifies interpretation of the results. The complementary 
information obtained allows differentiation between endothermic and exothermic 
events which have no associated weight loss (e.g., melting and crystallization) and 
those which involve a weight loss (e.g., degradation). 
 
3.3.7  Brunauer-Emmett-Teller (BET) 
     BET theory aims to explain the physical adsorption of gas molecules on a solid 
surface and serves as the basis for an important analysis technique for the 
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measurement of the specific surface area of materials. The BET theory applies to 
systems of multilayer adsorption, and usually utilizes probing gases that do not 
chemically react with material surfaces as adsorbates to quantify specific surface area. 
Nitrogen is the most commonly employed gaseous adsorbate used for surface 
probing by BET methods. For this reason, standard BET analysis is most often 
conducted at the boiling temperature of N2 (77 K). Generally, the two key pieces of 
information including specific surface area and pore size distribution can be obtained 
from the BET measurements. Specific surface area was calculated from the 
adsorption data in the relative pressure (P/P0) range from 0.05 to 0.35 while the pore 
size distribution was calculated by the Barrett-Joyner-Halenda (BJH) method, using 
the amount of nitrogen adsorbed at a relative pressure of P/P0 = 0.99. 
 
3.3.8  Ultraviolet-visible (UV-vis) spectroscopy 
     UV-vis spectroscopy refers to absorption spectroscopy or reflectance 
spectroscopy in the ultraviolet-visible spectral region. This means it uses light in the 
visible and adjacent (near-UV and near-infrared) ranges. The absorption or 
reflectance in the visible range directly affects the perceived color of the chemicals 
involved. Absorption spectroscopy is complementary to fluorescence spectroscopy, 
in that fluorescence deals with transitions from the excited state to the ground state, 
while absorption measures transitions from the ground state to the excited state. UV-
Vis spectroscopy is routinely used in analytical chemistry for the quantitative 
determination of different analytes, such as transition metal ions, highly conjugated 
organic compounds, and biological macromolecules. Spectroscopic analysis is 
commonly carried out in solutions but solids and gases may also be studied. For a 
liquid sample, the UV-vis absorption comes from molecules absorbing light in 
different wavelengths range, which can demonstrates a number of absorption bands 
corresponding to structural groups within the molecule. In this thesis, all the 
measurement of UV-vis spectroscopy is carried out in solution samples. 
 
3.3.9  Dynamic light scattering (DLS) 
     DLS is a technique that can be used to determine the size distribution profile of 
small particles in suspension or polymers in solution. In the scope of DLS, temporal 
fluctuations are usually analyzed by means of the intensity or photon auto-correlation 
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function (also known as photon correlation spectroscopy or quasi-elastic light 
scattering). When light hits small particles, the light scatters in all directions 
(Rayleigh scattering) as long as the particles are small compared to the wavelength 
(below 250 nm). The scattered light signal is collected with one of two detectors, 
either at a 90 degree or 173 degree scattering angle. The provision of both detectors 
allows more flexibility in choosing measurement conditions. Particles can be 
dispersed in a variety of liquids. Only liquid refractive index and viscosity needs to 
be known for interpreting the measurement results. Even if the light source is a laser, 
and thus is monochromatic and coherent, the scattering intensity fluctuates over time. 
This fluctuation is due to small molecules in solutions are undergoing Brownian 
motion, and so the distance between the scatterers in the solution is constantly 
changing with time. This scattered light then undergoes either constructive or 
destructive interference by the surrounding particles, and within this intensity 
fluctuation, information is contained about the time scale of movement of the 
scatterers. Sample preparation either by filtration or centrifugation is critical to 
remove dust and artifacts from the solution. DLS is widely used to characterize size 
of various particles including proteins, polymers, micelles, carbohydrates, and 
nanoparticles. If the system is not disperse in size, the mean effective diameter of the 
particles can be determined. This measurement depends on the size of the particle 
core, the size of surface structures, particle concentration, and the type of ions in the 
medium. The  DLS measurement (hydrodynamic size for aqueous solution) in this 
thesis was measured at 25 °C with a Malvern Zetasizer Nano ZS90 equipped with a 
solid state He-Ne laser (λ = 633 nm). 
 
3.4 Bioimaging techniques 
3.4.1 Photoacoustic tomography (PAT) 
     PAT can create multiscale multicontrast images of living biological structures. 
This emerging technology overcomes the high degree of scattering of optical photons 
in biological tissue by making use of the photoacoustic effect, in which non-ionizing 
laser pulses are delivered into biological tissues. Some of the delivered energy will 
be absorbed and converted into heat, leading to transient thermoelastic expansion and 
thus wideband ultrasonic emission. The generated ultrasonic waves are detected by 
ultrasonic transducers and then analyzed to produce images. The basic principles of 
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PAI is shown in Figure 3.1a. Two types of PAI systems, 
photoacoustic/thermoacoustic computed tomography (also known as 
photoacoustic/thermoacoustic tomography, i.e., PAT/TAT) and photoacoustic 
microscopy (PAM), have been developed. A typical PAT system (Figure 3.1b) uses 
an unfocused ultrasound detector to acquire the photoacoustic signals, and the image 
is reconstructed by inversely solving the photoacoustic equations. A PAM system, on 
the other hand, uses a spherically focused ultrasound detector with 2D point-by-point 
scanning, and requires no reconstruction algorithm. 
 
Figure 3.1 (a) Schematic illustration of the basic principles of photoacoustic imaging. 
(b) Multispectral optoacoustic tomography in Sight/in Vision 256. 
 
3.4.2 Single-photon emission computed tomography/computed tomography 
(SPECT/CT) 
     SPECT is a nuclear medicine tomographic imaging technique using gamma rays, 
which is very similar to conventional nuclear medicine planar imaging using a 
gamma camera. However, it is able to provide true 3D information. This information 
is typically presented as cross-sectional slices through the patient, but can be freely 
reformatted or manipulated as required. This technique requires delivery of a 




I) into the patient, 
normally through injection into the bloodstream. On occasion, the radioisotope is a 
simple soluble dissolved ion, such as an isotope of gallium(III). Most of the time, a 
marker radioisotope is attached to a specific ligand to create a radioligand, whose 
properties bind it to certain types of tissues. SPECT imaging is performed by using a 
gamma camera to acquire multiple 2-D images from multiple angles. A computer is 
then used to apply a tomographic reconstruction algorithm to the multiple projections, 
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yielding a 3-D data set. This data set may then be manipulated to show thin slices 
along any chosen axis of the body, similar to those obtained from other tomographic 
techniques, such as magnetic resonance imaging (MRI), X-ray computed 
tomography (X-ray CT), and positron emission tomography (PET). SPECT is similar 
to PET in its use of radioactive tracer material and detection of gamma rays. In 
contrast with PET, however, the tracers used in SPECT emit gamma radiation that is 
measured directly, whereas PET tracers emit positrons that annihilate with electrons 
up to a few millimeters away, causing two gamma photons to be emitted in opposite 
directions. A PET scanner detects these emissions "coincident" in time, which 
provides more radiation event localization information and, thus, higher spatial 
resolution images than SPECT (which has about 1 cm resolution). SPECT scans, 
however, are significantly less expensive than PET scans, in part because they are 
able to use longer-lived more easily obtained radioisotopes than PET. In some cases 
a SPECT gamma scanner may be built to operate with a conventional CT scanner, 
with coregistration of images. This SPECT/CT allows location of tumors or tissues 
which may be seen on SPECT scintigraphy, but are difficult to locate precisely with 
regard to other anatomical structures. Such scans are most useful for tissues outside 
the brain, where location of tissues may be far more variable. For example, 
SPECT/CT may be used in sestamibi parathyroid scan applications, where the 
technique is useful in locating ectopic parathyroid adenomas which may not be in 
their usual locations in the thyroid gland. Figure 3.2 shows the SPECT/CT used in 
this thesis. 
 
Figure 3.2 Ultra-fast and sensitive SPECT/CT. 
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3.4.3 Magnetic resonance imaging (MRI) 
     MRI is a medical imaging technique used in radiology to form pictures of the 
anatomy and the physiological processes of the body in both health and disease. MRI 
scanners use strong magnetic fields, radio waves, and field gradients to generate 
images of the inside of the body. MRI is distinct from computed tomography (CT), 
or (CAT). Whereas CT uses higher-energy x-rays with known harmful effects, MRI 
operates in the radio-frequency portion of the spectrum where there is much less 
evidence of harm. While the hazards of x-rays are now well understood and 
mitigated in most medical contexts, MRI can still be seen as superior in this regard. 
MRI can often yield different diagnostic information compared with CT. MRI scans 
have the disadvantages of being longer in duration, louder, and usually require that 
the subject be placed in a narrow and relatively long tube. In addition, people with 
some medical implants or other non-removable metal inside the body may be unable 
to safely undergo an MRI examination. MRI is based upon the science of nuclear 
magnetic resonance (NMR). Certain atomic nuclei can absorb and emit radio 
frequency energy when placed in an external magnetic field. In clinical and research 
MRI, hydrogen atoms are most-often used to generate a detectable radio-frequency 
signal that is received by antennas in close proximity to the anatomy being examined.  
 
Figure 3.3 MR Solution MRS 3000. 
 
While MRI is most prominently used in diagnostic medicine and biomedical research, 
it can also be used to form images of non-living objects. MRI scans are capable of 
producing a variety of chemical and physical data, in addition to detailed spatial 
images. MRI requires a magnetic field that is both strong and uniform. The field 
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strength of the magnet is measured in teslas and while the majority of systems 
operate at 1.5 T, commercial systems are available between 0.2-7 T. Most clinical 
magnets are superconducting magnets, which require liquid helium and lower field 
strengths can be achieved with permanent magnets. Figure 3.3 demonstrates the 
micro-MRI that is suitable for small animal. 
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Chapter 4 Facile Fabrication of Dendritic Mesoporous SiO2@CdTe@SiO2 
Fluorescent Nanoparticles for Bioimaging 
 
 
This chapter reported the synthesis of a seeded watermelon-like mesoporous 
nanostructure (mSiO2@CdTe@SiO2, mSQS) composed of a novel dendritic 
mesoporous silica core, fluorescent CdTe quantum dots (QDs), and a protective solid 
silica shell by loading QDs into dendritic mesoporous silica nanoparticles through 
electrostatic interaction, and then coating with a solid silica shell by the modified 
Stöber method. The shell thickness of mSQS can be tuned from 0 to 32 nm as desired 
by controlling the reaction parameters, including the amount of silica precursor, 
tetraethyl orthosilicate, that is introduced, the solvent ratio (H2O: ethanol), and the 
amount of catalyst (NH3⋅H2O). These fluorescent mSiO2@QDs@SiO2 nanoparticles 
possess excellent stability and thickness-dependent cytotoxicity, and are successfully 
applied to bioimaging.  
 
 




     Semiconductor quantum dots (QDs) have attracted intense scientific interest due 
to their remarkable optoelectronic properties, including size-tunable fluorescence, 
narrow emission, and excellent solution processability, which have made significant 
contributions to the development of biological labels and optoelectronic devices.
[1-
6]
Despite they have distinct advantages (e.g. larger Stokes shift, and higher resistance 
to photobleaching) over conventional organic dyes,
[7, 8]
 the practical bioapplications 
of QDs are limited, owing to their photo- and colloidal instability in harsh 
environments and cytotoxicity caused by the release of heavy metal ions from the 
QDs.
[9-14]
 To overcome these problems, coating QDs with a silica shell is a promising 
method because of the excellent stability, biocompatibility, and nontoxicity of silica. 
In addition, diverse functional groups can be easily introduced onto the silica shell 
and offer more options for conjugation with biomolecules.
[14-17]   
Among the different silica nanostructures, ordered mesoporous silica has been 
widely applied for drug delivery, adsorption, and catalysis due to its high surface 
area and large pore volume, controllable mesopore channels, and high stability with 
respect to temperature and organic solvents.
[18-22]
 Very recently, Zhao‘s group
[23]
 first 
developed a new oil-water biphase stratification approach to fabricate three-
dimensional dendritic mesoporous silica nanospheres (3D-dendritic MSNSs) with 
tunable multigenerational and center-radial mesopore channels. This type of 
innovative 3D-dendritic MSNSs are very useful for a wide range of applications 




The Stöber method and the reverse microemulsion approach are two typical 
strategies to prepare silica nanostructures.
[15, 28-32]
 The Stöber method is based on sol-
gel chemistry and has been used to prepare silica nanoparticles since 1960s.
[33]
 
Compared with the Stöber method, reverse microemulsion shows better control over 
particle size and its distribution. The experimental procedures are more complex and 
time-consuming than for the Stöber method, however, when these methods are used 
to coat QDs, they lead to a huge loss of fluorescence in comparison with un-coated 
QDs.
[15, 16, 34-36]
 Many efforts have been made to improve the photoluminescence (PL) 
efficiency of the resultant QD-silica nanospheres. For example, Gao‘s group reported 
in 2005 that fluorescent core-shell CdTe@SiO2 nanoparticles (quantum yield of 7%) 
                                                                                              Chapter 4 mSiO2@CdTe@SiO2  
89 
 
with a single CdTe nanocrystal core or multiple CdTe cores can be obtained by 
reducing the electrostatic repulsion between the QDs and the silica 
intermediates.
[15]
Later on, they prepared highly fluorescent CdTe@SiO2 
nanoparticles with a quantum yield of 47% by incubating QDs in an alkaline solution 
to improve the quantum yield of the QDs to 85% prior to silica coating.
[31]
 In contrast 
to these reports, in-situ growth of QDs on the surface of a solid silica core and then 
coating with a protective silica shell has been explored to improve the PL 
efficiency.
[32, 37] 
The highest fluorescence quantum yield of such QD-silica 
nanoparticles reported is up to ~61% to the best of our knowledge.
[32] 
It is worth 
noting most studies of QD-silica nanoparticles are focused on coating QDs with solid 
silica, and there are a few reports on the loading of QDs into mesoporous silica,
[38] 
but no report on encapsulation of QDs into 3D-dendritic MSNSs which could serve 
as ideal nanocontainers for small QDs due to their tunable large pore sizes and 
excellent biocompatibility. By combination of the modified Stöber method with the 
novel oil-water biphase stratification approach, we successfully prepare seeded 
watermelon-like, mesoporous dendritic mSiO2@CdTe@SiO2 (mSQS) fluorescent 
nanoparticles (NPs) for bioimaging.  The resultant mSQS NPs possess excellent 
stability and low cytotoxicity, and show great potential in bioimaging.  
 
4.2 Experimental Section 
4.2.1 Chemicals 
Cetyltrimethylammonium chloride (CTAC) solution (25 wt% in H2O), 
triethylamine (TEA, 99%), tetraethylorthosilicate (TEOS, 99%), cyclohexane 
(99.5%), ammonium nitrate (NH4NO3, 98%), cadmium chloride hemi(pentahydrate) 
(CdCl2∙2.5H2O, 98%), sodium citrate tribasic dihydrate (99.0%), sodium tellurite 
(Na2TeO3, 99%), sodium borohydride (NaBH4, 99%), (3-
aminopropyl)triethoxysilane (APS, 99%), (3-mercaptopropyl)trimethoxysilane (MPS, 
99%), mercaptosuccinic acid (MSA, 99%),and ammonium hydroxide solution (28.0-
30.0% NH3 basis) were purchased from Sigma-Aldrich. Milli-Q water (> 18 MΩ·cm) 
was used in the experiments. 
4.2.2 Synthesis of negatively charged CdTe QDs  
Negatively charged CdTe QDs were synthesized by using MSA as a stabilizer. 
Typically, cadmium chloride (CdCl2, 0.04 M, 4 mL) and sodium citrate tribasic 
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dihydrate (400 mg) were diluted to 50 mL in a three-necked flask, and stirred at 
room temperature for 1 h. Na2TeO3 (0.01 M, 4 mL), mercaptosuccinic acid (100 mg), 
and sodium borohydride (NaBH4, 50 mg) were then added under vigorous stirring. 
When the color of the mixture turned green, the flask was attached to a condenser 
and refluxed at 100 °C under N2 flow for 3 h. The resultant MSA-capped QDs were 
used directly without any treatment. 
4.2.3 Synthesis of positively charged dendritic mesoporous silica nanospheres  
The DMSNs with diameter of about 110 nm were synthesized by using a one-
pot biphase stratification approach.
[26]
 Typically, a mixed solution (the lower 
aqueous phase) containing 18 mL H2O, 12 mL CTAC (25 wt% in H2O), and 45 µL 
of TEA was added into a 100-mL round bottom flask and stirred for 1 h at 60 °C. 
Then, 1 mL TEOS (20 v/v % in cyclohexane) as upper oil phase was gently dropped 
in, and the solution flask was attached to a condenser. The reaction was maintained 
at 60 °C for 8 h in an oil bath with reflux under magnetic stirring (100 rpm). The 
products were collected after removal of the upper oil layer, and then centrifuged and 
washed several times with ethanol to remove the residual reactants. The products 
were extracted twice with a 0.6 wt% ammonium nitrate ethanol solution at 60 °C for 
6 h to remove the templates. The extracted DMSNs (~50 mg) were then refluxed at 
110 °C for 6 h with 1 mL APS in a toluene solution under stirring to allow the 
grafting of the -NH2 groups to form positively charged DMSNs (i.e. mSiO2-NH2). 
The mSiO2-NH2 nanoparticles were centrifuged and thoroughly washed with ethanol 
and water to remove the unreacted chemicals. The resultant positively charged 
nanoparticles were redispersed in 5 mL water for further use. 
4.2.4 Synthesis of mesoporous-SiO2@CdTe and mesoporous-SiO2@CdTe@SiO2  
The electrostatic adsorption approach was adopted to prepare mSQ with strong 
fluorescence. Briefly, 7 mL of the as-prepared MSA-capped CdTe QD solution (0.7 
mM) was slowly added dropwise into 1 mL of mSiO2-NH2 solution (0.17 M) under 
magnetic stirring at room temperature. After stirring for several minutes, the 
negatively charged QDs would be electrostatically adsorbed on the framework of the 
positively charged mSiO2-NH2 to form mesoporous-silica@CdTe (mSQ) 
nanoparticles, which were separated by centrifugation and washed with water for 
further use. The supernatant solution was collected to determine the amount of free 
QDs in solution. 
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       For MPS or APS incubation, 35 µL APS/MPS-ethanol solution (1:100 by 
volume) was introduced into the mixture of 1 mL mSQ aqueous solution (0.17 M) 
and 8 mL ethanol and stirred for 6 h. Then, 40 µL TEOS and 80 µL ammonia were 
added dropwise into the above mixture in succession. The mixture was stirred for 16 
h at room temperature to promote the growth of the solid silica shell over the mSQ. 
The resultant mSQS nanoparticles were separated via centrifugation and washed with 
ethanol and water several times. The mSQS samples that originated from mSQ 
incubated with APS and those from mSQ incubated with MPS were denoted as 
mSQS-1 and mSQS-2, respectively. 
4.2.5 Characterization 
Ultraviolet-visible (UV-Vis) absorption spectra were recorded at room 
temperature with a Shimadzu UV-3600 in the range of 300 to 800 nm. 
Photoluminescence (PL) spectra were measured in the range of 455 to 800 nm on a 
Fluorolog FL3-221 (Horiba) under 450 nm light excitation. The PL quantum yields 
(QYs) of the QDs were calculated from the integrated emission of the QD samples in 
solution compared with that of rhodamine 6G (PL QYs, 95%) in ethanol at identical 
density. Transmission electron microscope (TEM) images of the resultant mSiO2, 
mSQ, and mSQS NPs were obtained on a JEOL JEM-2010 electron microscope 
operating at an acceleration voltage of 200 kV. High-angle annular dark field 
(HAADF) image and scanning transmission electron microscopy-energy dispersive 
X-ray spectroscopy (STEM-EDS) spectra were collected using a JEOL ARM-200F 
and Tecnal G2 F20 operating at 200 kV with an EDAX solid-state X-ray detector. 
Samples were prepared by drop-casting ethanol-dispersed nanostructures onto TEM 
copper grids. Ultrathin TEM sample was prepared by embedding mSQS 
nanoparticles into epoxy and then cut into slices with a thickness of 30 nm by an 
ultramicrotome. Nitrogen adsorption-desorption measurements were conducted at 77 
K with a Quantachrome Autosorb iQ (USA). Before measurements, the samples 
were degassed under vacuum at 180 °C for 6 h. The Brunauer-Emmett-Teller (BET) 
specific surface area was calculated from the adsorption data at relative pressure 
(P/P0) ranging from 0.05 to 0.35. The pore size distribution was calculated from the 
adsorption branch of the isotherms using the Barrett, Joyner, and Halenda (BJH) 
formula. For in vivo fluorescence imaging, the BALB/c female mice were 
anesthetized with 1.5% isoflurane and the 3D tomographic images were recorded 
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with the IVIS Spectrum imaging system. Then the mice were dissected and major 
organs such as liver, spleen, heart etc were removed and used for fluorescence 
imaging. Images were acquired and analyzed using the Living Image 4.4 software 
(Caliper life sciences, Hopkinton, MA, USA). The hydrodynamic size was measured 
at 25 ℃ with a Malvern Zetasizer Nano ZS90 equipped with a solid-state He-Ne 
laser (λ = 633 nm). 
4.2.6 Chemical stability test 
The MSA-capped CdTe QDs were freshly prepared, and the mSQ and mSQS 
were collected by centrifuge, and then redispersed in solutions with different pH 
values (1, 3, 5, 7, 9, 11, 13, with the pH value of the solutions adjusted by 
hydrochloric acid or sodium hydroxide), respectively. The photoluminescence (PL) 
was measured 30 min later, and the integrated area of each spectrum was calculated. 
All the integrated area values were divided by that of the sample in solution with pH 
7. 
4.2.7 Cell culture 
A549 human lung cancer cells and RAW 264.7 murine macrophage cells were 
cultured in a standard cell medium by American type culture collection (ATCC) at 
37 ℃ in 5% CO2 atmosphere.  
4.2.8 Cell viability assay 
Colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
(MTT) assays were performed to assess the metabolic activity of cells in the presence 
of nanoparticles. Cells were seeded into 96-well plates at a density of 1.0 × 10
4
 
(A549) or 2.0 × 10
4
 (RAW 264.7) cells per well in 200 mL of medium incubated 
with different concentrations of NPs for 24 h. The cells were then incubated in a 
medium containing 0.5 mg/mL MTT for 2 h at 37 ℃. After this, the medium was 
removed, and 100 mL dimethyl sulfoxide (DMSO) was added to each well, followed 
by incubation for 0.5 h at 37 ℃. A Bio Tek multifunction microplate reader (Synergy 
2) was used to measure the absorbance of each well with background subtraction at 
490 nm. All of the tests were independently performed three times. 
4.2.9 Cellular uptake and intracellular distribution  
To detect the internalization of NPs, sample processing could be briefly 
described as follows. A549 and RAW 264.7 cells were seeded in dishes at a suitable 
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concentration for 24 h, then incubated with 100 μg/mL mSQS for another 2 h or 24 h, 
and finally thoroughly rinsed with phosphate-buffered saline (PBS). After being 
fixed with nucleus staining by Hoechst 33258 for 30 min at 37 ℃, the samples were 
observed via a confocal microscope (PerkinElmer) with the excitation and emission 
wavelength were 488 nm and 525 nm respectively. 
4.3 Results and discussion 
     As outlined in Figure 4.1, we first prepared monodispersed 3D-dendritic MSNs 
and then functionalized them with amino groups to form mSiO2-NH2. The 3D-
dendritic MSNs were synthesized via an oil-water biphase stratification approach.
[23] 
The upper oil phase contains the silica source (tetraethyl orthosilicate (TEOS)) and a 
hydrophobic organic solution (cyclohexane), and the lower aqueous phase is a mixed 
solution of surfactant (cetyltrimethylammonium chloride (CTAC)) and catalyst 
(triethy lamine (TEA)). After extraction by NH4NO3-ethanol solution to remove the 
surfactant templates, the DMSNs were modified with amino groups via refluxing in 
(3-aminopropyl) triethoxysilane (APS)-toluene solution. The resultant mSiO2-NH2 
nanoparticles were used as carriers for loading of QDs to form mesoporous-
silica@CdTe (mSQ) nanoparticles which were incubated with APS or (3-
mercaptopropyl)trimethoxysilane (MPS). Subsequently, another solid silica shell was 
coated onto the functional mSQ nanoparticles to produce the mSQS nanoparticles, 
with the aim of protecting the QDs and improving their stability. 
 
Figure 4.1 Preparation procedure for mSiO2@CdTe@SiO2 fluorescent 
nanostructures. 
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     The transmission electron microscope (TEM) image in Figure 4.2a shows the 
highly uniform spherical morphology of the monodispersed mSiO2-NH2 
nanoparticles with radial and dendritic mesopore channels and a mean diameter of 
109 ± 7.32 nm (Figure 4.3). The presence of amino group was verified by the X-ray 
photoelectron spectroscopy (XPS) spectrum of N 1s for mSiO2-NH2, which is shown 
in Figure 4.2 d (black line) and in the high resolution XPS spectra in Figure 4.4b. 
The peak with a binding energy of 399.6 eV is consistent with that of N 1s reported 
elsewhere.
[31, 39]
 The successful grafting of amino groups onto the framework of 
mesoporous silica can also be confirmed by the zeta potential analysis shown in 
Figure 4.5. The mSiO2-NH2 shows positive charge with a zeta potential of 14.7 mV. 
The dendritic mSiO2-NH2 nanoparticles were also characterized by nitrogen 
adsorption-desorption analysis, and their Brunauer-Emmett-Teller (BET) surface 









respectively (Figure 4.6 and Table 4.1). The mesopore size calculated from the 
adsorption branch using the Barrett-Joyner-Halenda (BJH) method (Figure 4.6, black 
line) reveals a narrow distribution centered at ≈5.0 nm, which is consistent with that 
observed in high resolution transmission electron microscope (HRTEM) in Figure 
4.3b. 
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Figure 4.2 TEM images of a) mSiO2-NH2, b) mSiO2@CdTe (inset: magnified TEM 
image of mSiO2@CdTe), c) mSiO2@CdTe@SiO2, and d) XPS survey spectra of 
mSiO2-NH2, mSiO2@CdTe, and mSiO2@CdTe@SiO2. 
 
 
Figure 4.3 (a, b) TEM and (c) SEM images of mSiO2-NH2 nanoparticles [the inset of 
(b) shows its HRTEM image], and (d) corresponding histogram of size distribution 
counted from 100 particles in TEM images. 
 
The above positively charged 3D-dendritic MSNs were used to adsorb 
negatively charged CdTe QDs (average size is 4.10 ± 0.57 nm; Figure 4.7) through 
electrostatic interactions to generate mSQ (Figure 4.1b). The energy dispersive X-ray 
spectroscopy (EDS) elemental mapping images in Figure 4.9a indicate the 
homogenous distribution of QDs on the 3D-dendritic MSNs. The adsorption of 
negatively charged QDs leads to a drop in the zeta potential to −29.6 mV. The mSQ 




), which is attributable to the 
anchoring of the QD particles on the mSiO2-NH2, while the pore size shows little 
change.  
In order to homogeneously coat mSQ with a solid silica shell by the modified 
Stöber method, the use of a functional silane such as APS or MPS is generally 
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required to modify the mSQ prior to silica coating. Such a functional silane agent can 
render the mSQ surface vitreophilic and provide nucleation sites for deposition of a 
silica shell on its surface. In our study, APS and MPS were chosen because their NH2 
and SH groups can strongly bind to the QD surface and leave silane groups for 
hydrolysis and condensation into a very thin silica shell. If the mSQ nanoparticles 
were not coated with APS or MPS, it would be very difficult to coat them with a 
solid silica shell because TEOS becomes hydrolyzed in the alcohol-water medium 
(conditions: Rv = 1:8, 100 µL of NH4OH, 60 µL of TEOS; Figure 4.8) to form a 
silica network with random necking and fusion between mSQS spheres (Figure 4.8). 
After precoating the mSQ with APS or MPS, the growth of the silica shell is easier 
and mainly governed by three primary parameters, e.g., the H2O:EtOH ratio (Rv), the 
amount of ammonia solution, and the amount of TEOS introduced, which were 
comprehensively investigated (Table 4.2) and are discussed later. 
 
Figure 4.4 High resolution XPS spectra of (a-b) Si 2p and N 1s of mSiO2-NH2, and 
(c-d) Cd 3d and Te 3d of mSiO2@CdTe. 
 




Figure 4.5 Zeta potential of (a) mSiO2-NH2, (b) mSiO2@CdTe, and (c) 
mSiO2@CdTe@SiO2 in pure water media (pH=7). 
 





Figure 4.6 Nitrogen adsorption-desorption isotherms and pore size distribution of 
mSiO2-NH2, mSQ and mSQS. 
 
 




Figure 4.7 TEM image (a) and HRTEM image (b) of MSA-capped CdTe QDs with 
PL peak at 550 nm (The inset of (a) shows the size distribution histogram of MSA-









Figure 4.8 Different magnification of TEM images of mSQS without incubation with 
APS or MPS. A network structure by necking and fusion between mSQS spheres is 
clearly observed.  
 
A typical TEM image of mSQS nanoparticles is shown in Figure 4.2c. These mSQS 
nanoparticles have a large mean size of 125 ± 6.3 nm with a shell thickness of about 
7.5 nm. The scanning transmission electron microscopy-high-angle annular dark 
field (STEM-HAADF) images and EDS-elemental mapping in Figure 4.9b 
demonstrate the complete encapsulation of mSQ by the solid silica shell. In order to 
investigate the location of CdTe QDs in the mSQS nanoparticles, mSQS 
nanoparticles were embedded into epoxy and cut into ultrathin films (30 nm) with an 
ultramicrotome for TEM analysis. Figure 4.9c and Figure 4.13 clearly show that QDs 
were densely anchored on the surface of the mSiO2 due to their dendritic structure 
and a number of QDs were distributed in the channels of the mSiO2. 
 
Figure 4.9 High resolution STEM-HAADF images and EDS-elemental mapping of a) 
mSiO2@CdTe, b) mSiO2@CdTe@SiO2, and c) ultramicrotomed mSiO 





Table 4.1 Mean size of pores, BET surface area and total pore volume of mSiO2-NH2, 
mSQ and mSQS. 












mSiO2-NH2 5.3 443.1 1.16 
mSiO2@CdTe 5.2 268.7 0.84 
mSiO2@CdTe@SiO2 NA 60.2 0.07 
 






































0 1 8 100 60 182.0  36.0 4.8 








35 1 4 80 40 119.1 4.5 4.11a 
Sr2 35 1 8 80 40 127.1 8.5 4.11b 
Sr3 35 1 12 80 40 125.8 7.9 4.11c 
Sr4 35 1 16 80 40 117.6 3.8 4.11d 
Sr5 35 1 4 40 40 117.1 3.5 4.12a 
Sr6 35 1 8 40 40 119.8 4.9 4.12b 
Sr7 35 1 12 40 40 119.4 4.7 4.12c 





35 1 8 100 20 120.0 5.0 4.14b 
St2 35 1 8 100 40 130.0 10.0 4.14c 
St3 35 1 8 100 60 145.0 17.5 4.14d 
St4 35 1 8 100 80 164.0 27.0 4.14e 











35 1 8 100 100 174.0 32.0 4.14f 
St6 35 1 8 60 20 120.1 5.05 4.15a 
St7 35 1 8 60 40 132.5 11.2 4.15b 
St8 35 1 8 60 80 135.0 12.5 4.15c 
St9 35 1 8 60 100 135.1 12.6 4.15d 
St10 35 1 8 60 140 135.2 12.6 4.15e 
St11 35 1 8 60 180 136.0 13.0 4.15f 
St12 35 1 8 60 220 136.1 13.1 4.15g 
St13 35 1 8 60 260 138.6 14.3 4.15h 
St14 35 0.2 8 100 10 118.0 4.0 4.16a 
St15 35 0.2 8 100 20 123.0 6.5 4.16b 
St16 35 0.2 8 100 40 125.0 7.5 4.16c 
St17 35 0.2 8 100 60 126.0 8.0 4.16d 
St18 35 0.2 8 100 100 126.0 8.0 4.16e 
St19 35 0.2 8 100 150 127.0 8.5 4.16f 
a 
Mean particle sizes are calculated by averaging 100 particles from the TEM images. 
b 
Sa2 
and St3 are the same sample, but are given different names and are placed at various 
positions in the table to allow a clear comparison 
 
The resultant seeded watermelon-like mSQS particles show a negative zeta potential 
of -28.3 mV due to the surface silicon hydroxyl on the solid silica shell. Their BET 









, respectively, owing to the complete encapsulation by the solid 
nonporous silica shell. Moreover, the disappearance of the pore size distribution peak 
further confirms the protective effect of the solid silica shell over the mSQ core 
(Figure 4.6, blue line). In the XPS survey spectra of mSiO2-NH2, mSQ, and mSQS in 
Figure 4.2d, the binding energies of Si 2p, Si 2s, Cd 3d5/2, Cd 3d3/2, O 1s, Te3d5/2, 
and Te 3d3/2 were found to be 104.2, 154.1, 405.5, 412.4, 532.8, 572.6, and 583.1 eV, 
respectively (for high resolution XPS spectra see Figure 4.4), in which the 
characteristic binding energies of Cd 3d5/2 and Te 3d5/2 are consistent with those of 
reported CdTe QDs.
[32]
 The absence of signals of Cd, Te, or N in the spectrum of the 
mSQS sample indicates that the mSQ were completely coated by the solid silica shell. 
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4.3.1 Shell thickness control 
     As mentioned previously, after pre-coating mSQ with APS or MPS, the growth of 
the solid silica shell can be tuned by manipulating the H2O/EtOH ratio (Rv), the 
amount of ammonia solution, and the amount of TEOS that is introduced. In order to 
control the thickness of the shell, a series of mSQS nanoparticles were fabricated by 
optimizing these three parameters. In this paper, we have investigated the impact of 
each parameter on the synthesis of mSQS by using mSQ nanoparticles with the same 
diameter (~110 nm) and incubating them with APS or MPS for the same time (6 h) 
as seeds. Figure 4.10a presents the dependence of shell thickness on the H2O/EtOH 
ratio obtained with the same amount of TEOS and two different ammonia 
concentrations (TEM images in Figure 4.11 and 4.12). The results show that 
H2O/EtOH ratio strongly affected the hydrolysis of TEOS and the thickness of the 
silica shell. Lower water content favors the nucleation and growth of silica around 
mSQ seeds in the range of Rv from 1:4 to 1: 8. Decreasing the ratio of H2O/EtOH 
from 1: 8 down to 1: 16 led to a decrease in the shell thickness of the mSQS, which 
could be due to the fact that less water restrained the hydrolysis of TEOS.
[33]
 
Therefore, H2O/EtOH ratio was optimized to be 1:8. Ammonia was used as a catalyst 
for TEOS hydrolysis and determined the hydrolysis rate. Under the catalysis with 
more ammonia, the fast hydrolysis of TEOS gave rise to a thicker silica shell [Figure 
4.10a and Figure 4.11, 4.12]. Figure 4.10b demonstrates that the shell thickness can 
be tuned from 0 to 32 nm by adjusting the amount of TEOS from 20 to 100 µL under 
the conditions of 100 µL of NH4OH and an Rv of 1:8. Low-magnification TEM 
images with more particles are presented in Figure 4.14. The shell thickness of 
mSQS increases with the amount of TEOS introduced. When more than 60 µL of 
TEOS was introduced,  however, and 




Figure 4.10  (a) Effect of H2O to EtOH volume ratio (Rv) on the shell thickness 
control with 40 µL of TEOS; and shell thickness control by adjusting the amount of 
TEOS with (b) 100 µL of NH4OH, Rv = 1/8, (c) 60 µL of NH4OH, Rv = 1/8, and (d) 
100 µL of NH4OH, Rv = 1/40. 
 
100 µL of NH4OH was used (Rv of 1:8), a peanut-like mSQS structure was 
predominantly observed, which may due to the too fast hydrolysis of TEOS [Figure 
4.14(e-f)]. By decreasing the amount of ammonia from 100 to 60 µL, a set of mSQS 
samples was successfully synthesized with an Rv of 1:8 over a wide range of TEOS 
amounts from 20 to 260 µL of TEOS (Figure 4.15). The dependence of shell 
thickness on the amount of TEOS introduced is shown in Fig. 4.10c. The data show 
that when TEOS amount was more than 80 µL, the shell thickness of the resultant 
mSQS increased slowly with increasing amounts of TEOS. A similar trend in shell 
thickness depending on the amount of TEOS was observed under the condition of 
100 µL of NH4OH and an Rv of 1:40 (Figure 4.16). This result further proves that 
slow hydrolysis of TEOS can deposit a uniform silica layer on the surface of mSQ to 
result in monodispersed mSQS NPs. 




Figure 4.11 TEM images of mSQS obtained with 40 µL TEOS, and 80 µL NH4OH 
but different H2O:EtOH ratios (Rv ): a) Rv = 1:4, b) Rv = 1:8, c) Rv = 1:12 and d) 









Figure 4.12 TEM images of mSQS obtained with 40 µL TEOS, and 40 µL NH4OH 
but different H2O:EtOH ratios (Rv ): a) Rv = 1:4, b) Rv = 1:8, c) Rv = 1:12, and d) 
Rv = 1:16. 
 
 
Figure 4.13 TEM images of (a) normal mSiO2@CdTe@SiO2 sample and (b) 
mSiO2@CdTe@SiO2 ultrathin sectioning sample with a thickness of 30 nm. 
 




Figure 4.14 TEM images of mSQ and mSQS obtained with different TEOS feeding 
amount of TEOS (20 ~ 100 µL), Rv of 1/8, and 100 µL NH4OH. 
  




Figure 4.15 TEM images of mSQS obtained with different TEOS feeding amount of 
TEOS (20 ~ 260 µL), Rv of 1/8, and 60 µL NH4OH. 




Figure 4.16 TEM images of mSQS obtained with different TEOS feeding amount of 
TEOS (10 ~ 150 µL), Rv of 1/40, and 100 µL NH4OH. 
 
4.3.2 Fluorescence and stability of mSQS 
     The loading amount of QDs was determined by measuring the UV-Vis absorption 
of free QDs in the supernatant as the absorption of the QDs was linear proportion 
with the concentration and the standard Absorbance-concentration curve and 
corresponding linear fitting plots were shown in Figure 4.17, suggesting the lambert-
beer law is suitable in the our system. After addition of different amounts of QD 
solution to the aqueous dispersion of mSiO2-NH2, the QDs were immediately 
adsorbed on the framework of mSiO2-NH2. The mixture was centrifuged to separate 
the unloaded QDs from the mSQ nanoparticles [Figure 4.19(a) and (c)]. The results 
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showed that the optimal molar ratio of MSA-CdTe to mSiO2-NH2 was 2.48 × 10
-4
: 1. 
Further quantitative analysis of the fluorescence of QDs and mSQ in Figure 4.19(b) 
indicates that 57.1% of the original QD fluorescence is retained after encapsulation 
into mSiO2-NH2 (The PL QY of CdTe QDs is 72.4% compared with rhodamine 6G 
in ethanol at identical optical density; see Figure 4.18). In addition, a 15-nm red-shift 
of the fluorescence peak was observed, probably due to the sharp change in the zeta 
potential of the solution.
[40]
 Before further coating of mSQ with the outer solid silica 
shell, APS or MPS was used for pre-coating and incubation with mSQ for 6 hours. 
The fluorescence of mSQ incubated with APS shows no obviously changes (99.6%), 
indicating that modification of mSQ particles with APS has no influence on their 
fluorescence. After coating with the solid silica shell, the fluorescence of the final 
mSQS sample (mSQS-6h-1) is up to 80.4% of the initial fluorescence [Figure 
4.19(e)]. In the case of mSQ modified with MPS, the fluorescence of mSQ was 
increased to 112.3%, which is expected because MPS has been reported to help 
protect QDs and lead to enhanced fluorescence.
[41]
 Only 45.0% of the initial 
fluorescence was retained for mSQS, however, after coating with the solid silica 
shell (mSQS-6h-2) [Figure 4.19(f)], because the negatively charged intermediates 
from the hydrolysis of TEOS quench the fluorescence.
[15]
 Figure 4.19(d) shows a 
comparison of the fluorescence of the control mSQ, mSQS-1, and mSQS-2, which is 
consistent with their fluorescence spectra in Figure 4.19(e) and (f). The overall 
fluorescence QYs of mSQS NPs is in the range of 33% to 18%, which depends on 
the encapsulation process  as summarized in Table 4.3.  
 
Figure 4.17 (a) The UV-Vis absorption spectra of MSA-CdTe QDs at different 
concentration. (b) Corresponding linear fitting plots of absorbance at 530 nm versus 
concentration. 
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Figure 4.18 PL spectra of CdTe and Rhodamine 6G with an identical optical density. 
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Figure 4.19 (a) UV-Vis absorption spectra of mSiO2@CdTe supernatant at different 
MSA-CdTe to mSiO2-NH2 mol ratios. (b) PL spectra of QDs and mSQ. (c) Water 
dispersion of QDs and mSQ under UV light at 365 nm and room light (inset). (d) 
Photographs of mSQ, mSQS-1, and mSQS-2 under 365-nm UV lamp. (e) PL spectra 
of mSQ, mSQ-6h-1, and mSQS-1. (f) PL spectra of mSQ, mSQ-6h-2, and mSQS-2. 
  
Table 4.3 Overall particle sizes, silica shell thicknesses and optical properties of QDs, 



























4.1 —— 530 550 51 72.4 
mSQ 110 —— 530 565 45 41.3 
mSQS-1 125 7.5 530 557 45 33.2 
mSQS-2 125 7.5 530 557 44 18.6 
St1 
(mSQS-5) 












164 27 530 557 44 28.2 
  




Figure 4.20 Fluorescence efficiency of  MSA-capped CdTe, mSQ, and mSQS in 
solutions with different pH values (a), TEM images of mSQS used in pH = 7 solution 
(b) and mSQS treated with pH = 13 solution for 2 hours (c). 
 
The external solid silica shell is expected to provide protection to the internal 
CdTe QDs. We investigated the chemical stability of mSQS NPs by using mSQS 
sample with a shell thickness of 7 nm. The fluorescence of the QDs, mSQ, and 
mSQS NP solutions versus different pH values is shown in Figure 4.20(a). The 
fluorescence of CdTe QDs is strongly influenced by minor variation of the solution 
pH. For example, only 40% and 10% of fluorescence were retained when the pH of 
the CdTe QD solution was changed from 7 to 3 and 13, respectively. In contrast, the 
mSQ NPs are stable in a solution pH of 3, and their fluorescence can be enhanced 
under basic conditions. It worth noted that in the pH range of 1 to 5, obvious 
aggregation of QDs and mSQ NPs occurred as shown in Figure 4.21.  By contrast, 
the fluorescence of mSQS NPs  is stable even in a strongly acidic solution (pH = 1) 
and no obviously aggregation was observed in the pH range of 1 to 13 (Figure 4.21), 
owing to the protection of outer soild silica shell. Therefore, mSQS shows 
significantly improved chemical stability compared with the QDs and mSQ NPs. It 
should be noted that the fluorescence of both mSQ and mSQS NPs markedly 
increase under basic conditions, which may due to the corrosion of the external silica 
shell by NaOH, which is verified by the morphology change of mSQS before [Figure 
4.20(b)] and after the alkaline solution treatment [Figure 4.20(c)], and the surface 
passivation of QDs to eliminate surface defects under basic conditions.
[29, 31]  




Figure 4.21 The Hydrodynamic size of  MSA-capped CdTe, mSQ, and mSQS in 
solutions with different pH values.  
4.3.3 Cytotoxicity assay 
     The cytotoxicity of mSQ and mSQS in A549 cells and RAW 264.7 cells has been 
investigated by using the MTT cell viability assay. A series of mSQS nanoparticles 
with a shell thickness of around 5 nm, 10 nm, 17 nm and 27 nm (named as mSQS-5, 
mSQS-10, mSQS-17, mSQS-27 respectively, i.e. the samples of St1 ~ St4 in Table 
4.2 and 4.3), together with mSQ NPs, were used to investigate their cytotoxicity for 
A549 cells. Figure 4.22(a) shows the viability of A549 cells labelled with six 
different concentrations of mSQ and mSQS, ranging from 0 to 200 µg/mL. The cell 
viability of the blank control (i.e. untreated cells) was set as ―100%‖, and the 
absorbance of each sample was compared to that of the blank control. It clearly 
shows that the cell viability remained almost 100% with a concentration of 50 µg/mL 
and even more than 80% at the high concentration of 200 µg/mL after 24 h 
incubation, which could be attributed to the good protection afforded by the solid 
silica shell. In comparison, the cell viability for mSQ was reduced to about 50% at 
the concentrations of 200 µg/mL. In addition, the cell viability increased with the 
increase of shell thickness at high concentration (i.e. 200 µg/mL), which supports 
that a solid silica shell (>5 nm) can provide good protection for QDs. In the case of 
the RAW 264.7 cells, The mSQS-10, mSQS-17 and mSQS-27 NPs showed lower 
cytotoxicity (50.2%, 65.6% and 69.3% cell viability at 200 µg/mL respectively) than 
mSQS-5 (44.5% cell viability at 200 µg/mL ) and mSQ NPs (less than 30% viability 
at ≥ 50 µg/mL) as demonstrated in Figure 4.22(b), suggesting a thicker shell (>5 nm) 
                                                                                              Chapter 4 mSiO2@CdTe@SiO2  
115 
 
can provide better protection for QDs. The high cytotoxicity of mSQ NPs may be 
due to the release of  
 
 
Figure 4.22 Cell viability tests performed on (a) A549 cells and (b) RAW 264.7 cells 
incubated for 24 h with mSQ NPs and mSQS NPs at different concentrations. 






Figure 4.23 CLSM images of A549 cells (a) and RAW 264.7 cells (b) after 
incubation with mSQS for 2 h and 24 h. Scale bar: (a) 15 μm, (b) 6 μm. 
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CdTe QDs. These results reveal that a solid silica shell can efficiently prevent the 
release of CdTe QDs and improve their biocompatibility. The difference in viability 
of RAW 264.7 cells and A549 cells can be attributed to the stronger phagocytosis of 
RAW 264.7 cells than A549 cells as RAW cells are macrophages.
[42]
 
4.3.4  In vitro cell bioimaging   
     The intracellular distribution of SQS NPs was examined using a confocal laser 
scanning microscope (CLSM). As showed in Figure 4.23, after incubation for 2 h, 
mSQS-5 NPs were taken up by the RAW 264.7 cells and the A549 cells. The RAW 
264.7 cells as macrophages could internalize more mSQS NPs than A549 cells 
because of their higher phagocytosis capability. The dynamic cell uptake process for 
mSQS NPs described in the supplementary video also suggests that mSQS NPs can 
be effectively taken up by macrophages via phagocytosis. For the same cell line, 
there is no significant difference in cell uptake of mSQS NPs for different incubation 
times (i.e. from 2 to 24 h). We didn‘t find that more NPs were taken up by A549 and 
RAW 264.7 cells with longer incubation. This means that both the A549 and RAW 
264.7 cells could internalize mSQS NPs in a short incubation time and reach the 
maximum uptake at around 2 h. The time-independent cell uptake after 2 h could be 
attributed to the balance of endocytosis and exocytosis of cells. 
 
Figure 4.24 In vivo fluorescence images acquired pre- a) and at different time points 
(b): 3 min, c): 60 min, d): 120 min, e): 120 min (supine position)) after tail 
intravenous injection of mSQS-5 nanoparticles into the mouse and f) fluorescence 
images of corresponding dissected organs. 
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4.3.5 In vivo fluorescence imaging 
     In order to explore the potential of mSQS NPs for in vivo fluorescence imaging, 
200 µL of mSQS-5 samples (2 mg/mL) was injected via the tail vein into the mouse. 
In vivo fluorescence images were acquired at different time points post injection (3 
min, 60 min and 120 min) using the IVIS Spectrum imaging system. As 
demonstrated in Figure 4.24, strong fluorescence signal were observed after the 
injection of mSQS-5 NPs in comparison with the pre image (Figure 4.24a). These 
fluorescent mSQS NPs were rapidly distributed over the whole body within 3 min. 
With the increase of circulation time, these nanoparticles were gradually 
accumulated in liver, spleen, lung and heart, of which liver displayed stronger 
fluorescence after injection 120 min as shown in Figure 4.24d,e. The strong 
fluorescence of liver revealed the most of nanoparticles were in the liver, which 
could be due to the large size and negative surface of the mSQS NPs, and the rich 
macrophages in liver. These results demonstrate the potential of mSQS NPs in 
bioimaging, and preparation of smaller mSQS NPs with proper surface modification 
is under the way. 
4.4 Conclusions 
In summary, a series of size-tunable, core-shell, novel watermelon-like 
fluorescent mSQS NPs were successfully synthesized. The shell thickness could be 
tuned from 0 to 32 nm by adjusting the amount of silica precursor, the solvent ratio, 
and the amount of catalyst. The solid silica shell coating significantly improved the 
chemical stability of the QDs inside. The resultant mSQS NPs investigated with the 
MTT assay, CLSM images, dynamic cell uptake and in vivo fluorescence imaging 
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Chapter 5 Ambient Aqueous Synthesis of Ultra-small PEGylated Cu2-xSe 
Nanoparticles as a Multifunctional Theranostic Agent for Multimodal Imaging 
Guided Photothermal Therapy of Cancer 
 
 
     This chapter reported a kind of ultrasmall PEGylated Cu2-xSe nanoparticles with 
strong near-infrared absorption prepared by an ambient aqueous method. The 
resultant water-soluble and biocompatible nanoparticles are demonstrated to be a 
novel nanotheranostic agent for effective deep-tissue photoacoustic imaging, 
computed tomography imaging, single-photon emission computed tomography 

















     In recent years, nanoscale copper chalcogenides (Cu2-xE, E = S, Se, Te, 0 ≤ x ≤ 
1) have attracted considerable attention due to their simple chemical formula with 
complicated crystal structures and variable compositions, which offer an incredible 





 quantum-dot-sensitized solar cells,
[5, 6]
  photoacoustic (PA) 
imaging,
[7]
 and photothermal therapy (PTT).
[8-10]
 Their applications in PA imaging 
and PTT are attributable to their strong localized surface plasmon resonances (LSPR) 
in the near-infrared (NIR) window arising from copper deficiency.
[7, 10-19] 
Compared 
with conventional photothermal agents such as large gold nanostructures (usually 
larger than 50 nm in one dimension for producing NIR LSPR), Cu2-xE nanostructures 
could be much smaller. In addition, they are biodegradable and can release vital trace 
elements copper and chalcogen for maintaining good health, e.g., selenium can 
reduce the occurrence and fatality of liver, prostate, and lung cancers,
[20]
 and copper 
deficiency can contribute to the development and deterioration of a number of 
diseases such as cardiovascular disease and diabetes.
[21]
 
It should be noted that most research on in vivo applications of Cu2-xE 
nanostructures is focused on Cu2-xS nanoparticles,
[9, 22-24]
 and there have been only a 
few reports in the literature on nanoscale Cu2-xSe,
[7, 10, 25]
 due to the difficulties in the 
preparation of high-quality water-soluble and biocompatible Cu2-xSe nanomaterials. 
Monodisperse Cu2-xSe nanoparticles are usually prepared in organic solvents at high 
temperature, and laborious surface post-modification is necessary to make them 
suitable for bioapplications.
[7, 10]
 For example, 16-nm Cu2-xSe particles synthesized 
by a colloidal hot injection method were demonstrated to be an effective in vitro 
photothermal transduction agent after modification by an amphiphilic polymer.
[10]
 
7.6-nm Cu2-xSe nanocrystals synthesized by a similar method were employed as a 
contrast agent for in vivo PA imaging of a sentinel lymph node after encapsulation by 
a phospholipid.
[7]
 From the perspective of PA imaging and PTT, ultra-small 
nanoparticles with high photothermal conversion efficiency are highly desirable, 
because they are less likely to be rapidly recognized and cleared by phagocytes and 
the reticuloendothelial system (RES) than larger ones, and they can circulate in the 
blood for long time and passively accumulate within tumors through the enhanced 
permeability and retention (EPR) effect.
[26-29]
 In this context, the direct preparation of 
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biocompatible ultra-small copper selenide (Cu2-xSe, 0 ≤ x ≤ 1) nanoparticles with 
strong NIR LSPR in aqueous solution under ambient conditions is highly significant 
and remains a challenging task.
[25] 
 
Apart from their potential in PA imaging and PTT, the large X-ray attenuation 





/g at 20 keV for Cu and Se, respectively) highlight their potential in X-
ray computed tomography (CT) imaging, which has not been investigated for ultra-
small Cu2-xSe nanoparticles. In this study, a facile aqueous route has been developed 
to prepare water-soluble and biocompatible ultra-small omnipotent Cu2-xSe 
nanoparticles (3.6 ± 0.3 nm) for PA imaging, CT imaging, single-photon emission 
computed tomography (SPECT) imaging, and PTT of cancer. To the best of our 
knowledge, sub-5-nm ultra-small Cu2-xSe particles with excellent water solubility 
and biocompatibility for effective multimodal imaging-guided PTT have not yet been 
reported. 
5.2 Experimental Section 
5.2.1 Chemicals 
All chemicals and reagents were used as received without any further purification. 
CuCl2·2H2O (≥ 99%), Se powder (-100 mesh, ≥ 99.5%), sodium borohydride 
(NaBH4, 99%), and mercaptosuccinic acid (MSA, 99%) were purchased from Sigma-
Aldrich. Dimercapto poly(ethylene glycol) (HS-PEG-SH, Mg = 5000) was bought 
from Adamas. Milli-Q water (> 18 MΩ·cm) was used in the experiments. 
5.2.2 Synthesis of MSA-capped Cu2-xSe nanoparticles and HS-PEGylated Cu2-xSe 
nanoparticles 
In a typical synthesis, 39.48 mg (0.5 mmol) Se powder was reduced by 56.75 mg 
(1.5 mmol) NaBH4 in 50 mL H2O under magnetic stirring at room temperature with 
the protection of inert gas. 0.17 g (1 mmol) CuCl2·2H2O and 1 g (6.66 mmol) MSA 
were completely dissolved in 5 mL distilled water and then added into the selenium 
precursor solution to immediately generate a black solution, which indicates the 
formation of copper selenide nanoparticles (i.e. Cu2-xSe NPs). The black solution was 
subsequently purified by ultrafiltration at 5000 rpm, using a membrane with a 
molecular weight cut-off (MWCO) of 30 kDa. After removal of free MSA from the 
nanoparticle solution, 0.2 g HS-PEG-SH was added to modify the surfaces of the 
MSA-capped Cu2-xSe NPs at room temperature. The obtained PEGylated Cu2-xSe 
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nanoparticles (i.e. Cu2-xSe-PEG-SH NPs) were purified by a similar ultrafiltration 
method and then dialyzed against Milli-Q water to remove free HS-PEG-SH. The 
final product was stored at 4 °C for further characterization and use. 
5.2.3 Characterization  
Ultraviolet-visible-near-infrared (UV-Vis-NIR) spectra were recorded with a 
PerkinElmer Lambda 750 UV-Vis-NIR spectrophotometer. TEM images were 
captured using a FEI Tecnai F20 transmission electron microscope operating at an 
acceleration voltage of 200 kV. The crystal structure of the nanoparticles was 
characterized with a Shimadzu XRD-6000 X-ray diffractometer equipped with Cu 
Kα1 radiation (λ = 0.15406 nm). X-ray photoelectron spectroscopy (XPS) 
measurements were carried out on a Thermo Scientific Sigma Probe instrument using 
Al Kα X-ray radiation and fixed analyzer transmission mode. Thermogravimetric 
analysis (TGA) was performed to analyze the weights of surface ligands at a heating 
rate of 10 °C min
-1
 from room temperature to 700 °C under argon atmosphere. The 
hydrodynamic size was measured at 25 °C with a Malvern Zetasizer Nano ZS90 
equipped with a solid state He-Ne laser (λ = 633 nm).  
5.2.4 Cytotoxicity assay of the PEGylated Cu2-xSe nanoparticles 
MTT assays were performed to assess the cytotoxicity of the Cu2-xSe NPs. In 
detail, 4T1 cells were first seeded in 96-well plates at a density of 4000 cells per well 
and cultured for 24 h in DMEM supplemented with 10% FBS. Then, the cells were 
washed with PBS and incubated with Cu2-xSe NPs at different concentrations at 
37 °C for 24 h. After that, the cells were washed twice with PBS and cultured for 48 
h. Then, 20 μL MTT with a concentration of 5 mg/mL was added and allowed to 
react with the cells for 4 h before the addition of 150 μL dimethyl sulfoxide (DMSO) 
to dissolve the precipitates. The absorption of each solution was measured at 490 nm 
on a microplate reader (Thermo, Varioskan Flash). 
5.2.5 Animal model 
The tumor models used were established by subcutaneous injection of 50 µL 4T1 
cell suspension (~5 × 10
6
 cells) into the flank region of the right back of 5-week-old 
male BALB/c mice (for the PTT treatment) or nude mice (for the PA imaging). The 
tumor imaging studies were carried out 10 days after the inoculation with tumor cells. 
All animal experiments were carried out according to the protocols approved by the 
Soochow University Laboratory Animal Center. 
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5.2.6 In vivo Photoacoustic Imaging 
For in vivo photoacoustic (PA) imaging, nude mice bearing subcutaneous tumors 
were anesthetized with 1.5% isoflurane delivered via a nose cone, and then Cu2-xSe 
NPs (500 µg/mL of Cu, 200 μL) were injected via the tail vein. Photoacoustic images 
were acquired at different time points post-injection by a multispectral optoacoustic 
tomography (MSOT) instrument. 10 slices were obtained at each position and 
averaged to minimize the influence of animal movement in the images. 
5.2.7 CT imaging  
The contrast efficacy of Cu2-xSe-PEG-SH NPs as a CT contrast agent in vitro was 
compared with commercial iopromide agent in aqueous solution, with concentrations 
of 0.5, 1, 2, 4, and 5 mg/mL of Cu2-xSe-PEG-SH NPs and iopromide. For in vivo CT 
imaging, 4T1 tumor-bearing mice were anesthesized with isoflurane and placed in an 
animal bed. Cu2-xSe-PEG-SH NPs were then intratumorally and intravenously 
injected for CT imaging respectively. The images were scanned in an accurate mode 
using full angle, 3 frame averaging, a 615 mA tube current, and a 55 kV tube voltage. 
5.2.8  
99m
Tc Labeled Cu2-xSe-PEG-SH NPs for SPECT Imaging 
Technetium-99m (
99m
Tc, purchased from Shanghai GMS Pharmaceutical Co., Ltd) 
with radioactivity of 3 mCi was added into the Cu2-xSe-PEG-SH NPs solution (500 
µg/mL, 500 µL,) in the presence of 200 µL of stannous chloride (SnCl2, 5 mg/mL in 
0.1 M HCl) and then stirred gently for 1 h at room temperature. The obtained 
99m
Tc 
labeled Cu2-xSe-PEG-SH solution was purified by ultrafiltration to remove free 
99m
Tc. 
For SPECT imaging, mice bearing 4T1 tumors were intravenous injected with Cu2-
xSe-PEG-SH-
99m
Tc nanoparticles and imaged by an animal SPECT (MILabs, Utrecht, 
the Netherlands) imaging system at various time points post injection. 
5.2.9 Photothermal Therapy 
24 tumor-bearing BALB/c mice with an average tumor volume of 130 mm
3
 were 
randomly allocated into 4 groups, which were intravenously injected with the same 
volume of either saline or Cu2-xSe-PEG-SH NPs solution. The dose of Cu2-xSe-PEG-
SH NPs was 200 μL of solution containing 100 µg Cu. The laser irradiation was 
performed using an 808-nm NIR laser (Hi-Tech Optoelectronics Co., Ltd. Beijing, 
China) with a power density of 1.5 W/cm
2
 for 6 min. The tumor sizes and body 
weights were measured every two days, and the tumor volume was expressed by L × 
W
2
/2, where L and W represent the length and width of the tumor, respectively. 
                                                                                              Chapter 5 Ultra-small Cu2-xSe  
127 
 
Relative tumor volumes were obtained by dividing by the initial tumor size before 
laser treatment. Analysis of Variance (ANOVA) was used to assess statistical 
significance. *p < 0.5, **p < 0.01, ***p < 0.001. The mice treated with NIR 
irradiation after injection of Cu2-xSe-PEG-SH NPs were sacrificed at day 40 to 
harvest the major organs for histological analysis. 
5.2.10 Biodistribution 
21 tumor-bearing mice were respectively intravenously injected with 200 μL of 
Cu2-xSe-PEG-SH NPs solution containing 100 µg Cu. They were divided into seven 
groups, and the various organs or tissues, such as heart, liver, spleen, lung, kidney, 
tumor, blood, stomach, intestines, skin, bone, and muscle, were resected from the 
mice in each group at 2 h, 4 h, 6 h, 8 h, 12 h, 24 h, and 48 h post injection, wet-
weighed, and dissolved in the digesting solution (HNO3:H2O2 of 2:1 by volume). The 
contents of copper in each organ/tissue were determined by inductively coupled 
plasma − optical emission spectrometry (ICP-OES). 
5.2.11 Blood circulation behavior 
4 healthy BALB/c mice were intravenously injected with Cu2-xSe-PEG-SH NPs, 
and blood from their retinal vein was collected before and after intravenous injection 
at 15 min, 30 min, 1 h, 2 h, 4 h, 6 h, 8 h, 12 h, 24 h, 48 h, and 72 h, respectively. The 
contents of copper in the blood were determined by ICP-OES after the samples were 
digested with HNO3/H2O2 mixture. The decay curve of the copper content in the 
blood was fitted with a two-compartmental model to extract the blood half-life. 
5.2.12 Histological Analysis 
For hematoxylin and eosin (H&E) staining, major organs, including the liver, 
spleen, kidney, heart, and lung, were harvested, fixed in 10% neutral buffered 
formalin, processed routinely into paraffin, sectioned into thin slices, and stained 
with H&E for histological analysis.  
 5.3 Results and discussion 
As illustrated in Figure 5.1a, Se powder was completely reduced by NaBH4 in 
aqueous solution under magnetic stirring under the protection of nitrogen gas.
[30]
 A 
mixture of CuCl2·2H2O and mercaptosuccinic acid (MSA)
[31, 32]
 was completely 
dissolved in distilled water and then immediately added into the selenium precursor 
solution to form a dark green solution, which indicates the formation of Cu2-xSe 
nanoparticles (denoted as MSA-Cu2-xSe NPs). The resultant ultra-small nanoparticles 
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were ultrafiltrated and then functionalized with dimercapto poly(ethylene glycol) 
(HS-PEG-SH) to improve their water solubility, colloidal stability, and 
biocompatibility. The PEGylated nanoparticles were denoted as Cu2-xSe-PEG-SH 
NPs, which not only exhibit long blood circulation time for efficient acccumulation 
in tumors through the EPR effect for PA imaging and PTT treatment, but also 
provide functional groups (i.e. -SH) for labelling with 
99m
Tc for SPECT imaging. 
 
Figure 5.1 (a) Schematic illustration of the synthesis of multifunctional Cu2-xSe PEG-
SH nanoparticles and (b) their applications in PA imaging, CT imaging, SPECT 
imaging, and photothermal therapy of cancer. 
 
The morphology and size of the as-prepared Cu2-xSe-PEG-SH NPs were 
examined by transmission electron microscopy (TEM). As shown in Figure 5.2a, b 
and Figure 5.3a, b in the Supporting Information, they are spherical particles with a 
mean size of 3.6 ± 0.3 nm. The well-defined crystalline lattice in the typical high-
resolution TEM (HRTEM) image (Figure 5.2b) with a lattice spacing of 0.33 nm 
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matches well with that of (111) planes of cubic berzelianite (Cu2-xSe), which can be 
further confirmed by the fast Fourier transform (FFT) pattern in the inset of Figure 
5.2b.
[1-5] 
The crystal structure of Cu2-xSe-PEG-SH NPs was further determined by 
powder X-ray diffraction (XRD, Figure 5.2c), and all the peaks in the pattern can be 
assigned to the characteristic lines of cubic berzelianite (Cu2-xSe, JCPDS Card No. 
06-0680). The atomic ratio of Cu to Se was determined by energy-dispersive X-ray  
 
Figure 5.2 Characterization of as-prepared Cu2-xSe-PEG-SH NPs: (a) TEM image, (b) 
HRTEM image with corresponding FFT pattern (inset), (c) XRD pattern in 
comparison with the standard peaks of cubic berzelianite (JCPDS Card No. 06-0680), 
(d) high resolution XPS spectra of Cu, (e) hydrodynamic size, and (f) ultraviolet-
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visible (UV-Vis)-NIR absorbance spectra of nanoparticle aqueous solutions with 
different Cu concentrations. 
 
Figure 5.3 (a) Low magnification TEM image of Cu2-xSe-PEG-SH NPs, (b) 
histogram of size distribution of Cu2-xSe-PEG-SH NPs, (c) EDS spectrum of Cu2-xSe-
PEG-SH NPs, with the inset showing the composition and atomic ratio of Cu, Se, 
and S, (d) XPS survey spectrum of Cu2-xSe-PEG-SH NPs, high resolution XPS 
spectra of (e) Se and (f) S, respectively. 
 
spectroscopy (EDS, Figure 5.3c) to be 1.74, which is consistent with the value 
determined by inductively coupled plasma optical emission spectroscopy (ICP-OES) 
and demonstrates the deficiency of copper in the nanoparticles. From the   viewpoint 
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of the molecular formula, non-stoichiometric Cu2-xSe can be considered as a mixture 
of stoichiometric Cu2Se and CuSe, and the valence states of Cu can be determined by 
X-ray photoelectron spectroscopy (XPS). The high-resolution XPS spectrum of the 









) of 4.21. The binding energy of Se 3d at 54.6 eV in the 
XPS spectrum is attributed to Se
2-
, and the peak at 58.8 eV is due to the oxidation of 
Se (Figure 5.3e).
[33]
 The Cu:Se ratio calculated from the XPS results is 1.78, which 
again supports the existence of a copper deficiency in nanoparticles.  
The resultant non-stoichiometric Cu2-xSe-PEG-SH NPs can be well dispersed in 
aqueous solution, saline solution (0.9 wt% NaCl), phosphate buffered saline (PBS) 
solution, pure Dulbecco‘s Modified Eagle‘s Medium (DMEM), and fetal bovine 
serum (FBS) solution with excellent colloidal stability, in comparison with MSA-
Cu2-xSe NPs which are aggregated in these media after 6 hours of dispersion, except 
in water solution (Figure 5.4a). The hydrodynamic sizes for MSA-Cu2-xSe and Cu2-
xSe-PEG-SH NPs in water were determined to be 6.4 nm and 13.6 nm by the 
dynamic light scattering (DLS) method, respectively (Figure 5.2e and Figure 5.4c). 
The stability of PEGylated Cu2−xSe nanoparticles in 10% fetal calf serum (FBS) 
media, which is widely used to mimick the physiological conditions, was monitored 
by measuring their hydrodynamic size over time. As shown in Figure 5.5, the 
PEGylated Cu2−xSe nanoparticles overall exhibit excellent stability in fetal calf serum 
as their hydrodynamic size only slightly increased over one week due to the 
adsorption of proteins, i.e. increased from 17.1 nm at day 1 to 34.0 nm at day 6. To 
further test their stability in serum, we dialysed PEGylated Cu2-xSe nanoparticles 
against fetal bovine serum for 48 h and determined the contents of Cu in the dialysis 
solution. Figure 5.6a shows a negligible difference in copper contents during dialysis. 
The good retention of high NIR absorbance further demonstrates the stability of 
Cu2−xSe nanoparticles (Figure 5.6b), and the slight increase of their absorbance in the 
visible region could be due to the adsorption of proteins. The zeta potential of Cu2-
xSe-PEG-SH NPs is -8.1 mV, higher than that of MSA-Cu2-xSe NPs (-14.1 mV) 
(Figure 5.4b). 
The PEGylation of ultra-small Cu2-xSe NPs is demonstrated by their Fourier 
transform infrared (FTIR) spectrum (Figure 5.4e), and the content of HS-PEG-SH 
coated on the surfaces of Cu2-xSe NPs was estimated by thermogravimetric analysis 
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(TGA) to be approximately 13.5 wt% (Figure 5.4f). These results demonstrate the 
successful modification of Cu2-xSe NPs by HS-PEG-SH.  
 
 
Figure 5.4 (a) Colloidal stability of Cu2-xSe-PEG-SH NPs and MSA-Cu2-xSe NPs 
dissolved in different media at 6 h after high speed centrifugation (10 krpm, 10 min), 
(b) zeta potentials of Cu2-xSe-PEG-SH NPs and MSA-Cu2-xSe NPs, (c) DLS 
measured sizes of MSA-Cu2-xSe and Cu2-xSe-PEG-SH in different solutions, 
including H2O, NaCl, PBS, DMEM, and FBS media. (d) linear fitting plots of 
ultraviolet-visible (UV-Vis)-NIR absorbance versus Cu concentration in aqueous 
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solutions at 808 nm. The inset shows a photograph of the Cu2-xSe-PEG-SH 
nanoparticle aqueous solutions with different Cu concentrations, labelled in units of 
µg/mL. (e) FTIR spectra of the MSA, HS-PEG-SH, and Cu2-xSe-PEG-SH NPs, and 
(f) TGA curves of MSA, MSA-Cu2-xSe NPs, HS-PEG-SH, and Cu2-xSe-PEG-SH NPs. 
 
 
Figure 5.5 Hydrodynamic size of PEGylated Cu2−xSe nanoparticles dispersed in 10% 
fetal bovine serum (FBS).  
 
 
Figure 5.6 (a) The stability of PEGylated Cu2−xSe nanoparticles after dialysis in FBS 
for different periods of time as indicated by the Cu contents measured with ICP-OES 
method The negligible change of Cu-percentage suggests their excellent stability. (b) 
UV-Vis-NIR absorbance spectra of PEGylated Cu2−xSe nanoparticles in FBS before 
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and after dialysis. The well retention of strong NIR absorbance further confirmed the 
stability of PEGylated Cu2−xSe nanoparticles.  
 
 
Figure 5.7 (a, b) Photothermal heating curves and corresponding infrared thermal 
images of pure water and aqueous dispersions of Cu2-xSe-PEG-SH NPs at different 
Cu concentrations under continuous irradiation by a 808 nm laser with a power 
density of 0.75 W/cm
2
 for 10 min, (c) in vitro relative cell viabilities of 4T1 cells 
after being incubated with various concentrations of Cu2-xSe-PEG-SH NPs for 24 h, 
(d) fluorescence images of 4T1 cells stained with live/dead kit after in vitro 
photothermal ablation under NIR laser irradiation with and without the addition of 
Cu2-xSe-PEG-SH NPs solutions with different Cu concentrations. 
 
Calculation of the photothermal conversion efficiency 
1 mL of 20 µg/mL Cu2-xSe-PEG-SH NPs solution was loaded into a cuvette and 
irradiated using a 808-nm laser, followed by natural cooling after the laser was 
turned off. The monitored temperature profile is shown in Figure 5.8a. The 
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photothermal conversion efficiency (η) is calculated according to the following 
equation.  
                                                            (1) 
where m is the solution mass and equal to 1.0 g in the current study, c is the heat 
capacity of water and equal to 4.2 J/g, Tmax and Tmax, H2O are the maximum 
temperatures reached for the nanoparticle solution and for water, which are 40.58 ℃ 
and 22.09 ℃, respectively, I is the laser power and equal to 0.75 W/cm2 in the 
current study, A is the absorbance of the nanoparticle solution at 808 nm and equal to 
0.16236, and τ𝐬 is the system time constant and equal to 512.3 s, according to the 
linear regression of the cooling profile (Figure 5.8b). The photothermal conversion 
efficiency is calculated to be 64.8% by using these parameters. 
 
Figure 5.8 (a) The temperature profile of Cu2-xSe-PEG-SH NPs solution irradiated 
with a 808-nm laser, followed by natural cooling after the laser was turned off, (b) 
determination of the system time constant using linear regression of the cooling 
profile shown in (a). 




Figure 5.9 Temperature changes of MSA-Cu2-xSe (lower panel) and Cu2-xSe-PEG-SH 
NPs (upper panel) over five cycles of irradiation/cooling (0.75 W/cm
2
, 10 min). 
Insets: corresponding optical images of samples at 1 h after five cycles of 
photothermal stability testing. 
  
The aqueous solutions of Cu2-xSe-PEG-SH NPs (see inset of Figure 5.4d) show 
strong LSPR in the NIR region (from 600 to 1100 nm), as shown in Figure 5.2f, due 
to the high density of vacancies arising from copper deficiency.
[34, 35]
 Moreover, the 
absorption at 808 nm is linearly increased with increasing Cu concentration (Figure 
5.4d), which was determined by ICP-OES. According to the Lambert-Beer law (A/L 
= αC, where A is the absorption intensity, L is the length of the cuvette, C is the 
concentration, and α is the extinction coefficient), the extinction coefficient of Cu2-




, which is 













 both of which have been 
intensively applied in photothermal therapy.  
The large extinction coefficient of Cu2-xSe-PEG-SH NPs suggests that they have 
a pronounced photothermal conversion capability. Therefore, different 
concentrations of Cu2-xSe-PEG-SH NPs in aqueous solutions were exposed to an 808 
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nm NIR laser with a power density of 0.75 W/cm
2
 for 10 min. Figure 5.7a, b clearly 
demonstrates the concentration-dependent photothermal conversion of Cu2-xSe-PEG-
SH NPs, and their solution temperature can be precisely controlled between 25 °C 
and 75 °C by varying the Cu concentration from 0 to 100 μg/mL. In comparison, the 
temperature increase for pure water is less than 3 °C under the same experimental 
conditions. The photothermal conversion efficiency is calculated to be 64.8% (Figure 
5.8), which is approximately 3 times of previously reported Cu2-xSe nanocrystals 
(22%) synthesized by the colloidal hot injection method.
[10]
  
Photothermal stability is of key importance for photothermal agents during PA 
imaging and PTT treatment. To assess the photothermal stability of Cu2-xSe-PEG-SH 
NPs solution, for comparison purposes, the temperature profiles of two solutions 
containing the same amount of Cu2-xSe-PEG-SH NPs and MSA-Cu2-xSe NPs were 
recorded for five successive cycles of heating/cooling processes (Figure 5.9). Both 
MSA and HS-PEG-SH capped Cu2-xSe NPs exhibited stable photothermal 
conversion capability during five cycles of testing. The MSA-Cu2-xSe NPs were 
aggregated 1 hour after the test was finished, however, while the Cu2-xSe-PEG-SH 
NP solution remained stable at all times, as demonstrated by the insets of Figure 5.9. 
The improved stability of Cu2-xSe-PEG-SH NPs over MSA-Cu2-xSe NPs is due to the 
excellent water-solubility and steric hindrance of the PEG molecules. 
The remarkable photothermal conversion efficiency and photothermal stability 
of Cu2-xSe-PEG-SH NPs suggest that they could serve as excellent agents for PA 
imaging and PTT of cancer if they have good biocompatibility. Therefore, the 
potential cytotoxicity of Cu2-xSe-PEG-SH NPs towards 4T1 cells (murine breast 
cancer cells) was investigated by a standard methyl thiazolyl tetrazolium (MTT) 
assay (Figure 5.7c). The results show almost no cytotoxicity to 4T1 cells for Cu2-xSe-
PEG-SH NPs in solutions with copper concentrations below 50 µg/mL, and the cell 
viability remained 84% when the copper concentration was 100 µg/mL. 
Based on the excellent biocompatibility of Cu2-xSe-PEG-SH NPs, their 
capability of in vitro photothermal ablation of cancer cells (e.g. 4T1 cells) in 
different concentrations was investigated with an 808 nm NIR laser at power density 
of 0.5, 0.75, and 1.5 W/cm
2
. The living cells and dead cells were respectively stained 
green and red with a Live-Dead Cell Staining Kit after laser irradiation. As shown in 
Figure 5.7d, 4T1 cells could not be killed when they were treated only with Cu2-xSe-
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PEG-SH NPs or only with laser irradiation (0.5, 0.75, 1.5 W/cm
2
). In contrast, 4T1 
cells treated with a combination of Cu2-xSe-PEG-SH NPs and laser irradiation died 
with increasing particle concentration and/or laser power intensity. The results 
demonstrate that Cu2-xSe-PEG-SH NPs can effectively kill cancer cells through 
hyperthermia induced upon by NIR laser irradiation.  
The feasibility of Cu2-xSe-PEG-SH NPs for in vitro photothermal ablation of 
cancer cells suggests that these nanoparticles could be also used for PA imaging, as 
they both utilize the heat converted from the NIR laser. Therefore, the in vitro PA 
imaging performance of the as-prepared Cu2-xSe NPs was investigated. As expected, 
the photoacoustic signal was significantly enhanced with the assistance of Cu2-xSe 
NPs, and the signal intensity was linearly increased with increasing copper 
concentration (Figure 5.10a, b), suggesting that Cu2-xSe NPs could be a promising 
agent for in vivo PA imaging. Prior to the in vivo imaging experiment, it is important 
to know the blood circulation kinetics of Cu2-xSe-PEG-SH NPs. Blood samples were 
collected at different time points after intravenous injection of nanoparticles into 4T1 
tumor-bearing BALB/C mice, and then digested with HNO3/H2O2 solution 
(HNO3:H2O2 = 2:1 by volume) to determine their copper concentration by ICP-OES 
measurements. As shown in Figure 5.12, Cu2-xSe-PEG-SH NPs exhibit a relatively 
long blood circulation with a half-life of 8.14 h due to their ultra-small size and their 
surface PEG molecules, which can effectively reduce the phagocytosis of 
macropahges and the adsorption of proteins.
[38, 39] 
 




Figure 5.10 (a) In vitro PA images of Cu2-xSe NPs in different concentrations 
(concentration unit: µg/mL of Cu), (b) in vitro PA signals of Cu2-xSe-PEG-SH NPs 
as a function of Cu concentration, (c) in vitro CT images of Cu2-xSe-PEG-SH NPs in 
comparison with commercially used iopromide in different concentrations 
(concentration unit: mg/mL), (d) in vitro CT signals of Cu2-xSe-PEG-SH NPs and 
iopromide as functions of their corresponding concentrations, (e) in vivo PA intensity 
of tumor determined at different time points after intravenous injection of Cu2-xSe-
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PEG-SH NPs, (f) tumor uptake of nanoparticles at different time points after 
intravenous injection of Cu2-xSe-PEG-
99m
Tc NPs, (g) photograph of 4T1-tumor-
bearing mouse (tumor indicated by red circle) taken at 12 h post intravenous 
injection of Cu2-xSe-PEG-
99m
Tc, and (h) distribution of Cu2-xSe-PEG-
99m
Tc 
determined by counting gamma rays in the tissues and organs of a mouse sacrificed 
at 24 h post-injection.  
 
 
Figure 5.11 In vivo CT images of a mouse taken before injection (Pre), and 2 h, 4 h, 
6 h, 8 h, 10 h, 12 h, and 24 h post intravenous injection of Cu2-xSe-PEG-SH NPs (2.5 
mg/mL, 200 µL). The tumor is indicated by the circles. 
 
The long blood circulation time highlights that the as-prepared ultra-small 
nanoparticles could be used for in vivo tumor imaging. Therefore, Cu2-xSe-PEG-SH 
NPs were intravenously injected into 4T1 tumor-bearing BALB/c nude mice, and 
then a set of PA images of the tumor region were acquired before and after injection. 
Figure 5.12a and Figure 5.10e show the PA images and the signals from the tumor 
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site obtained at different times. The results clearly demonstrate that only a weak PA 
signal in the tumor area could be detected before the injection of Cu2-xSe-PEG-SH 
NPs, and the signal gradually increased with the circulation of nanoparticles after 
their intravenous injection, due to their gradual accumulation in the tumor through 
the EPR effect. The PA signal reached its maximum at 12 h post-injection and then 
decreased until 24 h post-injection. The maximal signal is 2.1 times higher than that 
of the pre-contrast image.  
 
Figure 5.12 (a) In vivo PA images of tumor (highlighted by red circles) from a 4T1 
tumor-bearing mouse collected before and after tail vein injection of Cu2-xSe-PEG-
SH NPs solution (500 µg/mL, 200 µL) at different time points, (b) 3D in vivo CT 
images of a mouse bearing a tumor (indicated by the red circles) before (left) and 
after (right) intratumoral injection of Cu2-xSe-PEG-SH NPs (2.5 mg/mL, 200 μL), (c) 
in vivo SPECT images of a mouse bearing a tumor (indicated by the red circles) after 
intravenous injection of Cu2-xSe-PEG-
99m
Tc solution, (d) blood circulation and (e) 
biodistribution of Cu2-xSe-PEG-SH NPs after intravenous injection into 4T1 tumor-
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bearing mice, as determined by measuring Cu concentrations in tissue lysates with 
ICP-OES.  
 
In addition to PA imaging, Cu2-xSe-PEG-SH NPs exhibit very interesting 
potential in computed tomography (CT) imaging. As shown in Figure 5.12b and 
Figure 5.10c, d, the CT signals produced by Cu2-xSe NPs and commercial clinically 
used iopromide are dependent on their concentration, and the Hounsfield units (HU) 
value of Cu2-xSe NPs (~120 HU L/g ) is approximately 1.6 times higher than that of 
iopromide (73.53 HU L/g) at the same concentration. Motivated by the excellent X-
ray attenuation capability of the Cu2-xSe-PEG-SH NPs in vitro, we intratumorally 
injected the Cu2-xSe-PEG-SH NPs (2.5 mg/mL, 200 μL) into an anesthetized 4T1 
tumor-bearing BALB/c mouse and conducted imaging with an animal micro-CT 
system. As demonstrated by the three-dimensional (3D) CT images in Figure 5.12, 
the contrast of tumor image can be greatly enhanced by Cu2-xSe-PEG-SH NPs. The 
average CT values for the tumor site were dramatically increased from 78.2 HU (Pre) 
to 763.2 HU (Post) after injection of Cu2-xSe-PEG-SH NPs. 
Based on the above results, a solution of Cu2-xSe-PEG-SH NPs (2.5 mg/mL, 200 
μL) was intravenously injected into another tumor-bearing BALB/c mouse, and CT 
images were collected at different time points post-injection (Figure 5.11). The 
images clearly show the contrast enhancement of the tumor due to its passive 
accumulation of NPs. The mean HU value was gradually increased from 96.8 HU 
before injection to 108.0 HU at 4 h, 126.7 HU at 8 h, 150.3 HU at 10 h, and 102.8 
HU at 24 h after intravenous injection.  
Both in vitro and in vivo CT imaging results provide evidence that ultra-small 
Cu2-xSe-PEG-SH NPs can serve as a promising CT contrast agent. Their excellent 
performance is attributed to the large X-ray attenuation coefficients (μ) of both Cu 
and Se elements, which drastically decrease with increasing X-ray energy, e.g., Cu 
and Se have μ values of 33.79 cm
2
/g and 48.18 cm
2
/g at 20 keV, respectively, which 
are decreased to 1.59 and 2.34 cm
2
/g at 60 keV, and 0.46 and 0.63 cm
2
/g at 100 
keV.
[40, 41]
 Due to the small energy of Cu-Se bonds compared with the X-ray energy, 
the attenuation of X-rays in Cu2-xSe can be treated as attenuation in Cu and Se, 
respectively, and the attenuation coefficient of Cu2-xSe (x = 0.26 in our case) can be 
expressed by Equation (2): 




              
         
              
      
    
              
                          
 
Where μCu and μSe are the attenuation coefficients of Cu and Se, respectively. The 
effective atomic number of Cu1.74Se is calculated to be 43.7 through Equation (3): 
 ̅  √        
        
                                       
Where Zcu and ZSe are the atomic numbers of Cu and Se, repectively. Both the 
large attenuation coefficients and the high effective atomic number demonstrate the 
potential of Cu2-xSe in CT imaging.  
 
Figure 5.13 The Cu concentration in the excreted urine at different intervals of post-
injection of the Cu2-xSe-PEG-SH NPs solution and PBS solution (control group), 
respectively.  
 
Besides their excellent performance in PA imaging and CT imaging for 
qualitative diagnosis, an advantage of our ultra-small Cu2-xSe-PEG-SH NPs is their 
multifunctional groups (–COOH and –SH), which provide more options for 
quantative analysis by multimodal imaging. Here, the clinically used radioisotope 
technetium-99m (
99m
Tc, half-life, t1/2 = 6.02 h, gamma-ray energy, Er = 140 keV) 
was selected to functionalize these nanoparticles for SPECT imaging due to its 
strong gamma-ray emission, short half-life, and low cost.
[42]
 Cu2-xSe-PEG-SH NPs 







Tc) were intravenously (i.v.) injected into a 
4T1 tumor-bearing mouse, which was imaged by a U-SPECT instrument at different 
time points post-injection. Obvious tumor uptake of Cu2-xSe-PEG-
99m
Tc appeared 
after injection, and the tumor became obviously black after 12 h (Figure 5.10g), 
which demonstrates the passive accumulation of Cu2-xSe-PEG-
99m
Tc in the tumor 
through the EPR effect. As a consequence, a remarkable emission of gamma-rays 
from Cu2-xSe -PEG-
99m
Tc NPs accumulated in the tumor was detected (Figure 5.12c). 
The time-dependent accumulation of nanoparticles in tumor were quantified by 
counting gamma-rays to be 1.27, 1.37, 1.53, 1.83 and 0.84 %ID/g  (percentage of 
injected dose per gram tissue) at 2 h, 4 h, 6 h, 12 h, and 24 h, respectively (Figure 
5.10f). The tumor-homing effect observed from the SPECT images is well consistent 
with the PA results. In addition, strong signals of gamma rays in the liver and the 
kidney were also observed due to the capture of Cu2-xSe-PEG-
99m
Tc NPs by the 
reticuloendothelial system (Figure 5.12). The intense signal in the bladder detected at 
2 − 12 h after injection and the weak signal in the bladder at 24 h suggest that these 
ultra-small Cu2-xSe-PEG-
99m
Tc NPs might be cleared out through renal excretion. To 
futher confirm the renal excretion of the ultra-small nanoparticles, the mouse was 
sacrificed, and the major organs were harvested for quantification of gamma-rays 
(Figure 5.10h). The results show that the kidney has the strongest signal, followed by 
the liver, spleen, and lung. The strong signal of kidney supports the renal excretion of 
of ultra-small Cu2-xSe NPs which could minimize their potential side effects. In 
addition, Urine solutions of mice were collected at different intervals for ICP-OES 
analysis. As shown in Figure 5.13, the amount of Cu per gram of urine significantly 
increased to the maximum at 1 h post injection and then declined to a constant at 8 h 
post injection of PEGylated Cu2-xSe nanoparticles, in comparison with that of mice 
injected with PBS solution. This result demonstrates that a fraction of PEGylated 
Cu2-xSe nanoparticles can be excreted by urine due to their ultrasmall size. The 
excretion of ultrasmall PEGylated Cu2-xSe nanoparticles through urine could 
significantly reduce their toxicity or side effects. 
All the imaging results (PA imaging, CT imaging, and SPECT imaging) 
demonstrate that Cu2-xSe-PEG-SH NPs could be passively accumulated in the tumor 
by the EPR effect. In order to further quantify their biodistribution, Cu2-xSe-PEG-SH 
NPs were intravenously injected into a group of 4T1 tumor-bearing BALB/C mice, 
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which were sacrificed at 2 h, 4 h, 6 h, 8 h, 12 h, 24 h, and 48 h, and their major 
organs were harvested to determine the copper contents by ICP-OES measurements. 
The results in Figure 5.12e reveal that the Cu2-xSe-PEG-SH NPs are mainly 
distributed in reticuloendothelial organs such as the liver, spleen, and lung. The high 
distribution in the kidney again supports the proposition that the ultra-small Cu2-xSe-
PEG-SH NPs can be excreted through renal clearance. The copper content in the 
tumor reached the maximum value of 4.4 %ID/g at 12 h post injection, which is 
consistent with the results of PA imaging and SPECT imaging. 
The highly efficient photothermal conversion efficiency of Cu2-xSe-PEG-SH 
NPs and their outstanding passive accumulation in tumors encouraged us to further 
investigate the feasibility of in vivo photothermal ablation of cancer cells under the 
guidance of multimodal imaging. 24 BALB/c mice bearing 4T1 tumors with a 
volume of around 130 mm
3
 were divided into 4 groups with 6 mice per group to 
respectively receive intravenous adminstration of either PBS solution (200 µL) or 
Cu2-xSe-PEG-SH NPs solution (500 µg/mL, 200 µL), and then irradiated for 6 min 
by an 808-nm NIR laser with a power density of 1.5 W/cm
2
 at 12 h post injection. 
The four groups of mice are referred to as (a) mice injected with PBS only (group 1, 
PBS); (b) mice injected with Cu2-xSe-PEG-SH NPs only (group 2, Cu2-xSe); (c) mice 
irradiated with the NIR laser after injection of PBS (group 3, PBS+NIR); and (d) 
mice irradiated with the NIR laser after injection of Cu2-xSe-PEG-SH NPs (group 4, 
Cu2-xSe+NIR). The temperature of the tumor area under NIR irradiation was 
monitored by an infrared thermal camera. The tumor volume and appearance, and the 
body weights of mice were measured every two days. The negligible differences in 
the weights of the four groups of mice (Figure 5.15) indicate that the current dose of 
ultra-small Cu2-xSe-PEG-SH NPs did not induced acute toxicity or noticeable 
systemic toxicity. As shown in Figure 5.14a and b, the tumor temperature of the 
mouse injected with Cu2-xSe-PEG-SH NPs increased dramatically to 57.6 °C under 
NIR irradiation, which is sufficient to ablate the cancer cells and eradicate their 
malignant proliferation. In huge contrast, the tumor temperature of mice injected 
with PBS solution only increased to approximately 44 °C. Hematoxylin and eosin 
(H&E) staining of tumor slices collected at day 3 after treatment was further carried 
out to reveal the therapeutic efficacy. As shown in Figure 5.14c, no obvious 
malignant necrosis was observed in the mice from control groups 1-3, while apparent 
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extensive karyopyknosis and necrosis were found in the mice intravenously injected 
with Cu2-xSe and then irradiated with the NIR laser (i.e. group 4), which 
demonstrates the excellent therapeutic efficacy of ultra-small Cu2-xSe-PEG-SH NPs. 
The tumors treated with NIR irradiation with the aid of accumulated Cu2-xSe 
NPs shrank and became black scars at day 3 (Figure 5.16), and were completely 
eliminated within 16 days. No recurrence was observed during the subsequent 
feeding (Figure 5.14d and 5.16). The tumors of the mice from the PBS+NIR group 
kept growing until the mice died, which is similar to the cases of mice injected with 
PBS or Cu2-xSe NPs only. In addition, the average lifespans of the mice in these 
groups are obviously shorter than that of mice treated with NIR irradiation after 
injection of Cu2-xSe (Figure 5.14e). The results demonstrate that the use of PBS, Cu2-
xSe NPs, or NIR irradiation alone could not prevent tumors from growing. All these 
results provide strong evidence that ultra-small Cu2-xSe-PEG-SH NPs could be a 
promising biocompatible PTT agent for in vivo photothermal therapy of tumor.  




Figure 5.14 In vivo photothermal therapy of tumors with Cu2-xSe-PEG-SH NPs: (a) 
infrared thermal images and (b) temperature curves of 4T1 tumor-bearing mice 
intravenously injected with Cu2-xSe-PEG-SH NPs solution (500 µg/mL, 200 μL) and 
then irradiated with an 808 nm NIR laser at a power density of 1.5 W/cm
2
 for 6 min, 
in comparison with injection of PBS solution followed by NIR irradiation, (c) H&E 
staining of tumor sections from different groups of mice sacrificed at day 3 of 
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treatment, (d) relative tumor volumes normalized to their initial volumes (Analysis of 
Variance (ANOVA) was used to assess statistical significance. *p < 0.5, **p < 0.01, 















Figure 5.16 Representative photographs of mice bearing 4T1 tumors taken at 
different times after treatment.  
 




Figure 5.17 H&E stained images of major organs collected from mice intravenously 
injected with PBS and then irradiated with a NIR laser (top row), from healthy 
mouse (middle row), and from mice intravenously injected with Cu2-xSe-PEG-SH 
NPs and then irradiated with a NIR laser (bottom row, images collected at 40 days 
after photothermal therapy). Red circles represent tumor metastasis regions. 
 
To further determine that there was no recurrence of tumors or metastasis of the 
cancer, the major organs, such as the liver, lung, kidney, spleen, and heart, were 
harvested at day 40 after treatment and stained with H&E. As displayed in Figure 
5.17, there are obvious metastases and inflammatory lesions in the livers and lungs of 
mice treated with PBS, Cu2-xSe NPs, or NIR irradiation after adminstration of PBS. 
In contrast, no evident inflammation or damage is observed in any of the major 
organs of the mice treated with NIR irradiation after injection of Cu2-xSe-PEG-SH 
NPs, and the H&E images of these organs are the same as for a healthy mouse, 
further confirming that there are no side effects or toxicity associated with the Cu2-
xSe-PEG-SH NPs.  
 
5.4 Conclusions 
In summary, a novel multimodal imaging-guided PTT nanotheranostic agent 
based on ultra-small PEGylated Cu2-xSe NPs was successfully fabricated via a facile 
aqueous route. The Cu2-xSe NPs possess a strong, significant NIR LSPR due to the 
high copper deficiency. The resultant NPs exhibit high stability and biocompatibility 
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both in vitro and in vivo. More importantly, they show highly efficient photothermal 
conversion for PA imaging and PTT in vitro and in vivo, and large X-ray attenuation 
coefficients for CT imaging, as well as multifunctional groups for coordinating with 
radioisotopes for SPECT imaging. Both the in vitro and the in vivo results 
demonstrate that ultra-small PEGylated Cu2-xSe NPs could serve as an ideal 
multifunctional platform for multimodal imaging-guided photothermal therapy of 
cancer. 
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Chapter 6 Vacancy Engineering for Tuning the Localized Surface Plasmon 
Resonances of Fe-doped Cu2-xSe Nanoparticles for Dual-modal Photoacoustic/MR 





    Designing a multifunctional nanotheranostic for integration of precise diagnosis 
and effective treatment of tumors is desirable but remains a great challenge. In this 
chapter, we developed a facile and chelator-free doping method for constructing Fe-
doped Cu2-xSe nanoparticles. The position and intensity in near-infrared localized 
surface plasmon resonance in the alloyed nanostructure can be tuned by altering the 
feeding amount of the Fe
3+
 ions precursors. Owing to their tunable near-infrared 
absorption and Fe doping, the hybrid nanostructure was demonstrated be a novel 
nanotheranostic agent for effective deep-tissue photoacoustic imaging, magnetic 
resonance imaging, and photothermal therapy of cancer.   
 




  Localized surface plasmon resonances (LSPRs) typically arise from the collective 
oscillation of free charge carriers (i.e., electrons or holes) in resonance with the 
driving electromagnetic field of incident light.
[1-7]
 Owing to these LSPRs, the 
nanoparticles show enhanced light absorption and scattering with potential 
applications in fields ranging from photoelectrical
[8-10]
 to biomedical, such as bio-
imaging and photothermal therapy.
[2, 11-17]
 LSPRs can be achieved not only in 
nanostructures of noble metals, but also in semiconductor nanocrystals (NCs) with 
appreciable free carrier concentrations.
[1, 4]
 The most common plasmonic noble 







 with corresponding LSPRs in the visible spectrum.
[18]
 In contrast to LSPRs 
in metals, which are attributable to oscillation of free electrons, the LSPRs in the 
near-infrared (NIR) in heavily doped copper chalcogenide (Cu2-xE, E = S, Se, Te) 
nanoparticles (NPs) arise from free holes, owing to the large amount of hole carriers 
with high mobility due to their copper deficiency.
[19, 20]
 Both the semiconductor 
nanocrystals and the noble metals exhibit size- and shape-tunability of LSPRs. The 
NIR LSPRs of semiconductors can be easily engineered, however, because their free 
carrier concentrations can be tuned by doping, temperature, and/or phase transitions. 
In contrast, the LSPR response of metal particles, once they are engineered by the 
choice of nanostructure parameters (such as shape, size, or metal), is permanently 
locked in and cannot be dynamically controlled.
[1] 
 
  The berzelianite Cu2-xSe is an important p-doped copper chalcogenide 
semiconductor with a relatively high hole concentration and exhibits strong free 
carrier absorption, which results in LSPRs. Due to the dynamic tunability of LSPRs 
by simple doping, doped copper chalcogenide nanocrystals have been widely used 
for photoacoustic (PA) imaging contrast and photothermal therapy (PTT) transducers 
in biomedical application due to their strong absorption in the NIR.
[16, 21, 22]
 Moreover, 
introducing various types of foreign functional ions into the vacancies of NPs by 
doping gives them additional properties and functions, and this has become a 
promising method to design multifunctional nanoparticles.
[23-27]
 It is well known that 
multimodal imaging can offer more accurate and reliable biomedical information to 
improve the efficacy and sensitivity of clinical imaging diagnostics.
[16] 
Magnetic 
resonance imaging (MRI) has evolved into a routinely used tool in noninvasive 
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diagnostic imaging thanks to its high spatiotemporal resolution, excellent soft tissue 
contrast, and non-ionizing radiation.
[28-30]
 PA imaging as an emerging non-invasive 
hybrid imaging technique possesses the unprecedented advantages of high contrast 
optical imaging as well as high resolution acoustic imaging at the centimeter 
penetration depth.
[31-33]
 Therefore, a new imaging technique that integrates MRI with 
PA imaging, which not only images subsurface tissue structures, but also offers 
higher resolution and deeper tissue penetration, will lead to better diagnosis of many 
diseases. Intense efforts have been made to fabricate various kinds of multimodal 
contrast agents (such as for positron emission tomography/ computed tomography 
(PET/CT),
[34]




 MRI/ upconversion 
luminescence (UCL)
[37]
) via doping. There are only a few reports in the literature on 
creating PA/MRI imaging contrast agents by the doping method,
[27]
 let alone detailed 
investigation on the mechanism of the doping process.  
  Herein, we have for the first time developed a facile doping method by making use 
of the oxidation-reduction reaction in the Fe-Cu2-xSe system to construct an Fe-doped 
Cu2-xSe therapeutic agent, which was non-covalently functionalized dimercapto 
poly(ethylene glycol) (HS-PEG-SH) for applications in tumor dual-modal imaging 
and PTT treatment. It should be noted that this doping method does not involve any 
surfactant or chelator, and it was performed at room temperature and atmospheric 
pressure; therefore, no special or complex apparatus is required. Moreover, the 
possible doping and phase transfer process has been carefully investigated, which 
surely will further promote the potential exploration of Cu2-xSe-based nanomaterials 
for cancer diagnosis and therapies. 
 
6.2 Experimental Section 
6.2.1 Materials  
All chemicals and reagents were used as received without any further 
purification. Copper sulfate (CuSO4·5H2O), polyvinylpyrrolidone powder (PVP) and 
Iron( Ⅲ ) chloride hexahydrate (FeCl3·6H2O) were purchased from Sinopharm 
Chemical Reagent. Selenium dioxide (SeO2) was obtained from Aladdin Chemistry, 
and vitamin C (Vc) was purchased from Alfa Aesar. Dimercapto poly(ethylene 
glycol) (HS-PEG-SH, MW = 5000) was bought from Adamas. Milli-Q water (> 18 
MΩ•cm) was used in the experiments. 
                                                                                                     Chapter 6 Fe doped Cu2-xSe  
156 
 
6.2.2 Synthesis of Cu2-xSe nanoparticles and PEGylated Fe-doped nanoparticles 
Cu2-xSe NPs were synthesized according to a modified protocol reported 
elsewhere.
[38] 
Briefly, 55 mL Milli-Q water and 16 mL 10 mg/mL PVP-K30 (i.e. 160 
mg PVP) were added to a round-bottomed flask, and then 1 mL 0.2 M SeO2 and 3 
mL 0.4 M Vc were added successively. After 15 min, a red Se solution was formed. 
A mixed solution of 1 mL 0.4 M CuSO4·5H2O and 4 mL 0.4 M Vc, in which Vc 
reduced the Cu
2+
 ions to Cu
+
, was added into the red Se solution under vigorous 
stirring. The resultant mixture was allowed to react under vigorous stirring at room 
temperature until a dark green solution was obtained in 30 h, indicating that PVP-
stabilized Cu2-xSe NPs had been prepared. The dark green solution was subsequently 
purified twice by centrifugation with water at 10000 rpm to remove the excess PVP 
and Vc. After that, 3 mL 0.1 M FeCl3·6H2O aqueous solution (i.e. 0.3 mol Fe
3+
, 
molar ratio: Cu2-xSe: Fe
3+
 = 1: 1.5) was added into the redispersed Cu2-xSe NP 
solution where the color rapidly changed from green to a dark color. After 6 h, the 
products were centrifuged, washed several times with water, and then redispersed in 
aqueous solution. 0.2 g HS-PEG-SH was added to modify the surfaces of the CuFeSe 
NPs at room temperature. The obtained PEGylated nanoparticles were purified by 
centrifugation at 10000 rpm and the final product was stored at 4 °C for further 
characterization and use.   
6.2.3 Characterization 
Ultraviolet-visible-near-infrared (UV-Vis-NIR) spectra were recorded with a 
PerkinElmer Lambda 750 UV-Vis-NIR spectrophotometer. TEM images were 
captured using a FEI Tecnai F20 transmission electron microscope operating at an 
acceleration voltage of 200 kV. HAADF images and STEM-EDS spectra were 
collected using a JEOL ARM-200F operating at 200 kV with an EDAX solid-state 
X-ray detector. Samples were prepared by drop-casting ethanol-dispersed 
nanostructures onto TEM aluminium grids. The crystal structure of the nanoparticles 
was characterized with a Shimadzu XRD-6000 X-ray diffractometer equipped with 
Cu Kα1 radiation (λ = 0.15406 nm). X-ray photoelectron spectroscopy (XPS) 
measurements were carried out on a Thermo Scientific Sigma Probe instrument using 
Al Kα X-ray radiation and fixed analyzer transmission mode. Thermogravimetric 
analysis (TGA) was performed to analyze the weights of surface ligands at a heating 
rate of 10 °C min
-1
 from room temperature to 900 °C under argon atmosphere. The 
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hydrodynamic size and zeta potential were measured at 25 °C with a Malvern 
Zetasizer Nano ZS90 equipped with a solid state He-Ne laser (λ = 633 nm). Fourier 
transform infrared (FTIR) spectra were recorded on a Magna-560 spectrometer 
(Nicolet, Madison, WI, USA). Raman spectra were collected with a Jobin Yvon 
HR800 Raman spectrometer with a 10 mW He-Ne laser. 
6.2.4 Cytotoxicity assay of the PEGylated CuFeSe nanoparticles 
MTT assays were performed to assess the cytotoxicity of the CuFeSe-PEG NPs. 
In detail, 4T1 cells were first seeded into 96-well plates at a density of 4000 cells per 
well and cultured for 24 h in Dulbecco‘s modified Eagle‘s medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS). Then, the cells were washed with 
PBS and incubated with CuFeSe-PEG NPs at different concentrations at 37 °C for 24 
h. After that, the cells were washed twice with PBS and cultured for 48 h. Then, 20 
μL MTT was added at a concentration of 5 mg/mL and allowed to react with the cells 
for 4 h before the addition of 150 μL dimethyl sulfoxide (DMSO) to dissolve the 
precipitates. The absorption of each solution was measured at 490 nm on a 
microplate reader (Thermo, Varioskan Flash). 
6.2.5 Animal model 
The tumor models used were established by subcutaneous injection of 50 µL 
4T1 cell suspension (~5 × 10
6
 cells) into the flank region of the right back of 5-week-
old male BALB/c mice (for the PTT treatment) or nude mice (for the PA imaging). 
The tumor imaging studies were carried out 10 days after the inoculation with tumor 
cells. All animal experiments were carried out according to the protocols approved 
by the Soochow University Laboratory Animal Center. 
6.2.6 In vivo Photoacoustic Imaging 
Nude mice bearing subcutaneous tumors were anesthetized with 1.5% 
isoflurane delivered via a nose cone, and then CuFeSe-PEG NPs (dose = 7 mg/kg) 
were injected via the tail vein. Photoacoustic images were acquired at different time 
points post-injection by a multispectral optoacoustic tomography (MSOT) instrument. 
10 slices were obtained at each position and averaged to minimize the influence of 
animal movement in the images. 
6.2.7 MRI Measurements  
MRI was performed on a clinical 3.0 T MRI scanner equipped with a special 
coil designed for small animals. In-vitro T2-weighted MRI images of nanoparticle 
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solutions with different Fe concentrations were measured. For in vivo imaging, the 
mouse was anesthetized with isoflurane (1.5%) at 1 L/min flow throughout the 
experiment. Prior to imaging, CuFeSe-PEG NPs (50 μL, 2 mg/mL) were 
administered by intratumoral injection. T2-weighted MRI images were acquired 
using the T2-RARE sequence (RARE = rapid acquisition with relaxation 
enhancement) with the following parameters: repetition time (TR) = 3.5 s, echo time 
(TE) = 76 ms, field of view = 40 mm × 40 mm, matrix size = 512 × 512, number of 
slices = 7, slice thickness/gap = 2.0 mm/0.4mm, flip angle = 150º, and number of 
excitations (NEX) = 4. 
6.2.8 Photothermal Therapy 
24 tumor-bearing BALB/c mice with an average tumor volume of 130 mm
3
 
were randomly allocated into 4 groups, which were intravenously injected with the 
same volume of either saline or CuFeSe-PEG NPs solution (7 mg/kg). The laser 
irradiation was performed using an 808-nm NIR laser (Hi-Tech Optoelectronics Co., 
Ltd., Beijing, China) with a power density of 1.5 W/cm
2
 for 5 min. The tumor sizes 
and body weights were measured every two days, and the tumor volume was 
calculated by a × b
2
/2, where a and b represent the length and width of the tumor, 
respectively. Relative tumor volumes were obtained by dividing by the initial tumor 
size before laser treatment. The mice treated with NIR irradiation after injection of 
CuFeSe-PEG NPs were sacrificed at day 30 to harvest the major organs for 
histological analysis. 
6.2.9 Histological Analysis 
For hematoxylin and eosin (H&E) staining, major organs, including the heart, 
liver, spleen, kidney, and lung, were harvested, fixed in 10% neutral buffered 
formalin, processed routinely into paraffin, sectioned into thin slices, and stained 
with H&E for histological analysis.  
 
6.3 Results and discussion 
  As demonstrated in Figure 6.1, monodispersed Cu2Se NPs with 
polyvinylpyrrolidone (PVP) as a stabilizer were prepared via a modified template-
directed synthesis method reported elsewhere (step 1 in Figure 6.1).
[38]
 More 
specifically, nano-Se NPs were firstly prepared as templates by using ascorbic acid 
(Vc) to reduce SeO2 in the presence of PVP. Second, Cu2Se NPs were formed with 
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the addition of Cu
+









. After that, the as-formed Cu2Se NPs can be gradually 
transformed into Cu2-xSe with a color change to deep green through a phase 
transformation process promoted by air exposure and the unreacted oxidants (step 2 
in Figure 6.1). The nano-Se NP templates were characterized by transmission 
electron microscopy (TEM), X-ray diffraction (XRD), and ultraviolet (UV) 
spectroscopy, as shown in Figure 6.2. Those nano-Se particles are quasi-spherical 
NPs with a mean diameter of 86.34 ± 10.07 nm. The XRD pattern in Figure 6.2c 
confirmed the crystal structure of Se NPs, suggesting their good crystallinity. It was 
noted that there was almost no absorption for Se NPs at wavelengths > 700 nm, as 
shown in Figure 6.2d.  
 
Figure 6.1 Schematic illustration of the synthesis of Fe-doped Cu2-xSe nanoparticles. 





Figure 6.2 The characterization of Se nanoparticles. (a) TEM images at different 
magnifications, and (b) the corresponding size distribution histogram. (c) XRD 
pattern and (d) UV spectrum.  
 
  The reaction route from the Se template to Cu2-xSe was composed of steps 1 and 2, 
as shown in Figure 6.1, and the whole reaction process was investigated by 
monitoring the evolution of UV-visible-near-infrared (UV-vis-NIR) spectra of the 
samples after different reaction times (Figure 6.3a). The Cu2Se nanocrystals were 
formed 3 hours after the Cu
+
 ions were mixed with nano-Se templates, which showed 
elevated absorption in the NIR region. With increasing reaction time, the absorption 
was gradually enhanced, and the spectrum showed a peak centred at 1256 nm after 
15 hours. On further extending the reaction time, a blue shift was observed in the 
absorption, indicating increasing copper deficiency and thus that the copper 
deficiency is controllable. After about 24 hours of reaction time, the absorption 
remained almost stable with only 40 nm of blue shift, as the reaction time went from 
24 h (peak centred at 1130 nm) to 30 h (peak centred at 1170 nm). Along with the 
monitoring of the UV-vis-NIR absorption spectra, their corresponding photothermal 
conversion capability was evaluated, as shown in Figure 6.3b. The same 
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concentrations of Cu2-xSe sample solutions were exposed to an 808 nm NIR laser 
with a power density of 0.75 W cm
-2
 for 10 min. Figure 6.3b clearly demonstrates the 
absorption intensity-dependent photothermal conversion of Cu2-xSe NPs, indicating 
the excellent photothermal conversion capability of the Cu2-xSe samples which have 
high copper deficiency.     
 
Figure 6.3 (a) Ultraviolet-visible-near-infrared (UV-vis-NIR) absorption spectra of 
the formation and evolution of Cu2-xSe sample. (b) Corresponding photothermal 
heating curves of Cu2-xSe sample. 
 
  As shown in the TEM images in Figure 6.4, the as-made Cu2-xSe NPs coated by 
different kinds of PVP surfactants were quite uniform and monodispersed, and their 
size could be slightly adjusted from 72.57 nm to 87.28 nm by changing the molecular 
weight (MW) of PVP. It is believed that with the increasing  K value of PVP, the 
viscosity increases, and therefore the mobility and reactivity of the surfactant-ion 
system are decreased, resulting in less nuclei and bigger growth. In addition, we also 
investigated the concentration effect on the particle size by feeding different amounts 
of the same kind of PVP-K30 (Figure 6.5). Those TEM images clearly demonstrate 
the size-tunability of the particles by simple changing the PVP concentration. The 
possible reason may be that the greater the amount of PVP molecules in the SeO2-Vc 
system, the smaller the template Se NPs that are formed due to more anchoring 
groups and more heavily steric hindrance of PVP. In order to better understand those 
reactions, the reaction procedures for step 1 and step 2 in Figure 1 can be proposed 
by Equations (1)-(2). 
Step 1:                   ;                       (1) 
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Step 1:                     
                     (2) 
Based on this optimization of the experimental conditions, we chose the Cu2-xSe NP 
samples obtained by using 160 mg PVP-K30 as stabilizer to perform the following 
Fe doping experiments.   
  In the third step in Figure 6.1, during which Fe
3+
 reacts with the Cu2-xSe NPs, we  
 
Figure 6.4 TEM images of Cu2-xSe NPs stabilized by (a) PVP-K12 (MW = 3500), (b) 
PVP-K16 (MW = 8000), (c) PVP-K30 (MW = 40,000), (d) PVP-K60 (MW = 
160,000), (e) PVP-K90 (MW = 360,000); and (f) their size obtained by counting 100 
particles of each sample.   
 
Figure 6.5 TEM images of Cu2-xSe NPs stabilized by PVP-K30 in different 
concentrations: (a) 80 mg, (b) 160 mg, (c) 320 mg, (d) 800 mg, (e) 1600 mg, and (f) 
3200 mg. (g) Statistical size of each sample.  
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tailored the precursor Cu2-xSe: Fe
3+
 molar ratio to monitor the evolution of the 
properties of the products, including their NIR plasmon absorbance, crystal 
structures, morphologies, compositions, etc.  
 
Figure 6.6 Evolution of (a) UV-vis-NIR absorbance spectra and (b) XRD patterns of 
products obtained with different precursor Cu2-xSe: Fe
3+
 molar ratios at room 
temperature (RT) without Vc and PVP. 
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As shown in Figure 6.6a, the NIR absorbance intensity of the NPs was continuously 
decreased and the LSPR absorbance peak was blue shifted with increasing amounts 
of Fe
3+
. The characteristic absorption peak disappeared with the addition of Fe
3+
 at a 
1:3 Cu2-xSe: Fe
3+
 molar ratio. According to the XRD analysis in Figure 6.6b, there 
was a progressive shift of the peak of the NPs, as the initial berzelianite (Cu2-xSe, 
JCPDS 06-0680) phase evolved to the copper iron selenide phase (CuFeSe2, JCPDS 
81-1959). In addition, a broad XRD feature in the range of 16-36º (region marked by 
red rectangle in Figure 6.6b) was observed in the Fe-doped NPs indicating the 
presence of amorphous phase.   
 
Figure 6.7 TEM images and corresponding size distributions of the nanostructures 
obtained with different Cu2-xSe:Fe
3+
 molar ratios: (a and a′) 1: 0.5, (b and b′) 1: 1, (c 
and c′) 1: 1.5, (d and d′) 1: 2, (e and e′) 1: 3, and (f and f′) 1: 6, at RT without Vc and 
PVP. 
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  A collection of TEM images of Fe-doped NPs prepared by reacting Cu2-xSe NPs 
with Fe
3+
 at different molar ratios at room temperature (RT) in the absence of Vc and 
PVP is shown in Figure 6.7. These Fe-doped NPs seems were corroded to different 
degrees, with rough surfaces that were different from that of the initial Cu2-xSe NP 
sample. A mean size reduction from 75 nm to 66 nm was found, as demonstrated in 
Figure 6.7(a′-f′), which could be attributed to the corrosion effect induced by the 
oxidizability of the Fe
3+
 ion. 
Figure 6.8 TEM and HRTEM images and the corresponding FFT patterns (insets) of 
the nanostructures obtained with different Cu2-xSe:Fe
3+
 molar ratios: (a1 and a2) 1: 0.5; 
(b1 and b2) 1: 1, inset of b1: corresponding scanning transmission electron 
microscopy (STEM) image;  (c1, c2, c3, and c4) 1: 1.5; (d1 and d2) 1: 2; (e1 and e2) 1: 
3; (f1 and f2) 1: 5, inset of f2: corresponding selected-area electron diffraction (SAED) 
pattern; and (g1 and g2) 1: 6.  
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In order to investigate the evolution of morphology and the crystal transition of the 
Fe-doped NPs more clearly, a series of high magnification TEM images and high-
resolution TEM (HRTEM) images were obtained and are presented in Figure 6.8. As 
Figure 6.8a2 shows, the as-formed Fe-doped NPs have a lattice spacing of 0.328 nm, 
corresponding to the (111) planes of the cubic berzelianite Cu2-xSe structure, JCPDS 
06-0680, which can be further supported by the fast Fourier transform (FFT) pattern 
in the inset of Figure 6.8a2. On increasing the amount of Fe
3+
 to 1: 1, the well-
defined crystalline lattice in Figure 6.8b2 has a lattice spacing of 0.318 nm that 
matches well with that of the (112) planes of CuFeSe2, JCPDS 81-1959. The FFT 
pattern in the inset of Figure 6.8b2 also supports the transition of the crystal structure 
after the Fe doping reactions. The HRTEM image in Figure 6.8c2 displays 
continuous lattice fringes with spacing of 0.322 nm, which could be indexed to the 
(112) planes of CuFeSe2 as well. In addition, 0.326 nm lattice spacing was found 
after carefully measurement of the 1: 1.5 sample in Figure 6.8c4, which can be 
referred to the (111) planes of Cu2-xSe and confirmed by its corresponding FFT 
pattern. Meanwhile, another series of lattice fringes possessing a 0.301 nm lattice 
spacing was found in the same particle from the 1: 1.5 sample, which can be 
attributed to the (103) planes of CuFeSe2, suggesting hybrid phases in this sample, i.e. 
the coexistence of Cu2-xSe and CuFeSe2 in this sample. It was considered that the 
amount of the Cu2-xSe was so small (< 5%) that it was unable to be detected by XRD. 
On further increasing the amount of Fe
3+
, the Fe-doped NPs became smaller and 
tended to form a network with necking and fusion between NPs (Figure 6.8e1,f1,g1). 
Those HRTEM images and the corresponding FFT patterns and selected-area 
electron diffraction (SAED) patterns for the 1: 2, 1: 3, 1: 5, and 1: 6 samples all 
display the detected CuFeSe2 phase features, which are consistent with their XRD 
results.             
  The composition and element distribution for Fe-doped NPs can be determined by 
high-angle annular dark field-scanning transmission electron microscopy (HAADF-
STEM) with energy dispersive X-ray spectroscopy (EDS), conducted on a JOEL 
ARM-200F. Figure 6.9 shows the EDS elemental mapping and line scan results for 
representative Fe-doped NP samples. These results reveal the coexistence of Cu, Fe, 
and Se throughout the whole NPs (Figures 6.9 and 6.10), and the molar ratio of the 
three elements Cu, Fe, and Se for each sample was determined by EDS, as shown in 
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Table 6.1, which was highly consistent with the composition analysis of Fe-doped 
NPs supported by inductively coupled plasma − optical emission spectroscopy (ICP-
OES). 
 
Figure 6.9 HAADF-STEM EDS elemental mapping images and corresponding line 
scan results using carbon-coated aluminium grids for different Fe-doped NP samples: 
(a) 1: 1, (b) 1: 1.5, (c) 1: 3, (d) 1:6. 
 
Figure 6.10 EDS spectra for different Fe-doped NP samples using carbon-coated 
aluminium grids: (a) 1: 1, (b) 1: 1.5, (c) 1: 3, (d) 1:6. 
 
In addition, the EDS line scan results further confirmed the declining Cu content 
with increasing Se content on the addition of Fe
3+
. It should also be noted that the 1:3 
sample possesses the highest content of Fe (with a normalized formula: 
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Cu0.205Fe0.0658Se), which was mainly distributed on the surfaces of the NPs, as 
displayed in Figure 6.9c and Figure 6.10c. On the basis of the XRD results, no 
crystal Se signal was detected, but there was a rise in the broad background in the 
range of 16-36º, and from the elemental analysis by EDS and ICP-OES, there is 
reason to believe that amorphous Se was produced during the Fe
3+
 oxidation 
procedure. The evolution of X-ray photoelectron spectroscopy (XPS) measurements 
for different samples was investigated as shown in    
Table 6.1 Elemental analysis by energy dispersive X-ray spectroscopy (EDS) and 





1: 0 Cu1.91Se Cu1.87Se 
1: 1 Cu1.09Fe0.0257Se Cu1.08Fe0.028Se 
1: 1.5 Cu0.925Fe0.0289Se Cu0.91Fe0.031Se 
1: 2 Cu0.501Fe0.0217Se Cu0.577Fe0.0355Se 
1: 3 Cu0.205Fe0.0658Se Cu0.204Fe0.0706Se 
1: 6 Cu0.157Fe0.0218Se Cu0.184Fe0.0247Se 
 
Figure 6.11. It should be noted that there were no noticeable differences in the XPS 
spectra in Cu 2p region and Fe 2p region for all the corresponding samples, 
suggesting that the valence states of Cu and Fe are +1 and +3, respectively. The XPS 
spectra of Se 3d obtained from the 1: 0 sample (i.e. the pure Cu2-xSe sample) and the 
elemental Se sample can be treated as the standard spectra, with Se
2-
 in Cu2-xSe and 
Se
0





 with the addition of Fe
3+
, further supporting the formation of Se in 
coexistence with Se
2-
. In order to determine the structural properties of the Se (i.e. 
crystalline Se or amorphous Se) and their relative contents, Raman spectroscopy 
characterization and thermal gravimetric analysis were performed, as depicted in 
Figure 6.12. It has been pointed out in the literature that the resonance peak of 
crystalline Se (trigonal) is located at ~236.8 cm
-1
 and that of amorphous selenium is 
centred at around 250 cm
-1
, which are attributed to the stretching vibrations of Sen 
helical chains.
[39, 40]
 In our study, the Raman spectrum of the as-prepared template Se 
NPs exhibits a peak at 236 cm
-1
, which demonstrates that the product is crystalline Se, 
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which matches well with its XRD pattern (Figure 6.2d). The Raman spectrum of pure 
Cu2-xSe (i.e. the 1: 0 sample) shows two peaks at around 236 and 255 cm
-1
, owing to 
the characteristic vibration sof the Cu-Se bond,
[41]
 which overlaps the reported peaks 
for crystalline Se and amorphous Se, respectively.      
After the Fe doping, the Fe-doped NPs demonstrate a stronger and sharper peak at 
255 cm
-1
 than that of the pure Cu2-xSe sample, possibly supporting the generation of 
amorphous Se during the Fe-doping procedure. Thermogravimetric analysis (TGA)  
 
Figure 6.11 High resolution XPS spectra of (a) Cu 2p, (b) Fe 2p, and (c) Se 3d from 
the different as-synthesized Fe-doped NP samples. 
 
Figure 6.12 (a) Raman spectra and (b) thermogravimetric analysis (TGA) curves 
(under argon atmosphere) of different samples. 
 
was performed to determine the content of amorphous Se in the Fe-doped NPs. The 
TGA curve of the Se in Figure 6.12b shows two Se evaporation stages in the ranges 
of 380 to 560 ºC and 560 to 780 ºC, because the melting point and boiling point of 
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Se are 217.0 and 684.9 ºC, respectively. Compared with the weight loss of the pure 
Cu2-xSe sample (1: 0 sample), more weight loss of Se was observed for the Fe-doped 
samples. These results roughly suggest that there is ~14.94% (i.e. 89.4%-74.46%), 
~28.13%, 41.01%, 64.24%, and 68.76% of amorphous Se in these composite 1: 1, 1: 
1.5, 1: 2, 1: 3, and 1: 6 samples, respectively. On the basis of the above results and 
explanations, the reactions taking place in step 3 and step 5 can be proposed as 
follows: 
Step 3:                                             (3) 
Step 5:                                              (4) 
 
Figure 6.13 (a) The evolution of UV-vis-NIR absorbance spectra of samples reacted 
with Fe
3+
. (b) TEM image of the final sample after the second addition of Fe
3+
 (molar 
ratio of Cu2Se : total amount of Fe
3+
 added = 1: 2). 
 
Therefore, the composition of Fe-doped NPs can be adjusted by feeding different 
amount of Fe
3+
 to tune their LSPRs. It is worth mentioning that Fe
3+
 can also be used 
to replace O2 as the oxygenant in step 2 to react with Cu2Se directly. Figure 6.13a 
demonstrates the evolution of the UV-vis-NIR absorbance spectra for samples 
reacted with Fe
3+
. After the addition of a trace of Fe
3+
 solution, the PVP-K30-Cu2Se 
(the 1 h sample after mixing Cu
+
 with the template Se NPs ) shows a significant 
enhancement of LSPRs with the colour changing from brown to green. Adding more 
Fe
3+
 leads to the damping of the LSPRs with the colour changing to black, which 
was the same phenomenon as for the sample where Cu2-xSe was reacted with Fe
3+
. 
Figure 6.13b also confirms the same corrosion effect on the surfaces of NPs induced 





 ions. Thereby, Fe
3+
 in the step 4 can rapidly oxidize the Cu2Se and then 
modify Cu2-xSe NPs. 
  The introduction of Fe ions into the vacancies of Cu2-xSe and the integration of the 
amorphous Se would endow the hybrid products with different properties and 
functions. The magnetic properties of these samples were investigated, as shown in 
Figure 6.14 and Table 6.2. The pure Se NPs show strong diamagnetic behavior at 
both 300 K [i.e. room temperature (RT)] and 5 K [i.e. low temperature (LT)], while 
the pure Cu2-xSe sample (1: 0 sample) displays paramagnetic properties at RT and 
weak ferromagnetic properties at LT. The magnetization, with a value of 0.0193 
emu/g at RT for the Cu2-xSe sample, increased to 0.0615 emu/g and 0.133 emu/g at 
RT for the 1: 0.5 sample and the 1: 1.5 sample, respectively, suggesting the 
successful introduction of Fe ions into the Fe-doped samples. On further increasing 
the amount of Fe
3+
 in the precursor, the 1: 2 sample started to demonstrate weak 
diamagnetism at RT and paramagnetism at LT because the hybrid included some 
paramagnetic phase and some diamagnetic phase. As expected, the 1: 3 and 1: 6 
samples displayed strong diamagnetic signals as the generated amorphous Se 
dominated these samples.  
  For further biological applications, surface modification for NPs was necessary to 
improve their water solubility and biocompatibility. The as-prepared 1: 1.5 sample 
was chosen to perform the following experiments due to their adequate absorption 
which supports their excellent photothermal conversion capability and their potential 
ability to be MRI contrast agents due to the presence of Fe. The surfaces of the 
hydrophilic Fe-doped sample (1: 1.5 sample) was modified by HS-PEG-SH polymer 
at room temperature. The PEGylated 1: 1.5 sample can be denoted as Cu0.91Fe0.031Se-
PEG NPs (CuFeSe-PEG, for short) according to the ICP-OES results in Table 1. 
After the non-covalent functionalization, the PEGylated NPs were well dispersed 
with a hydrodynamic size of around 78.8 nm, and there were no precipitates or 
aggregations of the water-soluble NPs, even after 3 months of storage at 4 ºC in a 
refrigerator, as shown in Figure  
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Figure 6.14 Magnetization isotherms of NPs recorded at 5 and 300 K, and 
temperature dependence of the magnetization of NPs measured in a field of 100 Oe 
for different samples, respectively: (a1 and a2) Se sample; (b1 and b2) Cu2-xSe sample; 
(c1 and c2) 1: 0.5 sample; (d1 and d2) 1: 1.5 sample; (e1 and e2) 1: 2 sample; (f1 and f2) 
1: 3 sample; (g1 and g2) 1: 6 sample. 
  
Table 6.2 Magnetic properties of different samples. 
 
Sample 
Magnetic behaviour  
300 K 5 K 
Se diamagnetic diamagnetic 
1: 0 paramagnetic weak ferromagnetic 
1: 0.5 weak ferromagnetic weak ferromagnetic + 
paramagnetic 
1: 1.5 paramagnetic weak ferromagnetic 
1: 2 weak diamagnetic paramagnetic 









6.15a, suggesting their excellent stability, which is critical for their further biological 
applications. The aqueous solutions of the CuFeSe-PEG NPs exhibit well-retained 
absorbance in the NIR region (500-1100 nm), as shown in Figure 6.15b, and their 
absorbances at 808 nm linearly increase with the concentration (Figure 6.15c), so 




 according to the 





) at the same concentration.
[16] 
The zeta potential of the CuFeSe-PEG NPs was 
measured to be a negative, nearly -22 mV, as displayed in Figure 6.15d. The 
PEGylation of the CuFeSe NPs was confirmed by their Fourier transform infrared 
spectrum (FTIR, Figure 6.16a), and the content of HS-PEG-SH coated on the 
surfaces of the CuFeSe NPs was estimated by TGA to be approximately 8.21 wt% 
(Figure 6.16b). These results demonstrate the successful modification of CuFeSe 
NPs by HS-PEG-SH. 




Figure 6.15 Characterization of as-prepared CuFeSe-PEG NPs: (a) hydrodynamic 
size at different times, (b) UV-vis-NIR absorbance spectra of nanoparticle solutions 
with different concentrations, (c) corresponding linear fitting plots of UV-vis-NIR 
absorbance versus CuFeSe-PEG concentration in aqueous solutions at 808 nm, and 
(d) zeta potential of CuFeSe-PEG NPs.    
 
Figure 6.16 (a) FTIR spectra of the HS-PEG-SH and CuFeSe-PEG NPs, and (b) 
TGA curves of CuFeSe NPs samples recorded before and after PEG modification. 
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Prior to bioapplications in vitro and in vivo of the NPs, their potential cytotoxicity 
toward 4T1 cells (murine breast cancer cells) was first investigated by a standard 
methyl thiazolyl tetrazolium (MTT) assay (Figure 6.17a). The CuFeSe-PEG NPs 
demonstrated almost no cytotoxicity towards 4T1 cells with concentrations below 60 
μg mL
-1
, and the cell viability remained 82% when the concentration was 120 μg 
mL
-1
. The broad NIR absorbance and the large extinction coefficient of CuFeSe-PEG 
NPs reveal their excellent photothermal conversion capability. Therefore, the 
temperatures of solutions with different particle concentrations were monitored when 
irradiated with an 808 nm laser (0.75 W/cm
2
) for 600 s. Figure 6.17b clearly shows 
the concentration-dependent photothermal conversion of CuFeSe-PEG NPs, and the 
temperature increments can be tuned easily as desired by simply changing their 
concentration. It is well known that photoacoustic (PA) imaging is based on 
photothermal conversion efficiency, and therefore, the remarkable photothermal 
conversion capability of the CuFeSe-PEG NPs highlights their great potential in PA 
imaging.
[32]
 The in vitro PA imaging performance of the as-prepared CuFeSe-PEG 
NPs was investigated, as shown in Figure 6.17c. As expected, the PA signal was 
significantly enhanced with the assistance of CuFeSe-PEG NPs, and the signal 
intensity was linearly increased with increasing concentration, suggesting that 
CuFeSe-PEG NPs could be a brilliant photothermal transducer for in vivo PA 
imaging. Owing to Fe  




Figure 6.17 (a) Relative cell viabilities of 4T1 cells after being incubated with 
various concentrations of CuFeSe-PEG NPs for 24 h. (b) Photothermal heating 
curves of pure water and aqueous dispersions of CuFeSe-PEG NPs at different 
concentrations under irradiation by an 808 nm laser with a power density of 0.75 W 
cm
-2
 for 600 s. (c) In vitro photoacoustic signal intensity linearly fit to the 
concentration of Cu for CuFeSe-PEG NPs aqueous solutions; inset: the 
corresponding PA images. Inset: the corresponding PA images. (d) In vitro T2-
weighted magnetic resonance (MR) imaging using different concentrations of 
CuFeSe-PEG NPs. The transverse (r2) relaxivities of CuFeSe2 NCs per Fe ion and 









respectively. Inset: the corresponding MR images. 
 
doping, the magnetic resonance (MR) imaging capabilities of the NPs dissolved in 
water were also measured. T2-weighted magnetic resonance (MR) images of 
CuFeSe-PEG NP solutions were acquired on a 3.0 T clinical MR scanner equipped 
with a small animal imaging coil, revealing the concentration-dependent darkening 
effect. The transverse (r2) relaxivity was determined from the slope of the linear plot 
of 1/T2 versus Fe concentration (Figure 6.17d). From the plot, the r2 value was 
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 for per Cu0.91Fe0.031Se 
NP. To further demonstrate 
 
Figure 6.18 (a) In vivo tumour PA images from a 4T1 tumour-bearing mouse, 
acquired before and after intravenous injection of CuFeSe-PEG NP solution (dose = 
7 mg/kg) at different time points, and (b) corresponding time-dependent PA signal 
intensity of the tumour. (c) In vivo MR images of a mouse bearing a tumour 
(highlighted by the red circles) before and after intratumoral injection of CuFeSe-
PEG NPs. 
 
the in vivo MR imaging of CuFeSe-PEG NPs, a mouse bearing a 4T1 tumor was 
intratumorally injected with CuFeSe-PEG NPs (dose = 10 mg/kg). After 1 hour, the 
tumor in the mouse was imaged using the 3.0 T clinical MR scanner, and the image 
showed darkening effects when compared with the images before injection (Figure 
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6.18c), suggesting that the CuFeSe-PEG NPs can serve as an MR contrast agent. 
Besides the MR imaging, the in vivo PA imaging capability of CuFeSe-PEG NPs 
was evaluated, as shown in Figure 6.18a, b. Mice bearing 4T1 tumors were 
intravenously injected with 200 μL CuFeSe-PEG NPs solution (7 mg/kg for the 
dose), and the PA images at different times post-injection are shown in Figure 6.18a. 
The tumor contrast was gradually enhanced with time after injection and reached its 
maximum at 8 h post-injection, due to the accumulation of CuFeSe-PEG NPs in the 
tumor through the enhanced permeability and retention (EPR) effect.
[42, 43]
 The signal 
intensity is further quantified in Figure 6.18b, which clearly shows the gradual 
increase to the maximum, followed by a decrease.    
 
Figure 6.19 In vivo photothermal therapy for tumor. (a) Infrared thermal images and 
(b) the tumor heating curves of mice bearing 4T1 tumors after intravenous injection 
of CuFeSe-PEG NPs (7 mg/kg). (c) H&E staining of tumor sections from different 
groups of mice sacrificed at day 3 of treatment. (d) The relative tumor volumes 
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normalized to their initial volumes, and (e) survival curves and (f) body weights of 
different groups of mice after various treatments. 
 
  Encouraged by the PA imaging, we further investigate the feasibility of in vivo 
photothermal ablation of cancer cells by using the CuFeSe-PEG NPs as a 
photothermal agent. Mice bearing 4T1 tumors were intravenously injected with 
CuFeSe-PEG NPs (7 mg/kg) and then irradiated for 5 minutes by an 808 nm NIR 
laser with a power density of 1.5 W∙cm
-2
 at 8 h post-injection. The temperature 
change in the tumor area under NIR irradiation was monitored using an IR thermal 
camera. Figure 6.19a and b show the time-dependent thermographic images and 
temperature curves, respectively, for mice treated with CuFeSe-PEG NPs or 
phosphate buffered saline (PBS). Obviously, the CuFeSe-PEG NPs-mediated group 
exhibited a much higher hyperthermia effect, and the maximum temperature after 5 
min of irradiation reached 64 °C, which is sufficient to induce irreversible damage to 
the cancer tissue. It has been reported that even just a short-time exposure (about 5 
min) of cancer tissue to hyperthermia above 48 °C can induce massive cancer 
destruction.
[44]
 To confirm the phototherapeutic effect, tumor tissues were collected 
and sliced for hematoxylin and eosin (H&E) staining (Figure 6.19c). It was found 
that the tumor cells of mice treated with CuFeSe-PEG injection were severely 
damaged when compared with the control group. The in vivo therapeutic efficacy of 
CuFeSe-PEG induced PTT was then investigated. Tumor-bearing nude mice were 
randomly divided into five groups (n = 6, each group). For the treatment group 
(CuFeSe+Laser group), mice bearing 4T1 tumors were intravenously injected with 
CuFeSe-PEG (dose = 7 mg/kg) for 8 h circulation and then irradiated using an 808 
nm laser at a power density of 1.5 W∙cm
-2
 for 5 min. The other three control groups 
included: (1) mice irradiated with the NIR laser after injection of PBS (PBS+Laser 
group); (2) mice injected with CuFeSe-PEG NPs only (CuFeSe group); and (3) mice 
injected with PBS only (PBS group). The tumor sizes and appearance, and the body 
weights of the mice were measured every two days. The tumors in all three control 
groups exhibited a similar growth speed, indicating that neither CuFeSe-PEG 
injection nor laser irradiation of the tumors alone would affect the tumor growth 
(Figure 6.19d and Figure 6.20). In contrast, tumors in mice treated with both 
CuFeSe-PEG and laser irradiation were completely killed after the PTT treatment, 
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without tumor re-growth within 30 days (Figure 6.19e and Figure 6.20). Moreover, 
the body weights of mice with different treatments demonstrated no obvious change 
during our experiments, suggesting the biosafety of CuFeSe-PEG at the current dose 
(Figure 6.19f).      
 
Figure 6.20 Representative images of mice taken at different times post-treatment.  
 
 
Figure 6.21 Representative H&E stained images of major organs from mice treated 
with intravenously injected CuFeSe-PEG NPs (top row) and control mice (bottom 
row), taken 30 days after photothermal therapy. Yellow circles represent tumor 
metastasis regions.  
 
  To further confirm the successful treatment of tumors without metastasis, the major 
organs, including the heart, liver, spleen, lung, and kidney, were harvested at day 30 
after treatment and stained with H&E. As displayed in Figure 6.21, there are obvious 
metastases and inflammatory lesions in the livers and lungs of mice (yellow circles 
regions) from the control group (mice treated with PBS, CuFeSe, or laser irradiation 
after administration of PBS). In contrast, no evident inflammation or damage is 
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observed in any of the major organs of the mice treated with laser irradiation after 
injection of CuFeSe-PEG NPs, confirming the great feasibility of photothermal 
therapy for ablation of tumors by using CuFeSe-PEG NPs as a therapeutic agent. 
 
6.4 Conclusions 
  In summary, a facile ambient aqueous method was developed to prepare Fe-doped 
Cu2-xSe NPs with tunable LSPRs. The intensity of the LSPR absorption exhibited 
Fe
3+
-dependence, and the composition of the homogeneous alloyed NPs can be tuned 
simply, by varying the amount of the doped Fe
3+
 ion precursor. PEGylated Fe-doped 
NPs have been proved to be the excellent contrast agents, not only for PA imaging 
due to their NIR LSPRs absorption, but more importantly the NPs were also used 
successfully for MRI. In addition, CuFeSe-PEG NPs can be used as an excellent 
therapeutic agent for in vivo PTT of tumors. Therefore, our functional metal ion 
doping approach developed here could be extended to the fabrication of other alloyed 
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Chapter 7 Conclusions and Perspectives 
 
7.1 Conclusions 
In this doctoral work, different fabrication routes are demonstrated for construting 
three transition metal chalcogenides based molecular probes. The influence of 
different synthetic parameters on the quality of final probe is comprehensively 
investigated. In addition, their applications on biomedicine including bioimaging, 
photothermal therapy are evaluated. The general conclusions are given as following: 
(1) A series of size-tunable, core-shell, novel watermelon-like fluorescent mSQS 
NPs were successfully synthesized. The shell thickness could be tuned from 0 to 32 
nm by adjusting the amount of silica precursor, the solvent ratio, and the amount of 
catalyst. The solid silica shell coating significantly improved the chemical stability of 
the QDs inside. The fluorescence of CdTe QDs is strongly influenced by minor 
variation of the solution pH. Only 40% and 10% of fluorescence were retained when 
the pH of the CdTe QD solution was changed from 7 to 3 and 13, respectively. By 
contrast, the fluorescence of mSQS NPs  is stable even in a strongly acidic solution 
(pH = 1) and no obviously aggregation was observed in the pH range of 1 to 13, 
owing to the protection of outer soild silica shell. Moreover, the resultant mSQS NPs 
investigated with the MTT assay, CLSM images, dynamic cell uptake and in vivo 
fluorescence imaging exhibit low toxicity, high stability, and strong fluorescence for 
bioimaging. 
(2) The novel multimodal imaging-guided PTT nanotheranostic agent based on 
ultra-small PEGylated Cu2-xSe NPs was successfully fabricated via a facile aqueous 
route. The Cu2-xSe NPs possess a strong, significant NIR LSPR due to the high 
copper deficiency. The resultant NPs exhibit high stability and biocompatibility both 
in vitro and in vivo. More importantly, they show highly efficient photothermal 
conversion for PA imaging and PTT in vitro and in vivo, and large X-ray attenuation 
coefficients for CT imaging, as well as multifunctional groups for coordinating with 
radioisotopes for SPECT imaging. Both the in vitro and the in vivo results 
demonstrate that ultra-small PEGylated Cu2-xSe NPs could serve as an ideal 
multifunctional platform for multimodal imaging-guided photothermal therapy of 
cancer. 
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 (3) Based on the understanding of the above studies for Cu2-xSe, we developed a 
facile and chelator-free doping method for constructing Fe-doped Cu2-xSe 
nanoparticles. The position and intensity in near-infrared localized surface plasmon 
resonance in the alloyed nanostructure can be tuned by altering the feeding amount 
of the Fe
3+
 ions precursors. Owing to their tunable near-infrared absorption and Fe 
doping, the hybrid nanostructure was demonstrated be a novel nanotheranostic agent 
for effective deep-tissue photoacoustic imaging, magnetic resonance imaging, and 
photothermal therapy of cancer.                                                          
 
7.2 Perspectives 
    In this thesis, we have discussed in detail the synthesis and application of 
transition metal based probe, especially for Cu2-xSe NPs, for in vivo cancer imaging, 
PTT, image-guided therapy. Compared to other inorganic nanomaterials, such as 
gold nanoshells, gold nanorods, carbon nanotubes and CuS NPs, Cu2-xSe NPs have 
not been studied extensively. However, the number of publications dealing with Cu2-
xSe NPs in biomedical applications is growing. Because of their multifunctional 
characteristics, Cu2-xSe NPs are ideal materials for theranostic applications: they can 
serve as nuclear tracers or contrast agents for various imaging and diagnostic 
techniques; they can destroy cancer cells through photothermal effects; they also can 
release drugs in a controlled manner in response to an external stimulus. 
Significantly, all these features can be readily integrated in a single system to fulfill 
both diagnostic and therapeutic requirements. 
Despite many positive results in vitro and in vivo, much more effort should be 
focused on the in vivo properties and disposition of copper based NPs, including their 
pharmacodynamics, pharmacokinetics, and potential long-term toxicity before 
appropriated imaging and therapeutic strategies are tested in cancer patients. With 
regard to the toxicology of transition metal based probe, the data available to date are 
limited and fragmentary; more in vivo experiments are needed for a comprehensive 
understanding and assessment of their toxicity. Moreover, it would be interesting and 
important to compare the different transition metal based probes side-by-side, to 
evlauate the advantages and limitations of each probe, as well as identify the most 
promising ones with high photothermal conversion efficiency, optimal in vivo 
pharmacology, and manageable long-term toxicity. 
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